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Assisted Reproductive Technologies (ART) have rapidly evolved over the past decades. 
However, some forms of infertility remain difficult to overcome, with certain female-related 
factors particularly challenging to address. Overall, 0.1-1% of women exhibit severe oocyte 
maturation resistance in which pregnancy can rarely be achieved, while 1-5% of patients 
experience complete fertilization failure following intracytoplasmic sperm injection (ICSI). 
Furthermore, oocyte ageing, due to advanced female age (reproductive oocyte ageing) and 
prolonged in vitro culture (post-ovulatory ageing) is associated with decreased fertilization 
capacity and poor embryo quality – ultimately impairing ART treatment outcomes. At present, 
patients with recurrent maturation resistance and a lack of mature oocytes can only resort to 
oocyte donation, while assisted oocyte activation (AOA) may be applied for patients with 
fertilization failure. The treatment for reproductive oocyte ageing is also very limited, with 
antioxidant administration currently the only available treatment. Investigating the underlying 
mechanisms of oocyte maturation resistance, AOA and oocyte ageing is of vast importance 
and may shed light on the physiology of these processes in human, ultimately facilitating more 
effective diagnostic and therapeutic approaches.  
 
Successful oocyte maturation and activation are mediated by inositol 1,4,5-trisphosphate 
receptors (IP3Rs). These generate characteristic Ca2+-oscillations in the oocyte, which are 
either released spontaneously or triggered by the sperm factor phospholipase C zeta. 
Disrupted Ca2+ signaling is linked to reduced fertilization rates and impaired embryo 
developmental potential. In mouse, altered Ca2+ signaling is reported in maturation resistant 
oocytes, failed to fertilized oocytes, as well as in vitro aged oocytes. This PhD research is 
focused on Ca2+-signaling deficiencies, which affect these three processes in both human and 
mouse oocytes.  
 
We primarily investigated the nuclear normality of human oocytes resistant to meiotic 
maturation and further examined treatment outcomes from a patient group exhibiting 
maturation resistance. In addition, we employ a mouse model to further study meiotic 
maturation resistance, allowing for a comprehensive analysis of Ca2+-signaling related 
mechanisms. Furthermore, we define external factors present in culture media that influence 
ionomycin triggered AOA. Additionally, we investigate the efficiency of using strontium (Sr2+) as 
a potential regulator of the Ca2+-signaling pathway and a clinical AOA agent. Finally, we 
consider the difference of Ca2+ oscilation patterns in oocytes resulting from post-ovulatory and 
reproductive ageing. 
 
Firstly, we defined patients presenting with an abnormally high number of immature oocytes at 
retrieval (>40%). These patients were more likely to exhibit severe maturation resistance. We 
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recruited these patients as the Study group, while patients presenting with a normal number of 
mature oocytes at retrieval (≥ 60%), were termed the Control group. Donated immature 
oocytes from both groups were collected. Following in vitro culture, oocytes were classified as 
maturation resistant and in vitro matured (IVM). Treatment outcomes were evaluated in both 
the Study and Control groups based on the presence of maturation resistant oocytes. Overall, 
similarly high aberrant spindle-chromosome complex configurations were observed in 
maturation resistant oocytes from both Study and Control groups. IVM oocytes from the Study 
group revealed a significantly higher percentage of misaligned chromosomes compared to 
Controls. Remarkably, Study patients with at least one maturation resistant oocyte, showed 
significantly reduced cumulative pregnancy and live birth rates compared to Control 
maturation resistant patients. To further investigate this etiology, we applied a mouse model for 
maturation resistance and revealed defective Ca2+-signaling of maturation resistant oocytes at 
germinal vesicular breakdown (GVBD) and during parthenogenetic activation. In conclusion, 
appropriate treatment strategies, including clinical utilization of IVM oocytes from the Study 
group patients, warrant further investigation.  
 
Secondly, we investigated the efficiency of two chemical AOA agents, ionomycin and Sr2+ to 
induce Ca2+ rises in both human and mouse oocytes. The effect of ionomycin and external 
Ca2+ concentrations on the Ca2+-oscillatory pattern of both mouse and human oocytes was 
investigated, as well as the developmental potential of embryos generated from these oocytes. 
In mouse, we demonstrated that the application of 5μM ionomycin with KSOM or 10µM 
ionomycin in Ca2+-free KSOM, significantly reduced the amount of Ca2+ flux and resulted in 
blastocyst formation failure compared to 10μM ionomycin with KSOM. This highlights the 
importance of optimal culture conditions during the oocyte activation process. Moreover, the 
Ca2+ rise in human oocytes provoked by 10µM ionomycin increased together with the total 
calcium concentration present in the commercial embryo culture medium used during AOA. 
More specifically, we observed reduced mouse embryonic developmental efficiency when 
performing AOA during 10 minutes in SAGE and Vitrolife medium in contrast to COOK medium, 
while embryo culture was performed in identical conditions (KSOM-Cook Blastocyst).   
 
Furthermore, we demonstrated that despite the presence of its potential activating channel 
(TRPV3, transient receptor potential cation channel V3), Sr2+ failed to mediate Ca2+ rises in 
human oocytes. Both agonists of TRPV3, 2-aminoethoxydiphenyl borate (2-APB) and 
carvacrol promoted a single Ca2+ transient and activated more than half of the human oocytes 
exposed to these agents. However, Sr2+ was not capable of inducing Ca2+ rises and activation 
in human oocytes. The pattern of localization of the TRPV3 protein in human oocytes differed 
from the reported pattern in mouse oocytes. Therefore, the clinical application of Sr2+ to 




Finally, both Ca2+ oscillation patterns and embryo developmental potential, were investigated 
following the exposure of reproductive-aged, post-ovulatory aged IVM and in vivo matured 
(IVO) mouse oocytes, to Sr2+. We found variable disruptions to Ca2+ oscillation patterns in 
post-ovulatory aged IVO oocytes and reproductive-aged IVM and IVO oocytes, during 
activation. Moreover, we revealed that the altered Ca2+ oscillation pattern of post-ovulatory 
aged IVO oocytes, further impaired embryo development. However, this was not the case in 
reproductive-aged IVM and IVO mouse oocytes. Furthermore, by extending the in vitro culture 
time to 20-24 hours post GVBD, Ca2+ oscillatory ability and further blastocyst development 
were restored in IVM mouse oocytes with impaired Ca2+ oscillatory ability.  
 
Overall, these findings support the involvement of altered Ca2+ signaling in maturation 
resistant oocytes, oocytes undergoing AOA treatment, post-ovulatory and reproductive-aged 








































































Geassisteerde reproductieve technologieën (Assisted Reproductive Technologies, ART) zijn 
de laatste jaren snel geëvolueerd. Toch blijven bepaalde vormen van, meestal 
vrouwelijk-geassocieerde, infertiliteit moeilijk te behandelen. Van alle vrouwen vertoont 0.1-1% 
ernstige eicel maturatie resistentie, waardoor er zelden een zwangerschap kan bekomen 
worden, terwijl er bij 1-5% een compleet bevruchtingsfalen na intracytoplasmatische sperma 
injectie (ICSI) plaatsvindt. Daarnaast zijn eicel veroudering door een oudere leeftijd van de 
dame in kwestie (reproductieve eicel veroudering) alsook door langdurige in vitro cultuur 
(post-ovulatoire eicel veroudering) bijkomende factoren die geassocieerd worden met een 
verlaagde bevruchtings capaciteit en verminderde embryo kwaliteit. Tegenwoordig kunnen 
patiënten met een eicelmaturatie resistentie en een tekort aan mature functionele eicellen 
enkel een beroep doen op eicel donatie. Geassisteerde eicel activatie (assisted oocyte 
activation, AOA) toegepast kan worden bij patiënten waarbij er gefaalde bevruchting 
plaatsvindt. De behandeling van reproductieve veroudering is daarnaast ook erg gelimiteerd, 
waarbij men tegenwoordig enkel de inname van antioxidanten kan adviseren. Het onderzoek 
naar de onderliggende mechanismen van eicel maturatie resistentie, AOA en eicel 
veroudering is van groot belang, om meer inzicht te verkrijgen in deze processen, en er 
uiteindelijk tot een meer effectieve diagnose en therapeutische behandeling kan gekomen 
worden.  
 
Succesvolle eicel maturatie en activatie worden geregeld door inositol 1,4,5-trifosfaat 
receptoren (IP3Rs). Deze receptoren genereren karakteristieke Ca2+ oscillaties in de eicel, die 
ofwel spontaan tot stand komen ofwel uitgelokt worden door de zaadcel factor fosfolipase C 
zeta. Abnormale Ca2+ signalisatie is verbonden met gereduceerde bevruchtingsratio’s en een 
verlaagd embryo ontwikkelingspotentieel. In muis werd een gewijzigde Ca2+ signalisatie 
gerapporteerd in maturatie resistente eicellen, eicellen met gefaalde fertilisatie en in vitro 
verouderde eicellen. Dit doctoraatsonderzoek focust op Ca2+ signalisatie defecten die deze 
drie boven vernoemde processen beïnvloeden in zowel humane als muizen eicellen.  
 
Eerst onderzochten we de normaliteit van de kern in humane eicellen die resistent zijn aan 
meiotische maturatie en keken we naar de klinische uitkomstparameters  van deze 
patiëntengroep. Daarnaast gebruikten we ook een muismodel om meiotische maturatie 
resistentie verder te bestuderen, hetgeen een duidelijke analyse van de Ca2+ signalisatie 
gerelateerde mechanismen toelaat. Voor de toepassing van AOA hebben we nagegaan welke 
externe factoren die aanwezig zijn in het cultuurmedium die ionomycine getriggerde AOA 
kunnen beïnvloeden. Hierbij onderzochten we ook de efficiëntie van strontium (Sr2+) als 
potentiële regulator van de Ca2+ signalisatie pathway en als klinisch AOA agens. Finaal 
bekeken we de verschillen tussen Ca2+ signalisatie patronen in eicellen die post-ovulatoire en 
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reproductieve veroudering vertonen.  
 
We startten met het definiëren van patiënten met een abnormaal hoog aantal immature 
eicellen bij pick-up (>40%), aangezien deze groep met een grotere waarschijnlijkheid ernstige 
eicel maturatie resistentie zal vertonen. Deze patiënten werden geïncludeerd in de studie 
groep, terwijl patiënten met een normaal aantal mature eicellen bij pick-up deel uitmaakten van 
de controle groep. Gedoneerde immature eicellen van zowel de studie als de controle groep 
werden gecollecteerd. Na in vitro cultuur werden deze eicellen ingedeeld in twee groepen, 
maturatie resistent of in vitro gematureerd (IVM). Klinische uitkomstparameters werden zowel 
in de studie als de controle groep geëvalueerd op basis van de aanwezigheid van maturatie 
resistente eicellen. Er werd een gelijkaardig hoog aantal spoelfiguur-chromosoom complex 
abnormaliteiten geobserveerd in zowel de studie als de controle groep. IVM eicellen van de 
studie groep vertoonden een significant hoger percentage aan fout gealigneerde 
chromosomen in vergelijking met de controles. Opmerkelijk was dat patiënten met minstens 
één maturatie resistente eicel een significant lagere ratio vertoonden in cumulatieve 
zwangerschappen en levende geboortes in vergelijking met controle patiënten. Om dit 
fenomeen verder te onderzoeken pasten we een muizenmodel voor maturatie resistentie toe, 
waarbij er een defectieve Ca2+ signalisatie bij maturatie resistente eicellen tijdens germinale 
vesikel breakdown (GVBD) en tijdens parthenogenetische activatie aan het licht kwam. We 
kunnen concluderen dat desbetreffende behandelingsstrategieën, inclusief het klinisch gebruik 
van IVM eicellen, verder onderzocht moeten worden. 
 
Daarna onderzochten we de efficiëntie waarmee twee chemische AOA agentia, ionomycine en 
strontium (Sr2+), Ca2+ vrijstelling kunnen induceren in humane en muizen eicellen. Het effect 
van ionomycine en externe Ca2+ concentraties op het Ca2+ vrijstellingspatroon van zowel muis 
als humane eicellen werd onderzocht, alsook het ontwikkelingspotentieel van de embryo’s die 
vanuit deze eicellen ontwikkelden. In muis konden we aantonen dat de toepassing van 5μM 
ionomycine in KSOM medium of 10µM ionomycine in Ca2+-vrij KSOM medium, de hoeveelheid 
Ca2+ vrijstelling significant reduceerde in vergelijking met 10μM ionomycin in KSOM, hetgeen 
resulteerde in een gefaalde blastocyst vorming. Deze vaststelling wijst op het belang van de 
optimale cultuurcondities tijdens het eicelactivatie proces. De Ca2+ stijging in humane eicellen 
veroorzaakt door 10µM ionomycine steeg samen met de totale Ca2+ concentratie in het 
commerciële embryo cultuur medium dat tijdens AOA gebruikt werd. We observeerden een 
gereduceerde efficiëntie in de embryo ontwikkeling in muis na AOA in SAGE en Vitrolife 
medium ten opzichte van COOK medium, hoewel de embryocultuur in dezelfde cultuur 
omstandigheden plaatsvond (KSOM/Cook Blastocyst)  
 
Verder toonden we ook aan dat Sr2+ faalde om de Ca2+ vrijlating in humane eicellen te 
induceren, ondanks de aanwezigheid van zijn potentieel activerend proteïne, TRPV3 
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(transient receptor potential cation channel V3). Beide agonisten van TRPV3, 
2-aminoethoxydifenyl boraat (2-APB) en carvacrol, promootten één enkele Ca2+ piek en 
activeerden meer dan de helft van de humane eicellen die blootgesteld werden aan deze 
agentia. Toch was Sr2+ niet in staat om Ca2+ vrijstelling en activatie te induceren in humane 
eicellen. Het patroon van localisatie van TRPV3 eiwit in humane eicellen verschilde van het 
gerapporteerde patroon in muizen eicellen. Daarom wordt de klinische toepassing van Sr2+ om 
bevruchtingsfalen na ICSI te behandelen in vraag gesteld.  
 
Finaal werd zowel het Ca2+ oscillatiepatroon als het embryo ontwikkelingspotentieel 
onderzocht na blootstelling van reproductief verouderde, post-ovulatoire verouderde IVM en in 
vivo gematureerde (IVO) muizen eicellen aan Sr2+. We vonden variabele onderbrekingen in 
het Ca2+ oscillatiepatroon na activatie van post-ovulatoire verouderde IVO eicellen en 
reproductief verouderde IVM en IVO eicellen. We vonden ook dat het veranderde Ca2+ 
oscillatiepatroon van post-ovulatoire verouderde IVO eicellen de embryo ontwikkeling verder 
negatief beïnvloedde. Dit werd niet geobserveerd in reproductief verouderde IVM en IVO 
muizen eicellen. Verder konden we door de in vitro cultuur uit te breiden tot 20-24h post GVBD, 
de Ca2+ vrijlating en blastocyst ontwikkeling herstellen in IVM muis eicellen met een 
verminderd Ca2+ vrijstellingspotentieel. 
 
Samengevat ondersteunen deze bevindingen het belang van Ca2+ signalisatie in maturatie 
resistente eicellen, eicellen die AOA ondergaan, post-ovulatoire en reproductief verouderde 
eicellen, en brengen ze mogelijke diagnostische en therapeutische benaderingen voor 





























































1. General Introduction  
 
1.1.  The general physiological role of calcium  
Calcium ion (Ca2+) is known as a ubiquitous second messenger that regulates numerous 
cellular processes, ranging from secretion, contraction, metabolic enzymes, gene expression, 
to sensory signaling cascades and programmed cell death (Debant et al., 2015). Cells exhibit 
an extremely low permeability to inorganic Ca2+, due to the presence of a surrounding 
phospholid bilayer. To regulate cellular processes, an elevation in the concentration of 
intra-cytoplasmic Ca2+ by Ca2+ influx through the plasma membrane or Ca2+ release from 
intracellular Ca2+ stores, as well as the cross-talk between the Ca2+ and cyclic adenosine 
monophosphate (cAMP) signaling pathways are all required (Toescu and Dayanithi, 2012). 
Interestingly, different cytosolic Ca2+ signaling pathways are processed by excitable and 
non-excitable cells (Berridge, 2016) (Figure 1).  
 
Figure 1. Distinct Ca2+ signaling pathways in excitable and non-excitable cells. 








In excitable cells, the primary Ca2+ signaling depends on the entry of Ca2+ through 
voltage-operated channels (VOCs). This is a class of transmembrane proteins, which is 
activated by alterations in the electrical membrane potential. This signaling pathway regulates 
processes such as memory formation in neurons, insulin secretion from beta cells and 
contraction in muscle cells (Berridge, 2016) (Figure 1). Moreover, receptor-operated Ca2+ 
channels (ROCs) also play a role. For instance, ROCs are responsible for the Ca2+ entry into 
smooth muscle cells, to sustain cellular activation (Gibson et al., 1998) and ascribe the Ca2+ 
inflow in neurons, the classic example of an excitable cell (Moccia et al., 2015). The function of 
ROCs is modulated crucially on the action of agonists, antagonists and particular compounds 
that regulate receptors. Recently, the emergence of the transient receptor potential (TRP) 
cation family underpins different ROCs pathways in excitable cells. Furthermore, plasma 
membrane store-operated Ca2+ entry (SOCE) channels are also involved in Ca2+ influx to refill 
intracellular Ca2+ stores of excitable cells. The activation of SOCE engages certain, specific 
Ca2+-dependent processes, such as neuronal excitation (Moccia et al., 2015). Besides the 
Ca2+ permeable channels, intracellular localized Ca2+ signaling from the endo- and 
sarcoplasmic reticulum (ER/SR) are also important for generating Ca2+ signals in excitable 
cells. In this regard, Ca2+ release by ryanodine receptors (RYRs) in internal stores enhances 
primary Ca2+ signaling generated by VOCs (Berridge, 2016).  
 
Generally, non-excitable cells have only ROCs, and show a lack of VOCs. The primary Ca2+ 
signals in non-excitable cells are generated by inositol 1,4,5-trisphosphate (IP3), control 
processes as diverse as metabolism, secretion, fertilization and proliferation (Berridge, 2009; 
Mikoshiba, 2015) (Figure 1). To form IP3, external stimuli, for instance, neurotransmitters, 
hormones and growth factors activate either the G protein-coupled receptors or the protein 
tyrosine kinase-linked receptors that are coupled to different phospholipase C (PLC) isoforms 
(Cocco et al., 2015). Further downstream, the activated PLC hydrolyzes the precursor lipid 
phosphatidylinositol 4,5-bisphosphate (PIP2) to form both diacylglycerol (DAG) and IP3. The 
IP3 functions by further binding to the IP3 receptors (IP3Rs) to release Ca2+ from the ER into 
the cytoplasm, therefore, elevate the Ca2+ load (Fedorenko et al., 2014; Taylor et al., 2014; 
Mak and Foskett, 2015; Mikoshiba, 2015) (Figure 2). This IP3/Ca2+ signaling pathway further 
plays a modulatory role in the excitable pathway to induce subtle changes in the generation 










Figure 2. IP3 binding to IP3R. Figure reprinted with permission. (Berridge, 2016) 
 
 
The characteristic feature of the IP3/Ca2+ signaling pathway is that it normally generates Ca2+ 
release as oscillations. When sustained Ca2+ release is required for a longer period, repetitive 
increases occur as Ca2+ oscillations (Berridge, 1993; Fewtrell, 1993). The oscillations have 
been described in multiple cell types, from hepatocytes (Woods et al., 1986; Rooney et al., 
1989), osteoclasts (Takayanagi et al., 2002), astrocytes (De Pittà et al., 2009), renal epithelial 
cells (Aizman et al., 2001), mesoepithelial cells (Pecze and Schwaller, 2015), endothelial cells 
(Moccia et al., 2003) to oocytes (Cuthbertson and Cobbold, n.d.; Cheek et al., 1993).  
 
The theory of oscillator was suggested initially as the periodic sensitization of the IP3R, which 
is caused by the refilling of the intracellular store through the external Ca2+ entry (Berridge, 
2007). Later, it has been complemented by the re-uptake of Ca2+ into the ER following each 
transient. More recent studies indicate that the oscillatory mechanism may either involve 
complex feedbacks regarding IP3 and Ca2+ regulations, as the level of IP3 oscillates together 
with the level of Ca2+ (Hajnóczky and Thomas, 1997; Politi et al., 2006; Zhang et al., 2011; 
Gaspers et al., 2014) or is triggered by a constant concentration of IP3, independent of the 
Ca2+ oscillation period (Sneyd et al., 2017). Gene expression is initiated more effectively by 
Ca2+ oscillations than by a steady Ca2+ release (Li et al., 1998). Moreover, the frequency of 
Ca2+ oscillations regulates the activity of kinases, for instance protein kinase CaM kinase II, 
and thereby contributes to multiple cellular processes, such as neuronal plasticity, cell 




1.2. IP3/Ca2+ signaling during oocyte maturation and early embryo formation 
 
1.2.1 The story of oocyte maturation and oocyte activation  
In mammals, oogenesis initiates at the embryonic stage when primordial germ cells 
commence meiosis and develop to primary oocytes (Baltus et al., 2006). By birth, females 
have developed a finite number of primary oocytes arrested in meiotic prophase that comprise 
their lifespan egg supply (Lei and Spradling, 2013). At puberty, an increase of luteinizing 
hormone triggers the resumption of meiosis. It is marked by the breakdown of the large 
nuclear membrane of the oocyte, defined as germinal vesicle breakdown (GVBD).  
 
The resumption and progression of meiosis refers to both nuclear and cytoplasmic meiotic 
maturation. To process nuclear maturation from metaphase of meiosis I (MI) to metaphase of 
the second meiotic division (MII) arrest (Eppig, 1996), the chromosomal DNA is replicated 
(MacLennan et al., 2015). At the MI stage, homologous pairs move together along the 
metaphase plate by means of the meiotic spindle, and homologous chromosomes are pulled 
apart by shortening of the spindle in anaphase I (Page and Hawley, 2003; Baudat et al., 2013). 
Once separated, the nuclear membrane reforms and the spindle structure depolymerizes in 
telophase I, and a 2n haploid number of chromosomes is left by extruding the first polar body 
(PB) containing half the genetic material, but very little of the cytoplasmic contents (Sharma et 
al., 2013). Following PB extrusion, oocytes progress uninterruptedly to the MII stage and 
become arrested for a second time (Figure 3). Following both nuclear and cytoplasmic 
maturation, the oocyte is subsequently released from its associated somatic follicular 
compartment at the time of ovulation.  
 
Figure 3. From oocyte meiosis maturation to early embryo formation. Figure reprinted 








Cytoplasmic maturation occurs simultaneously with nuclear maturation, which consists of a 
number of changes necessary for acquisition of meiotic competence and subsequent oocyte 
activation and embryonic development (Sharma et al., 2013). This entails the relocation of 
organelles and cytoskeleton, the accumulation of mRNAs, extensive protein synthesis and 
subsequent post-translational modifications (Epel, 1990; Carroll et al., 1996).  
 
The protein changes regulate the resumption of meiosis. The re-initiation of meiosis coincides 
with a drop in intra-cytoplasmic cAMP concentration (Schultz et al., 1983; Vivarelli et al., 1983), 
which regulates the key protein complex Meta-phase promoting factor (MPF) that is formed 
from the Cyclin-Dependent Kinase 1 (CDK1) and kinase cyclin B (Jones, 2004) (Figure 4). A 
high concentration of intra-cytoplasmic cAMP activates protein kinase peA (PKA) (Viste et al., 
2005), which in turn, phosphorylates the phosphatase CDC25 and ensures the activity of 
CDK1 (Jones, 2004). The reduced cAMP level inhibits MPF activity, and as a direct 
consequence, meiotic maturation resumes (Jones, 2004).  
 
Figure 4. Activity of MPF during oocyte meiotic maturation. Figure reprinted with 
permission. (Molecular & Developmental Biology (BIOL3530)) 
 
 
Beside MPF, the balance between oocyte arrest and progression also depends on alternating 
levels of another key mediator: anaphase-promoting complex/cyclosome (APC/C). 
Resumption of meiosis from the diplotene arrest is controlled by the activation of MPF (Jones, 
2004). Exit out of prophase I and entry into M phase of meiosis I is hallmarked by the GVBD 
and the formation of the meiotic spindle. When the chromosomes are all properly aligned, the 
spindle assembly checkpoint (SAC) signal is extinguished, resulting in APC/C activation 
(Homer, 2013) (Figure 5). Thereafter, the oocyte progresses to the MII stage and remains 







Figure 5. APC/C and MPF activity during oocyte to embryo transients. Figure reprinted 
with permission. (Hörmanseder et al., 2013) 
 
 
Ca2+ signaling pathways are facilitated with these cytoplasmic changes. During cytoplasmic 
maturation, Ca2+ stored in the ER is elevated, while the number of Ca2+ channels, IP3Rs, and 
their sensitivity to IP3 are also increased (Murnane and DeFelice, 1993; Xu et al., 2003). 
 
During oocyte maturation, the primary Ca2+ store (ER) in the oocytes, dynamically changes 
during oocyte maturation. In GV oocytes, the ER accumulates in the inner cytoplasm. At 
GVBD, the ER forms a dense ring in the center of the oocyte around the MI spindle. In the later 
stage of maturation, the ER ring moves together with the MI spindle towards the oocyte cortex 
(FitzHarris et al., 2007). During the dynamic relocation of the ER, the concentration of stored 
Ca2+ is elevated.  
 
The number of type 1 IP3 receptor (IP3R1) increases during maturation, with MII oocytes 
containing almost two times more receptors than GV oocytes (Parrington et al., 1998). The 
distribution of IP3R1 also changes during oocyte maturation. In mouse GV oocytes, the IP3R1 
are spread throughout the cytoplasm forming a thin layer in the cortex (Fissore et al., 1999). In 
human oocytes, the IP3R1 form a patch-like structure in the cortex to facilitate the initiation of 
Ca2+ release or enhance their sensitivity (FitzHarris et al., 2007). All these changes are crucial 
for establishing the ability to generate Ca2+ oscillations by the oocyte.  
17 
 
The initiation of the second meiotic chromosome segregation occurs following fertilization by 
sperm (Sharma et al., 2013). This oocyte activation is a spatial-temporal regulated process 
triggered by the sperm entry. Firstly, the zona pellucida undergoes physical and chemical 
changes by the extrusion of the cortical granules from the oocyte to prevent polyspermy and to 
protect the embryo. The oocyte has to be released from the MII arrest to allow the completion 
of the cell cycle and the formation of the haploid female pronucleus capable of combining with 
the sperm-derived pronucleus. Also, maternal mRNA and proteins undergo dynamic changes 
and post-translational modifications. Finally, cytoskeletal rearrangements have to occur to 
support the zygote’s growth and embryo development (Horner and Wolfner, 2008). After 
fertilization, oocytes provides half of the nuclear genetic material, but endow the embryo with 
nearly all membrane and cytoplasmic determinants that are required for successful species 
propagation in sexually reproducing organisms (Baudat et al., 2013). Over the next few days, 
the mammalian embryo undergoes a series of cell divisions, ultimately leading to the formation 
of a blastocyst (Aplin and Ruane, 2017). 
 
1.2.2 Ca2+ homeostasis during oocyte maturation  
At oocyte meiosis, Carroll et al. first reported that spontaneous Ca2+ fluctuations existed during 
in vitro maturation (IVM) of mouse oocytes. The intracellular Ca2+ is released through the 
IP3R1 at GVBD and is crucial for successful cytoplasmatic maturation (Carroll and Swann, 
1992). Fully grown mammalian GV oocytes are arrested and endowed with low Ca2+ reserves 
in ER ([Ca2+]ER). As maturation progresses, [Ca2+]ER increases steadily until the MII stage 
(Tombes et al., 1992; Jones et al., 1995), while the most drastic increase in [Ca2+]ER is 
observed around GVBD (Wakai et al., 2013), which enhances IP3R1-mediated Ca2+ release 
and promotes the acquisition of further fertilization-like oscillations (Mehlmann and Kline, 
1994).  
 
During maturation, the elevation of [Ca2+]ER requires the function of both Ca2+ influx and efflux. 
The low levels of [Ca2+]ER at the GV stage are attributed to the constitutive Ca2+ leak out of the 
ER, and thereafter promote Ca2+ influx to display the necessary intracellular Ca2+ oscillations. 
Ca2+ influx ceases around the time meiosis is resumed (Carroll and Swann, 1992) and the first 
increase in [Ca2+]ER content occurs simultaneously (Jones et al., 1995). The association be-
tween [Ca2+]ER content and intracellular Ca2+ is related to the plasma membrane Ca2+-ATPase 
(PMCA) and SOCE (Putney et al., 1986; Hoth and Penner, 1993), as well as alterations of 
active Ca2+ influx during maturation (Cheon, et al., 2013). The function of the Ca2+ influx via 
SOCE and efflux through PMCA pathways is significantly downregulated at the GVBD stage 
(Norwood et al., 2000; El-Jouni et al., 2005), which ensures the high concentration of [Ca2+]ER 
around GVBD and supports the further sperm-associated intracellular Ca2+ responses in 




1.2.3 Generation of Ca2+-signals during development: from fertilization to early 
embryo 
Before the sperm can fertilize the oocyte, they must become hyperactived, to enable transport 
through the mucous layer within the oviduct and to penetrate the zona pellucida, to react with 
the oocyte plasma membrane. The process of hyperactivity is triggered by a Ca2+ increase in 
the redundant nuclear envelope that surrounds the sperm axoneme, which is mediated via 
IP3Rs, as well (Ho and Suarez, 2001). Vitamin D which acts in a nongenomic pattern to 
activate the formation of the IP3, is responsible for this Ca2+ release (Jensen, 2014). 
 
At fertilization, the hyperactivated sperm fuses with the oocyte and releases its testis-specific 
phospholipase C ζ (PLCζ), which is unique to sperm. PLCζ hydrolyzes PIP2 to form IP3, which 
binds to its receptor IP3Rs that localized on the ER, and thereby triggers the Ca2+ release 
(Swann and Lai, 2013; Kashir et al., 2014) (Figure 6). Recent data have emerged, suggesting 
the sperm factor may be a post-acrosomal sheath WW domain-binding protein (PAWP) 
(Aarabi et al., 2014). The importance of PAWP during the fertilization process seems low, as 
PAWP knockout mouse sperm is capable of triggering Ca2+ release and fertilization in mouse 
oocytes, while oocytes from PAWP knockout mice can also be fertilized (Nomikos et al., 2014; 
Amdani et al., 2015; Kashir et al., 2015).  
 
Figure 6. PLC-Z triggered IP3/Ca2+ signaling pathway. Figure reprinted with permission. 




During fertilization, a single Ca2+ peak was initially described in marine animals as an 
explosion, suggesting this pattern may be responsible for oocyte activation (Ridgway et al., 
1977; Steinhardt et al., 1977). Later, one single Ca2+ transient was demonstrated in oocytes 
from most non-mammals, during activation (Busa and Nuccitelli, 1985; Gillot and Whitaker, 
1994), excluding eggs from nemertean worms, bivalve etc. (Stricker, 1999). Conversely, 
oscillations which sustain for several hours and terminate around the moment of pronucleus 
formation are observed in mammalian species (Jones et al., 1995; Miao and Williams, 2012). 
The amplitude and frequency of the Ca2+ oscillation are crucial for the success of oocyte 
activation and further embryo development (Swann and Ozil, 1994; Miyazaki and Ito, 2006; 
Kashir et al., 2014). 
 
In both human and mouse oocytes, the initial surge of free cytoplasmic Ca2+ starts from the 
site of sperm penetration and expands as a wave through the oocyte (Swann, 1993). 
Subsequently, the intracellular cytoplasmic Ca2+ level starts to rise and persists for several 
minutes before returning to the baseline (Miao et al., 2012). The amplitudes of these sperm 
triggered Ca2+ oscillations range from 0.5-2.5 µM, while the approximate duration of individual 
Ca2+ transient is about 0.5 to 4 minutes (Stricker, 1999). However, there is also 
species-specific differences. Following the injection of the same human sperm into both 
human and mouse oocytes, mouse oocytes show a 20 times higher frequency of Ca2+ peaks 
during the first 2 hours of measurement. Conversely, human oocytes exhibit 1-2 peaks/hour 
during the 10-16 hours of measurement after ICSI with human sperm. To compare the Ca2+ 
signaling generated in different species, the parameter that reflects the total amount of Ca2+ 
flux should be used.  
 
During each oscillatory Ca2+ transient, there is a rapid decline in the [Ca2+]ER and the level of 
[Ca2+]ER is gradually replenished through SOCE. The buildup of [Ca2+]ER sensitizes the IP3Rs 
resulting in the activation of the next transient. These sperm-triggered Ca2+ oscillations induce 
chromosome separation and cell proliferation that occurs during early development. At mitosis, 
the local Ca2+ transients precede cell cleavage, which includes the lateral extension and 
deepening of the furrow (Gillot and Whitaker, 1994). 
 
1.2.4 Regulation of Ca2+ oscillatory mechanisms during fertilization  
Although oocytes only experience very small changes in membrane potential at fertilization 
(Jaffe et al., 1983) and the primary Ca2+ oscillating mechanism has been described as the 
IP3/Ca2+ signaling pathway, the regulation of the intracellular Ca2+ responses of mammalian 
oocytes is far more complex. To sustain Ca2+ oscillations without attenuation after each Ca2+ 
transient, Ca2+ levels have to be rapidly returned to baseline values, and the [Ca2+]ER has to be 
refilled in anticipation of the next Ca2+ rise (Berridge, n.d.). To drive intracellular Ca2+ back to 
baseline levels, oocytes need to either take up the free cytosolic Ca2+ into the ER refilling the 
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store by the sarco-endoplasmic reticulum Ca2+ ATPases (SERCA) and/or remove it to other 
organelles or to the extracellular space surrounding environment by the action of PMCA (83) 
and Na+/Ca2+ exchanger (“Na+-Ca2+ exchange in mouse oocytes: modifications in the 
regulation of intracellular free Ca2+ during oocyte maturation. - PubMed - NCBI,” n.d.). 
Nevertheless, to consistently replenish [Ca2+]ER and maintain long lasting oscillations, 
extracellular Ca2+ influx across the plasma membrane is required by a variety of channels, for 
instance, SOCE (Smyth et al., 2006).  
 
These channels/mechanisms play a pivotal role in sustaining Ca2+ homeostasis and 
supporting oscillations, IP3R modifications and ER re-organization (Wakai and Fissore, 2013). 
Moreover, TRP channels which are widely expressed in non-excitable cells may also have 
important roles in modulating Ca2+ influx (Gees et al., 2010). Of note, some TRP channels can 
be sensitized by Ca2+ or by PKC-dependent phosphorylation. For instance, PLC generated 
diacylglycerol activates canonical TRPC channels at fertilization (Hardie, 2007), which can be 
detected at the egg PM.  
 
Mitochondria also contribute to shape intracellular Ca2+ rises during oscillations (Duchen, 
2000). These organelles can uptake Ca2+ into their matrix, thereby alleviating the overall 
cytosolic Ca2+ load (Rizzuto et al., 1998). However, the uptake of Ca2+ does not seem to be 
their main function in terms of Ca2+ homeostasis, as inhibition of mitochondrial function causes 
a sustained increase in Ca2+ in mouse eggs (Liu et al., 2001), but does not immediately 
terminate sperm-initiated oscillations (Dumollard et al., 2004). Instead, the Ca2+-driven ATP 
output may be the mitochondria’s most critical contribution to Ca2+ homeostasis in MII eggs, as 
ATP production maintains SERCA activity, which is required for maintaining [Ca2+]ER and 
sustaining sperm-triggered Ca2+ oscillations (Kline and Kline, 1992).  
 
1.3 IP3/Ca2+ signaling accompanies molecular alterations during oocyte activation 
Upon sperm penetration at fertilization, each sperm-induced Ca2+ rise is accompanied by a 
parallel increase in Ca2+/Calmodulin dependent protein kinase II (CaMKII) activity (Backs et al., 
2010). Subsequently, this inhibits Emi2 and leads to the activation of APC/C (Medvedev et al., 
2014) (Figure 7). Thereafter, similar to the metaphase I-anaphase I transition, APC/C 
activation results in destruction of MPF, as well as mitogen-activated protein kinase (MAPK), 
and the release of separase (Terret et al., 2003), which triggers resumption of meiosis 
(Ducibella and Fissore, 2008; Sanders and Swann, 2016) (Figure 7). Similarly, protein kinase 
C activation which is implicated in cell-cycle resumption, occurs with a temporal pattern similar 






Figure 7. Ca2+ signaling triggers MPF related molecular pathway during oocyte 




1.4 Deregulation of Ca2+ signaling and female infertility  
Deregulation of Ca2+ signaling of excitable and non-excitable cells, accounts for the incidence 
of a large number of human diseases, as diverse as neural diseases (Alzheimer’s disease, 
bipolar disorder), cardiac diseases, such as atrial arrhythmias, ventricular hypertrophy, 
congestive heart failure, and cancer, diabetes, liver cholestasis, pancreatitis etc. (Carafoli and 
Brini, 2007; Feske, 2007; Berridge, 2012b, 2016; Derouiche et al., 2013; Mikoshiba, 2015). 
Moreover, reproductive failures may also relate to the deregulation of Ca2+ signaling of the 
oocyte, a representative example of non-excitable cells. 
 
1.4.1 Meiotic maturation resistance  
Abnormal Ca2+ signaling is observed in a maturation deficient mouse model, LT/Sv mice 
(Archacka et al., 2008). Oocytes from LT/Sv mice show an abnormal regulation of meiotic 
maturation, many of which are unable to complete the first meiotic division and become 
arrested at the MI stage. The origin of MI arrest of LT/Sv oocytes is suggested to be of a 
cytoplasmic nature and could be overcome by nuclear transfer (Hoffmann et al., 2012). 
However, only little is known regarding this treatment in patients with maturation resistant 
oocytes.  
 
In assisted reproductive technologies (ART) cycles, approximately 11% and 4% of the 
harvested oocytes are at prophase I and MI stage respectively (Reichman et al., 2010; De 
Vincentiis et al., 2013); most of these are meiotically competent and resume meiosis during 
subsequent in vitro culture (Combelles et al., 2002; Heindryckx et al., 2008). However, 
approximately 8.6% of infertility patients produce at least one maturation resistant oocyte, 
which fails to resume meiosis in vivo, even after subsequent in vitro incubation (Bar-Ami et al., 
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1994). Interestingly, this maturation resistance occurs repeatedly in 0.1-1% of the patients with 
all or most of the collected oocytes in immature stage. They are mostly arrested at the MI 
stage and resistant to further spontaneous meiotic maturation despite prolonged in vitro 
culture (Harrison et al., 2000; Bergere et al., 2001; Levran et al., 2002; Neal et al., 2002; Beall 
et al., 2010; Heindryckx et al., 2011a).  
 
A dozen of case reports and case series describe patients with recurrent oocyte maturation 
resistance (Table 1). The key clinical features of these patients include primary infertility, 
repetitive production of mostly immature oocytes, inability of IVM to stimulate further meiosis 
and mostly failed fertilization following ICSI (Beall et al., 2010). Highly aberrant 
spindle-chromosome complex configurations are observed in meiotic maturation resistant 
oocytes at the MI stage in some case reports (Windt et al., 2001; Combelles et al., 2003) and 
in 4 cases in our Department who were showing all immature oocytes at retrieval (Heindryckx 
et al., 2011b). Moreover, a study has shown that no pregnancies could be achieved in patients 
presenting with more than 25% of maturation resistant oocytes in an assisted reproductive 
cycle (Bar-Ami et al., 1994). Currently, the origin and cytoplasmic feature of human maturation 
resistant oocytes remains unclear. 
 
Table 1 Clinical outcomes of patients with a high number of maturation resistant 
oocytes 
 





1.4.2 Failed fertilization and assisted oocyte activation (AOA)  
Intracytoplasmic sperm injection (ICSI) results in fertilization rates between 70% and 80% 
when viable sperm is present in the ejaculate or testis (Palermo et al., 2009). While ICSI has 
overcome many infertility defects, in particular male infertility, it does not completely eliminate 
fertilization failure. In some ICSI cases, with a frequency ranging from 3 to 5% (Esfandiari et al., 
2005), complete fertilization failure or abnormal low fertilization still occurs (Devroey et al., 
1995; Flaherty et al., 1998; Yanagida, 2004). The possible etiologies underlying total 
fertilization failure are complex (Swain and Pool, 2008) and may relate to cycle-specific 
parameters, oocyte yield and quality, availability of motile spermatozoa and/or severity of 
sperm defects (Esfandiari et al., 2005), but deficiencies in the oocyte activation mechanism 
account for the primary cause. Additionally, ooplasmic dysmaturity in relation to the achieved 
nuclear maturation marked by the extrusion of the first polar body can result in failure to 
fertilize.  
 
More uncommon are cases where the spermatozoa partially or completely lack the specific 
oocyte activating factor (Kashir et al., 2010; Neri et al., 2014), leading to fertilization failure 
after ICSI (Kovacic and Vlaisavljevic, 2000). Under some circumstances, this ICSI failure has 
been successfully overcome by the application of the AOA technology, by manipulating 
intracellular Ca2+ influx with a variety of physical, mechanical or chemical activation stimuli, 
such as electrical pulses, modified ICSI procedure, or calcium  ionophores and strontium 
chloride (SrCl2) (Vanden Meerschaut et al., 2014). Among all these, the most widely used 
artificial activating agents for human oocytes are the Ca2+ selective ionophores, ionomycin and 
calcimycin (also known as A23187) (Heindryckx et al., 2008; Ebner et al., 2012).  
 
Despite the availability of different AOA technologies, some laboratories report lower 
fertilization and pregnancy rates after using different AOA protocols (Ebner et al., 2012; 
Montag et al., 2012) compared to others (Heindryckx et al., 2008), or no differences in 
fertilization rate after the application of AOA compared to routine ICSI (Borges  Jr. et al., 2009). 
The differences in the efficiency of AOA protocols might be due to the patients’ fertility 
background, the lack of diagnostic tests or the specific AOA protocols used (Vanden 
Meerschaut et al., 2014).  
 
The variability in protein source, ions and EDTA present in the various commercial human 
embryo culture media could attribute to the altered embryonic development potential (Morbeck 
et al. 2014a; Morbeck et al. 2017). The variation in the composition of protein supplements in 
the medium influences the blastocyst developmental potential in mouse (Morbeck et al. 2014b). 
Moreover, fertilizing oocytes in medium with reduced concentration of Mg2+ (0.2mM), 
significantly improved blastocysts rates in both mouse and human (Herrick et al., 2015). 
Furthermore, the concentration of the membrane-impermeable metal ion chelator could also 
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influence the treatment outcomes, for instance EDTA impairs embryonic developmental 
potential at a higher concentrations (>5mM) (Berridge et al., 2000). Investigations are required 
to verify the effect of specific components of the embryo culture medium. Currently, the 
concentration of Ca2+ ([Ca2+]) in the culture medium has not been taken into account during the 
application of AOA technology to overcome failed fertilization.  
 
Moreover, SrCl2 is widely used to induce very efficiently artificial activation of mouse eggs 
following somatic cell nuclear transfer or round spermatid injection (Loren and Lacham-Kaplan, 
2006). Although successful pregnancies were reported after using Sr2+ during AOA, in couples 
with low fertilization rates from several groups (Yanagida et al., 2006; Kyono et al., 2008; Kim 
et al., 2014) (Table 2), the efficiency of Sr2+ as an activating agent for human oocytes is still 
under debate. The exact mechanism by which Sr2+ induces activation in human oocytes 
remains unclear. One possible explanation is that Sr2+ moves into the oocyte down the 
concentration gradient, causing Ca2+ release from the ER through the IP3 receptor (Zhang et 
al., 2005). Recently, it was found that the TRP channel, subfamily V, member 3 (vanilloid 
3) (TRPV3) mediates Sr2+ induced oocyte activation (Carvacho et al., 2013) and Ca2+ influx 
induced by 2-aminoethoxydiphenyl borate (2-APB) in mouse oocytes (Lee et al., 2016). 
Generally, TRP channels are modulated by a variety of stimuli and ligands (Ramsey et al., 
2006), including various natural compounds like carvacrol, thymol and eugenol (Xu et al., 
2006). Remarkably, activation of TRPV3 channels by 2-APB and carvacrol promotes Ca2+ 
entry and provokes mouse oocyte activation without temperature sensitization, whereas, the 
absence of TRPV3 channels in mouse oocytes failed to provoke Sr2+ induced activation 
(Carvacho et al., 2013). However, it is still unknown if Sr2+ induces Ca2+ rise efficiently in 


















Table 2. Pregnancy outcomes of patients with fertilization failure following AOA 
treatment by using Sr2+  
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1.4.3 Oocyte post-ovulatory ageing and reproductive ageing  
An optimal window exists in fertilization of the MII stage oocyte, which is generally within 10 
hours of ovulation in mammals (Marston and Chang, 1964; Tarín et al., 1999). In the event that 
no fertilization occurs within this time frame, oocytes experience deterioration in quality 
referred to as post-ovulatory oocyte ageing (Lord and Aitken, 2013). It occurs both in vivo and 
in vitro, either in the oviduct of the female reproductive tract, or in the in vitro culture media in 
an assisted reproduction setting. At fertilization, Ca2+-signaling is deregulated in post-ovulatory 
aged oocytes, showing a higher frequency and lower amplitude in Ca2+ oscillatory patterns 
(Kolker et al., 2003; Takahashi et al., 2009). As such, they activate pathways of apoptosis, 
fragmentation, and cell death, instead of supporting fertilization and normal embryonic 
development (Gordo et al., 2002; Takahashi et al., 2009). 
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Post-ovulatory aged oocytes can still serve as valuable material for rescue-intracytoplasmic 
sperm injection to produce offspring in the clinic (Nagy et al., 1993) and establish embryonic 
stem cell lines from somatic cell nuclei by nuclear transfer (Thuan et al., 2010). These oocytes 
exhibit numerous aberrations in their cell biology, including a decrease in critical cell cycle 
factors including MPF and MAPK (Kikuchi et al., 2002), mitochondrial dysfunction (Tatone et 
al., 2011; Lord and Aitken, 2013), spindle abnormalities and losses of chromosomal integrity 
(Wakayama et al., 2004). This has also been associated with decreased fertilization capacity 
(Marston and Chang, 1964; Ben-Rafael et al., 1986; Badenas et al., 1989), poor embryo 
quality (Yanagida et al., 1998; Lord et al., 2013) and abnormalities in offspring (Tarín et al., 
1999).  
 
Reproductive ageing is a process that is distinct from post-ovulatory ageing, which relates to 
decreased oocyte quality in patients with advanced age. The reduced ovarian reserve and an 
increased rate of chromosomal aberrations leads to an increased risk of miscarriages and 
aneuploidy of older patients (Bartmann et al., 2004; Wright et al., 2008). Meiotic errors during 
MI stage represent the leading cause of pregnancy loss and congenital defects (Hunt and 
Hassold, 2008), and their incidence is strongly influenced by maternal age (Hook et al., 1981; 
Nagaoka et al., 2011). However, Ca2+ signaling alterations have not been demonstrated in 
reproductive ageing. 
 
In vitro maturation (IVM) is an emerging procedure incorporated into the world of assisted 
reproductive technologies. Fertilizing IVM oocytes represents a cheaper and safer approach 
compared to routine in vitro fertilization, particularly for women suffering from polycystic 
ovarian syndrome. However, in these cases, an impaired ability of generating Ca2+ at 
fertilization (Cheung et al., 2000; Mann et al., 2010) has been observed in both mouse and 
human. The impact of post-ovulatory and reproductive ageing on the Ca2+ signaling of IVM 
oocytes has also not been elucidated. 
 
1.5 Methodologies for investigating the Ca2+ signal 
To date, there are a number of viable tools to investigate certain Ca2+ signaling related 
parameters. For analysing the extracellular Ca2+ amount, the concentration of 
Ca2+ supplemented in the embryo culture medium could be measured by direct potentiometry 
with ion-selective electrodes, similar to Ca2+ measurements in serum, plasma, whole blood, 
and other biological fluid samples (Sena and Bowers, 1988). The measurement range of 
Ca2+ selective electrodes is 3µM to 1M. The pH monitor and the calibration of the electrode is 
critical to the accuracy of the measurement. The colorimetric assay kit is also used for 
quantification of Ca2+ present in cell lysates and other biological samples. This method can 
detect Ca2+ concentrations from 0.1 to 25mM. When analyzing the total amount of calcium, 
atomic absorption spectrometry and polarized Energy Dispersive X-Ray Fluorescence (XRF) 
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systems are available. The accuracy of XRF tech is 0.001M, while the detection limit is around 
0.1mM.  
 
To measure intracellular Ca2+, Ca2+-imaging is commonly applied. Ca2+-imaging is useful for 
measuring calcium signals in cultured cells. This technique takes advantage of Ca2+ indicator 
dyes, which are BAPTA-based organic molecules that change their spectral properties in 
response to the binding of Ca2+ ions. Ca2+ indicator dyes fall into two categories, ratio-metric 
dyes like Fura-2 and Indo-1 and single-wavelength dyes like Fluo-4. For our study, the 
ratio-metric dye Fura-2 is used, it has an emission peak at 505 nM and changes its excitation 
peak from 340 to 380 nm in response to Ca2+ binding, allowing the concentration of 
intracellular Ca2+ to be determined from the ratio of fluorescence excitation. The main 
advantage of this ratio-metric dye over single wavelength probes is that the ratio signal is 
independent of the dye concentration, illumination intensity, and optical path length allowing 
the concentration of intracellular Ca2+ to be determined independently of these artifacts 
(Barreto-Chang and Dolmetsch, 2009). 
 
Nowadays, for couples experiencing failed fertilization after ICSI, heterologous ICSI models 
and mouse oocyte Ca2+ analysis has been successfully used to reveal activation deficiencies 
and determine whether they are sperm- or oocyte-related (Rybouchkin et al., 1996; Araki et al., 
2004; Heindryckx et al., 2005). The Ca2+ oscillatory pattern analysis by Ca2+-imaging following 
heterologous ICSI has the strength to reveal subtle deficiencies in underlying sperm-borne 
activation deficiency responsible for low or failed fertilization after conventional ICSI. 
 
Non-invasive particle velocimetry can also evaluate the intracellular Ca2+ signals, this 
technique detects small cytoplasmic movements of the oocytes synchronous with and 
dependent on Ca2+ oscillations. This technique has been applied on failed fertilized oocytes 
(Swann et al., 2012). However, the detrimental effect of frequent light exposure (every 10 
second) has to be accessed before the application. Moreover, in oocytes, multiple Ca2+ 
signaling pathways may be activated by one stimulus. Therefore, it is difficult to identify the 
proportion of Ca2+ released from ER and the amount of Ca2+ influx through PM channels. The 
utility of selective inhibitors of certain Ca2+ channels may serve as a tool to define the origin of 
Ca2+, for example, thapsigargin, which blocks a class of enzymes known by the acronym 
SERCA, and thus inhibits the ability of the cell to pump calcium into the SR/ER which causes 


















































2. Aims of the thesis  
 
This thesis investigates the Ca2+ signaling alterations in oocytes showing maturation 
resistance, oocytes after specific AOA treatments and oocytes undergoing post-ovulatory 
ageing or reproductive ageing. 
 
1) Nuclear and cytoplasmic (Ca2+-signaling) abnormalities in maturation resistant 
oocytes  
 
In ART cycles, maturation resistance of oocytes can occur repeatedly in 0.1-1% of patients. In 
such cases, all or most of the oocytes retrieved are immature and further resistant to meiotic 
progression and pregnancies can rarely be achieved. Oocytes from LT/Sv mice also show an 
abnormal regulation of meiotic maturation, many of which are unable to complete the first 
meiotic division and become arrested at the MI stage. It has been suggested that the origin of 
MI arrest of LT/Sv oocytes is of a cytoplasmic nature (Hoffmann et al., 2012).  
 
In the first part of the thesis, we investigated the nuclear and cytoplasmic status of maturation 
resistant oocytes from patients presenting with >40% immature oocytes at retrieval. Oocytes 
obtained from this patient group are likely to be resistant to meiotic maturation. The ICSI 
treatment outcomes of these patients were followed-up. We further aimed to perform an 
in-depth evaluation of Ca2+-signaling alterations in the meiosis maturation resistant mouse 
model (Chapter 3). 
 
2) Evaluation of the effect of specific activating agents and culture components on 
the efficiency of AOA through Ca2+-signaling analysis 
 
Following ICSI treatment, 1-5% of patients experience complete fertilization failure. Oocyte- 
related ICSI failure may be successfully overcome by application of AOA. It is commonly 
performed by manipulating intracellular Ca2+ influx with chemical activation stimuli, for instance 
ionomycin and Sr2+. 
 
As variations in the composition of commercial culture media have been shown to affect 
embryo developmental potential (Morbeck et al. 2014a; Morbeck et al. 2017), varying media 
supplements and components may also influence the AOA outcome. In this part of the thesis, 
we assessed the effect of external factors (concentrations of ionomycin and Ca2+) present in 




Several successful pregnancies have been obtained after using Sr2+ during (Yanagida et al., 
2006; Kyono et al., 2008; Kim et al., 2014). However, the efficiency of Sr2+ as an activating 
agent for human oocytes is still under debate. As such, we further aimed to verify the 
effectiveness of Sr2+ for human oocyte activation (Chapter 5). 
 
3) Alterations in Ca2+ oscillatory patterns in aged mouse oocytes  
 
Oocyte ageing, due to advanced female age (reproductive oocyte ageing) and prolonged in 
vitro culture (post-ovulatory ageing) are both associated with decreased fertilization capacity 
and poor embryo quality (Marston and Chang, 1964; Ben-Rafael et al., 1986; Badenas et al., 
1989). The Ca2+ oscillatory pattern of reproductive-aged oocytes has not been investigated. 
Therefore, we aimed to evaluate the differences between post-ovulatory and 
reproductive-aged mouse oocytes with a focus on Ca2+ oscillatory pattern analysis and 





























3. Patients with a high proportion of immature and meiotically resistant 
oocytes experience defective nuclear oocyte maturation patterns and 




Patients presenting with an abnormally high number of immature oocytes at retrieval are more 
likely to exhibit maturation resistant oocytes. In the first study of this thesis, we investigated the 
spindle-chromosome abnormalities of immature oocytes following in vitro culture, from patients 
showing >40% of immature oocytes at retrieval. Pregnancy outcomes were additionally 















A high percentage of abnormal spindle-chromosome configurations was observed in 
maturation resistant and IVM oocytes from patients showing >40% of immature oocytes at 
retrieval. Cumulative pregnancy rates and live birth rates were significantly lower in these 
patients when compared to controls, who showed a normal number of mature oocytes at 
retrieval. The treatment strategy and the utility of IVM in patients with a high proportion of 
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Short title: Outcomes of patients with immature and maturation resistant oocytes 
 
Abstract 
Patients presenting with an abnormally high number of immature oocytes at retrieval are more 
likely to exhibit maturation resistant oocytes. However, the clinical relevance of such events 
remains unknown. We investigated the nuclear maturation competence of immature oocytes 
from patients showing >40% of collected immature oocytes (Study group) and Controls, in 
which a normal number of mature oocytes (≥60%) was retrieved. Following in-vitro culture, 
oocytes were classified as maturation resistant and in-vitro matured (IVM). Treatment 
outcomes were evaluated in Study and Control groups based on the presence of maturation 
resistant oocytes. Overall, similarly high spindle and chromosome abnormality rates were 
observed in maturation resistant oocytes from both Study and Control groups. IVM oocytes 
from Study group revealed a significantly higher percentage of misaligned chromosomes 
compared with Controls (P<0.05). Remarkably, Study patients with at least one maturation 
resistant oocyte, showed significantly reduced cumulative pregnancy and live birth rates 
compared with Control maturation resistant patients (P<0.05). To further investigate the 
aetiology, we applied a maturation resistant mouse model and revealed defective 
Ca2+-signaling of maturation resistant oocytes at germinal vesicular breakdown and 
parthenogenetic activation. In conclusion, appropriate treatment strategies, including clinical 
utilization of IVM oocytes from the Study group patients warrant further investigation.  
 
KEYWORDS: Ca2+-signaling, chromosome misalignment, meiosis resistant, immature 




Infertility is a complex pathophysiological disorder. It can be caused by various factors, ranging 
from hormonal imbalances to genetic alterations and even environmental influence (McCallie 
et al., 2017). The Human Fertilization and Embryology Authority (HFEA) reported that one out 
of six couples are struggling with infertility, and the origins are equally distributed between 
male and female (Bracewell-Milnes et al., 2017). Nowadays, assisted reproductive 
technology (ART) is used primarily for infertility treatments to achieve a pregnancy. 
 
Ovarian stimulation protocols, as part of standardized infertility treatments, predominately 
generate mature metaphase II (MII) oocytes. However, approximately 15-20% of oocytes 
retrieved after ovarian stimulation for conventional IVF are immature (Reichman et al., 2010). 
Previous reports have documented that most of these oocytes maintain meiotic competence 
and may resume meiosis during extended in-vitro culture (Combelles et al., 2002, Heindryckx 
et al., 2007). Nevertheless, approximately 8.6% of subfertile patients produce at least one 
oocyte resistant to meiotic maturation. Such maturation resistant oocytes fail to resume 
meiosis even following subsequent in-vitro culture (Bar-Ami et al., 1994). Moreover, in 0.1-1% 
of cases all or most of the recovered oocytes are immature and exhibit complete oocyte 
maturation arrest (Archacka et al., 2008). These oocytes are mostly arrested at the metaphase 
I (MI) stage and show resistance to further meiotic maturation even following prolonged in-vitro 
culture in standardized conditions (Harrison et al., 2000, Bergere et al., 2001, Levran et al., 
2002, Neal et al., 2002, Beall et al., 2010, Heindryckx et al., 2011).  
 
Although complete failure of human oocytes to resume meiosis is rare (Levran et al., 2002), 
previous reports have indicated that in cases where the percentage of maturation resistant 
oocytes was greater than 25%, IVF outcomes were significantly reduced and no pregnancies 
could be achieved (Bar-Ami et al., 1994, Levran et al., 2002). Patients showing an abnormally 
high percentage of immature oocytes at retrieval represent a great possibility of exhibiting 
maturation resistant oocytes, however, the oocyte maturation competence and the pregnancy 
outcomes of these patients currently remain largely unknown. Both nuclear as well as 
cytoplasmic, structural and biochemical changes provide oocytes with the capacity to progress 
through meiosis (Levran et al., 2002, Fulka  Jr. et al., 1998). Highly aberrant 
spindle-chromosome complex configurations have been observed in maturation resistant 
oocytes obtained from patients, for which no mature oocytes were retrieved (Windt et al., 2001, 
Combelles et al., 2003, Heindryckx et al., 2011).  
 
Moreover, evidence from a subfertile mouse model demonstrated that in-vitro cultured 
maturation resistant oocytes display aberrant spindles and an impaired ability to exhibit 
Ca2+-transients after fertilization (Archacka et al., 2008). The LT/Sv female mice show a high 
number of immature oocytes following ovarian stimulation, most of which are arrested at MI 
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stage (Eppig, 1978, Hupalowska et al., 2008), as observed in human maturation resistant 
patients (Beall et al., 2010). The LT/Sv maturation resistant oocytes can become activated 
spontaneously and undergo embryonic development forming teratoma in the ovary (Eppig, 
1978). The cause of the maturation resistant oocytes from LT/Sv mice was reported to be of 
cytoplasmic origin (Hoffmann et al., 2012), and related with the over-activation of 
spindle-assembly-checkpoint (SAC) proteins (Ciemerych and Kubiak, 1998; Hoffmann et al., 
2012; Hupalowska et al., 2008). However, further research into the exact mechanisms 
governing oocyte maturation is essential for defining precise deficiencies impeding meiotic 
competence (Levran et al., 2002).  
 
Successful oocyte maturation and activation are mediated by inositol 1,4,5-trisphosphate 
receptors (IP3Rs) generated characteristic Ca2+-oscillations in oocyte, either released 
spontaneously or triggered by the sperm factor phospholipase C zeta respectively (Saunders 
et al., 2002, Tesarik, 2002, Ramadan et al., 2012, Wakai et al., 2013). In LT/Sv mice, the 
Ca2+-oscillatory ability and the nuclear maturation normality of collected fresh MI arrested 
oocytes remains unclear. Analysis of Ca2+-signaling patterns of in-vitro cultured and in-vivo 
collected maturation resistant oocytes in this mouse model may provide additional insights into 
the underlying processes of meiotic resistance in human. Shedding light on the physiology of 
oocyte maturation in human may allow for more effective diagnostic approaches.  
 
In this study, we compared the nuclear maturation competence of immature oocytes obtained 
from patients presenting with a high rate (>40%) of immature oocytes at retrieval (Study group), 
with immature and in-vivo matured oocytes retrieved from patients showing a normal number 
(≥60%) of collected mature oocytes (Control group). Following in-vitro culture, immature 
oocytes from Study and Control group were classified for spindle-chromosome configuration 
analysis, based on their maturation status: maturation resistant and in-vitro matured (IVM). 
Moreover, fertilization rates and pregnancy outcomes were evaluated in both groups based on 
the presence of maturation resistant oocytes observed after in-vitro culture. Finally, we used a 
LT/Sv maturation resistant mouse model to assess the Ca2+-signaling of maturation resistant 
oocytes during oocyte maturation and at parthenogenetic activation.  
 
Materials and methods 
All chemicals and reagents were purchased from Sigma Chemical Co. (Diegem Belgium), 
unless otherwise indicated. 
 
Ethical approval 
The study was approved by the local Ethical Committee of Ghent University Hospital, Belgium 
(reference numbers: 2009/130 approved on March 31st, 2009, 2010/182 approved on April 21st, 
2010 and 2010/808 approved on January 20th, 2011). Written informed consents were 
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obtained from all patients. All procedures involving animal handling and sacrifice were 
approved by the Ghent University Hospital Ethical Committee for Laboratory Animals (ECD no. 
11/41) on December 12th, 2011. 
 
Source of human oocytes 
Patients (25-44 years old) undergoing ICSI treatment at the Ghent University Hospital, 
between November 2011 and May 2014, were included in this study. Patients undergoing a 
hormone stimulated cycle were administrated with a GnRH agonist (Decapeptyl; Ferring) or 
antagonist (Cetrotide;Merck Serono). Ovarian stimulation was performed by administering 
hMG (Menopur; Ferring) or recombinant FSH (Gonal-F; Merck Serono) at a dose of 
112.5-300IU daily and ovulation was induced with 5000IU hCG (Pregnyl;MSD). Oocytes were 
enzymatically denuded by brief exposure to 80IU/ml hyaluronidase (Irvine Scientific), followed 
by mechanical denudation prior to ICSI. Nuclear status was assessed and classified as 
germinal vesicle (GV) (presence of a GV structure), MI (absence of both a polar body and a 
GV structure) or MII stage (presence of a polar body and absence of a GV structure). Donated 
GV oocytes were further cultured in medium 199, supplemented with 10ng/ml epidermal 
growth factor, 1mg/ml estradiol, 10mIU/ml recombinant FSH, 0.5mIU/ml hCG, 1mM 
l-glutamine, 0.3mM sodium pyruvate, 0.8% (v/v) human serum albumin (Red Cross, Belgium), 
100IU/ml penicillin G and 100mg/ml streptomycin sulphate at 37°C in 6% CO2, 5% O2. Based 
on 1st polar body extrusion, GV oocytes which processed to MII stage after 24h or 48h of 
in-vitro culture were defined as GV-MII 24h or GV-MII 48h. Oocytes collected at MI stage were 
cultured in Sydney IVF cleavage medium (Cook Ireland Ltd), in which oocytes reached to MII 
stage following 3h or 24h of in-vitro culture were identified as MI-II 3h or MI-II 24h. GV oocytes 
that matured to the MI stage and showed resistance to progress to MII stage after 48 hours of 
culture were defined as GV-MI 48h. Donated MI oocytes which failed to extrude 1st polar body 
within 24h of in-vitro culture in Cook Cleavage medium were defined as MI-24h. For treatment 
of the patients, ICSI was performed by standardized techniques in normal in-vivo matured MII 
oocytes. Fertilization (oocytes showing 2PN and a second polar body) rate was assessed 
14-18h post injection.  
 
Embryos were vitrified/warmed using a closed vitrification protocol (Irvine Scientific). Embryos 
were initially incubated in a 50ml drop of Sydney IVF Gamete buffer medium (GB) (Cook 
Ireland Ltd) for 1min at 37°C and for 1min at room temperature (RT). The GB drop was then 
merged for 2min with an adjacent 50ml drop of equilibration solution (ES) containing 7.5% 
ethylene glycol and 7.5% DMSO. The resulting drop was further merged with a fresh drop of 
ES for 2min before incubating the embryos in a separate 50ml ES drop for 10min at RT. Then, 
embryos were sequentially incubated at RT in 4 drops of 25ml vitrification solution containing 
15% (v/v) ethylene glycol, 15% (v/v) DMSO and 0.5M sucrose for 60–90s in total. The 
embryos were finally loaded onto High Security straws (Cryo Bio System) with a minimal 
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volume and the straws were thermo sealed before being plunged into liquid nitrogen. For 
warming, embryos were immediately placed in a 500ml drop of thawing solution containing 1M 
sucrose for 1min at 37°C and then for 1min at RT. Embryos were subsequently placed in a 
50ml drop of thawing solution for 1min at RT and then in two 50ml drops of dilution solution 
containing 0.5M sucrose for 2min each. Finally, embryos were incubated in three 50ml drops 
of washing solution for 3min each. Following the warming procedure, embryos were cultured in 
Cook Blastocyst medium at 37°C under 6% CO2, 5% O2 until transfer. 
 
The treatment main end-points were fertilization rate, clinical pregnancy rate, miscarriage rate 
and live birth rate in this oocyte retrieval. The clinical pregnancy was defined as the 
visualization of at least one gestational sac by ultrasound confirmation at about 6-8 weeks 
gestational age. Additionally, cumulative pregnancy rate, miscarriage rate and live birth rates 
were recorded from the subsequent stimulations following the oocyte retrieval that was 
investigated.  
 
Oocytes (n=106) from a total of 24 patients showing an abnormally high percentage of 
immature oocytes (>40%) at oocyte retrieval were included in Study group and classified 
based on their maturation stage: maturation resistant oocytes (MI-24h) (n=34) and IVM 
oocytes (13 GV-MII 24h, 20 MI-II 3h and 39 MI-II 24h) (n=72) (Supplementary Figure 1). 
Patients with 40% or more immature oocytes retrieved during an ICSI cycle represented 5% of 
the assisted reproductive population in our center (based on the database from Jan 2003 to 
September 2011 in Ghent University Hospital). For defining the Controls, we allocated oocytes 
(n=99) from 59 patients presenting with a normal number (≥60%) of mature oocytes at oocyte 
retrieval, included 55 maturation resistant (9 GV-MI 48h and 46 MI-24h) and 23 IVM oocytes (8 
GV-MII 24h and 6 MI-II 3h, 9 MI-II 24h) from 54 patients, as well as 14 donated fresh in-vivo 
matured MII oocytes obtained from a cancelled treatment and 7 in-vivo matured MII oocytes 
showing visible aggregates of smooth ER clusters (SERs) from 4 patients (Supplementary 














Supplementary Figure 1. Flow chart showing the inclusion of human immature and mature 
oocytes in the study. 
 
 
Source of mouse oocytes         
GV mouse oocytes were isolated from the ovaries of 8 to 14-week-old female LT/SvEiJ mouse 
(JAX stock #006252)  (n=25) and control B6D2F1 (n=15) mice 44-48h post intraperitoneal 
injection of 7.5IU/ml PMSG (Folligon®, Intervet) and were cultured in IVM medium for 16h at 
37°C in 6% CO2, 5% O2. The IVM medium consisted of Minimum Essential Medium Alpha 
(α-MEM) with GlutaMAXTM (Invitrogen, Life Technologies) supplemented with 5% (v/v) 
heat-inactivated fetal bovine serum (FBS; Gibco BRL, Life Technologies), 5μg/ml insulin, 
5μg/ml transferrin, 5ng/ml selenium (BD Bioscience), 50mIU/ml FSH and 50mIU/ml hCG 
(Puregon, Organon) (Vanhoutte et al., 2009). In-vivo matured MI and MII mouse oocytes were 
obtained by priming LT/Sv (n=40) and B6D2F1 (n=20) mice with 7.5IU/ml PMSG, followed by 
7.5IU/ml hCG (Chorulon®, Intervet), 48h later. Oocytes were recovered 14h post-hCG. 
Cumulus cells were removed by short incubation in 200IU/ml hyaluronidase. Potassium 
simplex–optimized medium (KSOM) was used for culture, while HEPES-buffered KSOM was 
used for manipulation. Both media were supplemented with 4mg/mL bovine serum albumin 





Spindle and IP3R1 staining 
Both human and mouse oocytes were fixed in a microtubule-stabilizing buffer, as previously 
described (Mattson and Albertini, 1990, Heindryckx et al., 2011). Briefly, stripped in-vitro 
cultured or in-vivo matured oocytes were simultaneously fixed and extracted in a 
microtubule-stabilizing buffer (0.1M PIPES, 5mM MgCl2, 2.5mM EGTA, 0.01% aprotinin, 1mM 
dithiothreitol, 50% deuterium oxide, 1pM taxol, 0.1% Triton X-100, and 3% formalin) for 30min 
at 37°C. Following 3 times intensive washes (15min), oocytes were subsequently stored at 
4°C in PBS-azide until fluorescence staining. At staining, oocytes were incubated overnight at 
4°C with a 1/1 mixture of mouse monoclonal anti-α and β-tubulin (1/200) and/or a primary 
antibody (1/1000) against the IP3R1 in mouse oocytes (rabbit, polyclonal, KU Leuven) (Parys 
and Bezprozvanny, 1995). After washing (3x15min), samples were treated with the secondary 
antibodies Alexa Fluor 488 goat anti-mouse IgG (H+L) (Molecular Probes) (1/200) and/or CY3 
donkey anti-rabbit IgG (H+L) (Jackson ImmunoResearch) (1/500) for 1h, followed by extended 
washing (3x15min). Meanwhile, the negative controls were treated without primary antibody 
but with the secondary antibodies alone. In addition, chromosomes were stained with Ethidium 
Homodimer-2 for one hour for human and 20μg/mL Hoechst-33258 for 30min for mouse 
oocytes, respectively. Finally, the oocytes were mounted in Mowiol containing 0.01% 
phenylenediamine and imaged using a laser scanning confocal microscope, Nikon A1R 
confocal microscope (Nikon Instruments) with a 60× Plan Apo VC oil immersion objective. The 
microtubule structure, chromosomes and/or IP3R1 distribution were obtained from Z-stacks 
(0.5–0.75µm/Z-step), using ImageJ software. Microtubule configurations and chromosome 
alignments of mouse oocytes were classified from A to D, as previously described (Combelles 
et al., 2011). In human oocytes, the spindles were classified as normal (bipolar) (Figure 1 A), or 
abnormal (mono- or multi-polar) (Figure 1 B). The chromosomes were classified as aligned 
(Figure 1 A’), or misaligned (>3 chromosomes away from the spindle equatorial region or 
dispersed with all chromosomes located throughout the spindle) (Figure 1 B’) (Combelles et al., 
2011; Trapphoff et al., 2016). In human oocytes, telophase I spindle (Figure 1C) and 
chromosomes (Figure 1C’) (Yu et al., 2012), as well as maturation resistant oocytes with two 
MII spindles (Figure 1D) with aligned chromosomes (Figure 1D’) were also observed. The 
IP3R1 distribution was classified as uniform (normal) (Figure 2A) or patched (Figure 2B), as 











Figure 1. Classification of spindle structure configuration and chromosomes alignment 
in human oocytes 
 
(A) Spindle with representative bipolar structure (normal). (B) Spindle with multi-polar 
irregularities (abnormal). (C) Elongated telophase I spindle perpendicular to the oocyte 
membrane following 24-hour culture. (D) Maturation resistant oocytes with two bipolar 
metaphase II spindles. (A’) Chromosomes were classified as aligned (normal). (B’) Dispersed 
chromosomes located throughout the spindle (misaligned). (C’) Telophase I chromosomes 
distributed at the ends of the spindle. (D’) Two sets of normally aligned chromosomes within a 















Figure 2. Classification of IP3R1 distribution in LT/Sv mouse oocytes 
 
(A) Homogeneous IP3R1 distribution with clusters on the cortex, forming a complete circle 
around the oocyte (Uniform). (A’) Normal spindle configuration and chromosome alignment (A’’) 
of B4D2F1 in-vivo matured MII oocytes. (B) Heterogeneous non-uniform distribution with 
patches and disconnection of IP3R1 (Patched). (B’) Un-focused MI spindle poles and not 
perfectly aligned chromosomes (B’’) of LT/Sv mouse in-vivo collected maturation resistant 
oocyte. (A’’’-B’’’) Merged images of three confocal channels. Scale bars: 2μm. 
 
Intracellular Ca2+-measurements 
Human oocytes were loaded with 7.5μM of Ca2+-sensitive dye Fura-2 acetoxymethyl (AM) 
ester (Invitrogen, Life Technologies) at 37°C in 6% CO2, 5% O2 for 30min and subsequently 
extensively washed in Cook cleavage medium. Oocytes were placed in glass- bottomed 
dishes (MatTek Corporation) and Ca2+-imaging was performed on an inverted epi-fluorescence 
microscope (TH4-200, Olympus Soft Imaging Solutions GmBH) with a 20x objective. 
Fluorescence was recorded at an emission wave length of ~ 510nm every 5s. Baseline drifting 
was adjusted before retrieving values for amplitude (value at maximum increase in 
fluorescence intensity per peak) expressed in arbitrary units (AU). Frequency reflected the 
total number of oscillations per recording period. 
 
For measuring spontaneous Ca2+-oscillations in mouse oocytes, isolated GV oocytes were 
loaded with Fura-2 in KSOM-HEPES for 15min. Oocytes were transferred to a drop of IVM 
medium and Ca2+-signals were recorded every 30s for a duration of 4h. The strontium induced 
Ca2+-oscillations were recorded every 5s for a duration of 2h, immediately after transferring the 
mouse oocytes to a drop of Ca2+-free KSOM with 10mM strontium chloride, in the 






The Statistical Package for Social Sciences version 21 (SPSS® Statistics, IBM Corp., USA) 
was used for statistical analysis. Means of multiple groups were compared using ANOVA and 
Bonferroni's Multiple Comparison Test. Proportions were compared by a contingency table 
analysis followed by a chi-squared or Fisher’s exact test. Differences yielding a P value <0.05 
were considered as being statistically significant. 
 
Results 
Nuclear maturation competence of human oocytes 
In the study group, oocytes were analyzed after in-vitro culture, with 34 MI maturation resistant 
oocytes retrieved at MI stage and 72 IVM oocytes matured from GV (n=13) and MI stage 
(n=59) (Supplementary Figure 1). The control group consisted of 55 MI maturation resistant 
oocytes retrieved at GV (n=9) and MI (n=46) stage, and 23 IVM oocytes matured from GV 
(n=8) and MI (n=15) stage. Moreover, a total of 21 in-vivo matured MII oocytes (including 7 MII 
oocytes with SERs) were also included as Controls (Supplementary Figure 1).  
 
Spindle morphology was analyzed by tubulin immunofluorescence (Figure 1 A-D). Abnormal 
spindle configuration was observed in 62% and 60% of maturation resistant oocytes from the 
Study and Control group respectively, and no significant difference was found (Table 1). IVM 
MII oocytes revealed the presence of spindle aberrations in 50% of the oocytes from the Study 
group compared with 30% of the oocytes from the Controls, which was not significantly 
different between the two groups (Table 1). Interestingly, in the Controls, the observed 
percentage of abnormal spindles was not significantly different between IVM and in-vivo 
matured oocytes (30% versus 14%); in contrast, a significantly higher percentage of oocytes 
with spindle abnormalities was found in the Study IVM group compared with the in-vivo 
















Table 1. Comparison of the spindle-chromosome configuration in maturation resistant, IVM 
and in-vivo matured human oocytes from study and control groups 













Number of oocytes (N) 34 72 55 23 21 
Spindle abnormalities N  
(%) 
21 (62) 36 (50)a 33 (60) 7 (30) 3 (14) 
Misaligned Chromosomes  
N (%) 
24 (71) 45 (63)a,b 35 (64) 8 (35) 4 (19) 
Telophase I spindle N (%) 0 9 (13) 1 (2) 0 0 
Two-spindle oocyte N (%) 4 (12) 0 0 0 0 
Chi-squared test and Fisher’s exact test; aP<0.01 when compare with Control in-vivo matured 
MII oocytes; bP<0.05 when compared with Control IVM MII oocytes.  
 
The proportion of oocytes with misaligned chromosomes (Figure 1B’) was comparable in 
maturation resistant oocytes from the Study and Control group (71% versus 64%, Table 1). 
Moreover, a significantly higher percentage of misaligned chromosomes persisted in the IVM 
MII oocytes from Study group compared with the Control IVM MII and in-vivo matured MII 
oocytes (63% versus 35% versus 19%, P<0.05). However, the rate of misaligned 
chromosomes of Control IVM MII oocytes was not significantly different from the Control 
in-vivo matured MII oocytes (Table 1). The percentage of oocytes at telophase I stage as well 
as oocytes with two sets of MII spindle-chromosomes was higher in Study group, when 

















Pregnancy outcomes of patients showing an abnormally high number of immature 
oocytes 
In total, 83 patients were included to evaluate the fertilization rates and subsequent treatment 
outcomes. For the analysis, the patients from the Study and Control group were further divided 
in two subgroups respectively, patients in which at least one maturation resistant oocyte was 
present after IVM (Study-maturation resistant patients versus Control-maturation resistant 
patients) and patients in which IVM induced meiotic progress in all oocytes (Study-IVM 
patients and Control-IVM patients), based on the presence of maturation resistant oocytes 
observed following in-vitro culture. No significant difference was observed in the mean of the 
patients age, the number of oocytes retrieved at oocyte retrieval across all groups (Table 2). 
Study-maturation resistant patients showed a significantly lower number of collected in-vivo 
matured MII oocytes, when compared with Control-maturation resistant patients (P<0.05, 
Table 2). 
 
Our analysis revealed that the mean of the fertilization rate and the number of embryos per 
transferred (fresh/frozen) did not differ across all groups (P>0.05, Table 2). Moreover, no 
significant difference was observed in the median of the number of frozen embryo transfers in 
current retrieval and the number of subsequent stimulations have been performed (P>0.05, 
Table 2). Moreover, the clinical pregnancy rate from all cycles was significantly lower in 
Study-maturation resistant patients when compared with Control-maturation resistant patients 
and Study-IVM patients (P<0.05, Table 2). All pregnant patients from Study-maturation 
resistant group (n=2) suffered miscarriages in her frozen cycle or a subsequent stimulation. 
However, no significant difference was observed in the miscarriage rate amongst all 
subgroups either from the current oocyte retrieval or across all cycles (P>0.05, Table 2). 
Within 11 patients allocated to Study-maturation resistant group, 4 of them present with all 
immature oocytes at retrieval, representing approximately half the number of analyzed 
maturation resistant oocytes (16 out of 34). Conversely, from the Study-IVM patients, 38.5% 
achieved a clinical pregnancy and with all of them resulted live offspring following current 
oocyte retrieval (Table 2). The clinical pregnancy and live birth rate of Study-IVM patients did 
not differ from the Control-IVM patients following the current stimulation, the cumulative clinical 
pregnancy and live birth rate of Study-IVM patients were comparable to the Controls as well 










Table 2. Embryological and cycle outcome data in the Study and Control patients for the 
investigated oocyte retrieval.  
 
ANOVA or Kruskal-Wallis or Chi-squared test; aP<0.05, when compared with Control 
maturation resistant patients; bP<0.05, when compared with Control IVM patients; cP<0.05 
when compared with Study IVM patients.  
Study/Control maturation resistant patients: patients in which at least one maturation resistant 
oocyte was observed following in-vitro culture of retrieved immature oocytes. Study/Control 
IVM patients: patients in which in-vitro culture induced meiotic completion in all retrieved 
immature oocytes. Values presented as mean ± SD, median (range), number or number/total 







In Control-maturation resistant patients, 32.6% achieved a clinical pregnancy, resulting in a 
live birth rate of 23.3% following current oocyte retrieval. No significant differences were 
observed when compared with Control-IVM patients (Table 2). Moreover, the overall 
pregnancy and live birth rates did not differ when additional cycles were included in the 
analysis (Table 2). Of note, the treatment outcomes of Control in-vivo matured patients (n=5) 
were not displayed in Table 2, due to the small sample size. Briefly, the fresh cycles from two 
patients who presented all oocytes with SERs were cancelled and no subsequent stimulation 
has been treated. Other two patients had a fresh embryo transfer and a subsequent 
stimulation, no pregnancy has been achieved. The patient who donated normal in-vivo 
matured MII oocytes in the investigated oocyte retrieval achieved an ongoing pregnancy in her 
second cycle. 
 
Defective IP3R1 distribution and Ca2+-oscillations during maturation and activation in 
LT/Sv maturation resistant oocytes 
Based on the immunostaining pattern of spindle integrity (Figure 2A’-B’), chromosome 
configurations (Figure 2A’’-B’’) and IP3R1 distribution (Figure 2A-B), we found a significantly 
higher percentage of LT/Sv IVM MII oocytes with both abnormal spindles and misaligned 
chromosomes, compared with LT/SV in-vivo matured MII oocytes and IVM MII oocytes from 
the B6D2F1 control (P<0.01, Table 3). Moreover, we observed a higher percentage of patched 
IP3R1 distribution in both IVM and in-vivo matured LT/Sv MII oocytes, when compared with 
in-vivo matured B6D2F1 MII controls (P<0.05, Table 3).  
 
Table 3. Comparison of abnormal spindles, misaligned chromosomes and patched IP3R1 
distribution of LT/Sv maturation resistant MI, IVM MII and in-vivo matured MII oocytes with 
B6D2F1 controls 
 
Chi-squared test and Fisher’s exact test; aP<0.01 compared with control B6D2F1 IVM MII 
oocytes; bP<0.05 compared with control B6D2F1 in-vivo matured MII oocytes; cP<0.05 




The maturation competence and the Ca2+-oscillatory pattern of LT/Sv GV oocytes was 
investigated at GVBD, during in-vitro maturation. After 2h of in-vitro culture, a significantly 
lower number of LT/Sv GV oocytes (49%, 24/49) transit to the GVBD stage compared with 
control B6D2F1 (80%, 20/25) GV oocytes (P<0.01, data not shown). When Ca2+ analysis was 
performed in oocytes collected at GV stage, only 33% (8/24) of LT/Sv oocytes showed 
Ca2+-oscillations compared with the majority of control B6D2F1 GV oocytes (75%, 15/20), with 
a significantly lower amplitude (0.07-0.1 AU versus 0.3-0.7 AU) (P<0.01, Figure 3).  
 
Figure 3. Spontaneous Ca2+-oscillations during GVBD of LT/Sv and B6D2F1 oocytes 
 
(A) Ca2+-oscillations during GVBD of LT/Sv oocytes. High frequency of Ca2+-oscillations with 
a reduced amplitude of 0.3-0.7 in 1-3min intervals during the first hour of measurement. (B) 
Ca2+-oscillations during GVBD of B6D2F1 oocytes. High frequency Ca2+-oscillations repeated 
with amplitude of 0.07-0.1 at 20-45s interval, during the first hour of measurement.  
 
Following the exposure to strontium, the frequency of Ca2+-rise was significantly lower in LT/Sv 
in-vitro cultured maturation resistant compared with the in-vivo collected LT/Sv maturation 
resistant and in LT/Sv IVM MII oocytes compared with LT/Sv in-vivo matured MII oocytes (both 
P<0.01, Table 4). Furthermore, LT/Sv in-vitro cultured maturation resistant and IVM MII 
oocytes showed a higher frequency of Ca2+-oscillations, when compared with IVM B6D2F1 MII 
oocytes (P<0.01, Figure 4A-C, Table 4). Additionally, in-vivo collected LT/Sv maturation 
resistant oocytes exhibited a significantly higher number of Ca2+-oscillations, compared with 
in-vivo matured LT/Sv MII and in-vivo matured B6D2F1 MII oocytes (P<0.05, Figure 4D-F, 











Table 4. Ca2+-oscillations in LT/Sv and control B6D2F1 oocytes during parthenogenetic 
activation with strontium. 
 
Chi-squared or ANOVA test; aP<0.01when compared with LT/Sv in-vivo collected maturation 
resistant MI oocytes; bP<0.05 when compared with LT/Sv in-vivo matured MII oocytes; cP<0.01 
when compared with control B6D2F1 IVM MII oocytes; dP<0.05 when compared with B6D2F1 
in-vivo matured MII oocytes.  
 
Figure 4. The strontium induced Ca2+-release pattern in LT/Sv in-vitro cultured maturation 
resistant, IVM MII and B6D2F1 IVM MII control oocytes (A-C). The Ca2+-release trace of LT/Sv 
in-vivo collected maturation resistant, in-vivo matured MII oocytes and B6D2F1 in-vivo 












Although complete failure of oocytes to complete meiosis maturation during assisted 
conception cycles is rare, occasional and repetitive maturation resistant does occur in infertile 
patients (Bar-Ami et al., 1994, Avrech et al., 1997, Beall et al., 2010, Heindryckx et al., 2011). 
Patients presenting with an abnormally high number of immature oocytes at retrieval show a 
great possibility of exhibiting maturation resistant oocytes, however, the influence of such 
event on the nuclear maturation competence, as well as on the subsequent pregnancy 
outcomes of these patients have not been investigated. In this study, we reveal that patients 
presenting with a high proportion of immature oocytes retrieved at oocyte retrieval (>40%), in 
addition to one or more maturation resistant oocytes following routine ovarian stimulation, 
exhibited abnormal nuclear maturation and failed to achieve a live birth. The treatment and 
clinical utilization of IVM oocytes of these patients in IVF transfers should be reassessed. 
Similar nuclear abnormalities were observed in IVM and maturation resistant oocytes from a 
maturation resistant mouse model, in addition to aberrant Ca2+-signaling observed during 
oocyte maturation and following artificial activation. 
 
Previous reports have indicated that in ovarian stimulation cycles with a high percentage of 
maturation resistant oocytes present after oocyte retrieval, fertilization rates and blastomere 
numbers per embryo are significantly reduced (Bar-Ami et al., 1994). From our data, patients 
with >40% immature oocytes, in which at least one maturation resistant oocyte was observed 
after in-vitro culture (Study-maturation resistant patients), did not show reduced fertilization 
rates, compared with control patients. However, no live birth was achieved in this group of 
patients. In support of this poor clinical outcome, we observed that the IVM oocytes from the 
Study group had a significantly higher proportion of spindle abnormalities compared with the 
oocytes in the control in-vivo matured group and a significantly higher proportion of 
chromosome abnormalities compared with IVM and in-vivo matured MII oocytes from Controls. 
Although some reports suggest IVM treatment as a suitable strategy for patients showing a 
high number of immature oocytes (Reichman et al., 2010), our results indicate that this 
approach should be considered with caution, as it may not be applicable for patients with more 
than 40% immature oocytes. Moreover, a high percentage of spindle-chromosome 
abnormalities was observed in maturation resistant oocytes from both Study and Control 
group.  
 
Correct chromosome segregation during oocyte meiotic divisions is a crucial factor for 
successful embryogenesis. Defects during this process lead to reduced developmental 
outcomes and are associated with subsequent pregnancy loss (Maciejewska et al., 2009). 
Moreover, SAC malfunctions, as well as dysregulation of maturation promoting factor (cyclin B) 
activity have been linked to reduced pre-implantation development and implantation potential 
(Ciemerych and Kubiak, 1998, Maciejewska et al., 2009, Hoffmann et al., 2012). The observed 
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defective spindle-chromosome configurations of oocytes from the Study group, may lead to 
the over-activation of SAC as previously reported (Maciejewska et al., 2009). As such, spindle 
configuration and SAC activation of in-vivo matured MII oocytes from the Study group requires 
further validation.  
 
Moreover, we utilized our maturation resistant LT/Sv mouse model to investigate Ca2+-related 
cytoplasmic maturation markers, in detail, to provide further clues regarding the origin of 
maturation resistance in human oocytes. The LT/Sv mice showed a high percentage of 
maturation resistant MI oocytes from both in-vivo and in-vitro collection as observed in human 
Study-maturation resistant patients, moreover, LT/Sv IVM oocytes displayed aberrant 
spindle-chromosomes configurations, similar to observed human IVM oocytes from the Study 
group. We attempted to analyze IP3R1 distribution and ionomycin induced Ca2+-release 
patterns (data not shown) in human maturation resistant oocytes from the Study and Control 
groups. However, due to the limited number of maturation resistant oocytes collected, we 
could not draw any relevant conclusions. The impaired Ca2+-signaling during IVM observed in 
this study, might explain the observed high MI arrest rate of LT/Sv oocytes following IVM as 
reported (O’Neill and Kaufman, 1987). Deregulated Ca2+-signaling could be attributed to 
altered oocyte metabolism (Lam and Galione, 2013, Williams et al., 2013) and impaired IP3R1 
distribution (Lefevre et al., 1997). However, following strontium exposure, we also found higher 
frequencies of Ca2+-rises in both in-vitro cultured and in-vivo collected LT/Sv maturation 
resistant oocytes, when compared with B6D2F1 IVM and in-vivo matured MII oocytes, 
respectively. Results from our Ca2+ analysis of LT/Sv maturation resistant oocytes suggest a 
method to investigate that cytoplasmic competence of human IVM oocytes from the Study 
group.  
 
Several studies have demonstrated that GV nuclear or cytoplasmic transfer represent potential 
treatment techniques to alleviate oocyte meiosis arrest, shown in the maturation resistant 
mouse model (Hoffmann et al., 2012) and for human oocyte maturation defects (Cohen et al., 
1997, Zhang et al., 1999). Spindle transfer has also been successfully applied for the 
treatment of mitochondrial disease (Neupane et al., 2014). However, considering the 
compromised IP3R1 distribution and impaired spindle-chromosome configuration observed in 
both human and mouse IVM and MR oocytes from our Study groups, the application of these 
methodologies requires further validation. Certainly, in depth embryo developmental and 
safety studies are required prior to the clinical implementation of the treatments.  
 
In conclusion, patients with a high proportion of immature oocytes retrieved at oocyte retrieval 
(>40%), in addition to one or more maturation resistant oocytes following routine ovarian 
stimulation, exhibited abnormal nuclear maturation and failed to achieve subsequent 
pregnancy. The treatment and further application of IVM oocytes from these patients should be 
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reassessed. Defective Ca2+-signaling at GVBD of in-vitro cultured LT/Sv maturation resistant 
oocytes and abnormal Ca2+-signaling of in-vivo collected LT/Sv maturation resistant oocytes 
following strontium exposure, point to broader impaired cytoplasm and oocyte quality. Our 
findings, demand further research into human maturation resistant oocytes, particularly in 
patients with a high number of immature oocytes.  
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4. Culture conditions affect Ca2+ signaling in artificially activated mouse 





Ionomycin is a Ca2+-selective ionophore commonly used for assisted oocyte activation (AOA), 
to overcome failed fertilization. In the second study of this thesis, we investigated the effect of 
external ionomycin and Ca2+ concentrations in culture media during AOA on both activation 
















The Ca2+ signaling and subsequent embryo developmental potential of mouse oocytes is 
influenced by the concentration of both ionomycin and external Ca2+ supplemented in the 
culture media. In human oocytes, the rise in Ca2+ levels provoked by 10μM ionomycin, was 
affected by the total calcium concentration present in the commercial media. The influence of 
commercial media on the amount of Ca2+ rise and subsequent treatment outcomes should be 
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Inconsistent fertilization and pregnancy rates have been reported by different laboratories after 
application of ionomycin as a clinical method of assisted oocyte activation (AOA) to overcome 
fertilization failure. Using both mouse and human oocytes, we investigated the effect of 
ionomycin and Ca2+ concentrations on the Ca2+-oscillatory pattern and embryonic 
developmental potential. In mouse, we found that the application of 5μM ionomycin in KSOM 
or 10µM ionomycin in Ca2+-free KSOM medium, significantly reduced the amount of Ca2+ flux 
and resulted in blastocyst formation failure compared to 10μM ionomycin in KSOM medium. 
Increasing Ca2+ concentration up to 3 or 6 times did not benefit mouse embryonic 
developmental potential. Similarly, the Ca2+ rise provoked by 10μM ionomycin in human 
oocytes increased along with the total calcium concentration present in the commercial media. 
Remarkably, we observed significantly reduced mouse embryo development when performing 
AOA during 10 minutes in SAGE and Vitrolife medium in contrast to COOK medium, with the 
same culture system supported from post activation to blastocyst formation stage in different 
AOA groups. In conclusion, both the concentration of ionomycin and Ca2+ supplemented in 
culture media applied during AOA can have a significant impact on the Ca2+ rise and further 
embryonic developmental potential. 
 








Intracytoplasmic sperm injection (ICSI) is currently the most effective and widely applied 
technique for treating male-factor infertility. It is also routinely used for indications of failed or 
low fertilization after treatment with conventional in vitro fertilization (IVF). Research shows 
that fertilization rates after ICSI are between 70% to 80%, which is considerably higher than 
other assisted procedures (Palermo et al. 2009; Neri et al. 2014). However, complete 
fertilization failure still occurs in approximately 1-5% of all ICSI cycles and can reoccur in 
subsequent treatments (Flaherty et al. 1998; Esfandiari et al. 2005). The principal cause of 
ICSI failure is generally associated with a deficiency in the oocyte activation process (Rawe et 
al. 2000; Yanagida 2004; Swain and Pool 2008; Neri et al. 2014). Oocyte activation is triggered 
by the sperm factor phospholipase C zeta, which mediates specific oscillations in Ca2+ 
concentrations within the ooplasm (Saunders et al. 2002; Tesarik 2002). Further downstream, 
binding of inositol 1,4,5-trisphosphate to its receptors (IP3Rs) in the oocyte generates the Ca2+ 
release required for successful activation, fertilization and subsequent embryonic development 
(Ramadan et al. 2012; Wakai et al. 2013). As such, both sperm and oocyte factors play an 
equally imperative role during the oocyte activation process. Irregularities in the characteristic 
Ca2+ oscillation pattern in the oocyte during activation may thus prevent fertilization and reduce 
embryonic developmental potential (Ajduk et al. 2011).  
 
For couples experiencing failed fertilization after ICSI, heterologous ICSI models, such as the 
mouse oocyte activation test and the mouse oocyte Ca2+ analysis have been successfully 
used to establish activation deficiencies and determine whether they are sperm or 
oocyte-related (Rybouchkin et al. 1996; Araki et al. 2004; Heindryckx et al. 2005). Following 
diagnosis, the technologies named assisted oocyte activation (AOA) are commonly applied to 
overcome fertilization failure. Thus far, a number of physical, mechanical and/or chemical AOA 
methods have been evaluated to achieve activation, including electrical pulses, modified ICSI 
procedures, as well as Ca2+ ionophores (Tesarik et al. 2002; Egashira et al. 2009; 
Nasr-Esfahani et al. 2010; Vanden Meerschaut et al. 2014). The most widely utilized artificial 
activating agents for human oocytes are Ca2+ selective ionophores, ionomycin and calcimycin 
(also known as A23187) (Heindryckx et al. 2008; Ebner et al. 2012). In contrast to strontium 
that induces a series of Ca2+ oscillations as elicited by sperm penetration during fertilization, 
the Ca2+ ionophore triggers a single Ca2+ transient in mouse and human oocytes (Vanden 
Meerschaut et al. 2014; Nikiforaki et al. 2016; Tosti and Ménézo 2016). Remarkably, neither 
Ca2+ rises nor oocyte activation is observed in our group when applying strontium as an AOA 
method in human (unpublished data). 
 
The availability and application of a variety of AOA technologies across laboratories has led to 
inconsistent results, with discordant fertilization and pregnancy data reported to date (Ebner et 
al. 2012; Montag et al. 2012). Moreover, some studies describe similar outcomes with AOA 
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compared to routine ICSI, with no significant improvement in fertilization rates (Borges et al. 
2009b; Borges et al. 2009a). Although such discrepancies may be attributed to a number of 
patient related factors, such as fertility background, the lack of diagnostic tests to accurately 
determine activation deficiencies, the variability within the AOA protocols themselves may also 
play a role (Vanden Meerschaut et al. 2014). It was recently demonstrated that the commercial 
available calcimycin was less efficient in inducing oocyte activation when compared to 
ionomycin (Nikiforaki et al. 2016). Furthermore, some groups describe the concomitant 
injection of Ca2+ chloride during ICSI in their AOA protocol (Heindryckx et al. 2008; Vanden 
Meerschaut et al. 2012), while others limit the AOA protocol to a one-time ionophore exposure. 
Such variations make standardization difficult. Moreover, the medium used for embryo culture 
following activation may affect further embryonic development (Malik et al. 2014). The overall 
compositions vary notably in the human embryo culture media (Morbeck et al. 2014a; Morbeck 
et al. 2017). However, the effects of specific culture components, such as the concentration of 
Ca2+ in the medium ([Ca2+]) applied in clinical AOA has not been thoroughly considered. 
Studies using bovine and porcine oocytes reveal that AOA using ionomycin combined with a 
specific culture medium containing a certain amount of Ca2+, increases activation efficiency 
and significantly improves embryonic development (Miyoshi et al. 2008; Fernandes et al. 2013; 
Malik et al. 2014).  
 
Nevertheless, the exact mechanism of ionomycin induced Ca2+ rise within mammalian oocytes 
remains unknown. To activate cells, ionomycin induces Ca2+ influx from the surrounding 
culture medium by transporting ions across membranes to equilibrate concentrations, or acts 
directly on intracellular organelles, as observed in starfish oocytes and zygotes (Mason and 
Grinstein 1993; Morgan and Jacob 1994; Vasilev et al. 2012). The impact of certain 
parameters on the efficiency of ionomycin, such as the induced Ca2+-oscillatory pattern during 
oocyte activation, remains to be investigated. Furthermore, specific effects of varying Ca2+ 
media concentrations on subsequent outcomes such as blastocyst formation rate are still 
unknown. In this study, we establish the intra-oocyte Ca2+ response to different concentrations 
of ionomycin and the effect of [Ca2+] in the surrounding culture medium. Primarily, we 
investigated the effects of the ionomycin and [Ca2+] concentrations as an AOA method on 
mouse oocyte activation, and three commercial available culture media were further evaluated 
with mouse oocytes. We hypothesized that the external ionomycin concentration and the [Ca2+] 
in the culture medium could affect AOA efficiency and impact subsequent embryonic 
developmental potential in both mouse and human. To this end, we further considered the 
effect of the surrounding [Ca2+] from commercial media on the Ca2+-oscillatory pattern of 






Materials and methods 
All chemicals were purchased from Sigma-Aldrich unless otherwise indicated. 
 
Ethical Approval 
The study was approved by the local Ethical Committee of the Ghent University Hospital, 
Belgium (2009/130, 2010/808, and 2010/182). All procedures involving handling and 
sacrificing the animals were approved by the Ghent University Hospital Ethical Committee for 
Laboratory Animals (ECD no. 14/45). Written informed consent were obtained from all 
patients. 
 
Source and culture of mouse oocytes 
6-10-week-old B6D2F1 hybrid female mice were stimulated with 7.5IU pregnant mare serum 
gonadotrophin (PMSG, Folligon®, Intervet, Boxmeer, The Netherlands), followed by 7.5IU 
human chorionic gonadotrophin (hCG, Chorulon®, Intervet, Boxmeer, The Netherlands), 46-48 
hours later. Metaphase II (MII) oocytes were harvested 12-14 hours following hCG injection in 
HEPES buffered potassium simplex optimized medium (KSOM-HEPES) supplemented with 
4mg/ml bovine serum albumin (BSA, Calbiochem). Cumulus cells surrounding the oocytes 
were removed by treatment with 200 IU/ml hyaluronidase in KSOM–HEPES. Oocytes were 
cultured under paraffin oil at 37°C in 6% CO2 and 5% O2 in KSOM containing 4 mg/ml BSA 
(1.71mM [Ca2+]).  
 
Source and culture of human oocytes 
Human spare oocytes were donated by patients (22-43 years old) undergoing ICSI/IVF 
treatment at the Ghent University Hospital between Aug 2016 and Dec 2016. Women 
undergoing a hormone stimulated cycle were administrated with a GnRH agonist (Decapeptyl; 
Ferring) or antagonist (Cetrotide;Merck Serono). Ovarian stimulation was performed with 
administration of hMG (Menopur; Ferring) or recombinant FSH (Gonal-F; Merck Serono) at a 
dose of 112.5–300IU daily and ovulation was induced with 5000IU hCG (Pregnyl;MSD). 
Oocytes were enzymatically denuded by brief exposure to 80IU/ml hyaluronidase (Irvine 
Scientific), followed by mechanical denudation before ICSI. The nuclear status was assessed 
and classified as GV (presence of a Germinal Vesicle structure), Metaphase I (MI) (absence of 
both a polar body (PB) and a GV structure) or MII stage (presence of a PB and absence of a 
GV structure). Donated GV oocytes were further cultured in medium 199 supplemented with 
10ng/ml epidermal growth factor, 1mg/ml estradiol, 10mIU/ml recFSH, 0.5mIU/ml hCG, 1mM 
l-glutamine, 0.3mM sodium pyruvate, 0.8% (v/v) human serum albumin (Red Cross, Belgium), 
100IU/ml penicillin G and 100 mg/ml streptomycin sulfate at 37°C under 6% CO2, 5% O2 for 24 
hours. Immature MI stage oocytes were cultured in Sydney IVF COOK cleavage medium (CC) 




Exposure of mouse and human oocytes to combinations of ionomycin and culture 
medium 
In the first set of experiments, mouse MII oocytes were exposed to 5μM, 10μM or 15μM 
ionomycin (cat. no. I9657, Sigma-Aldrich, Bornem, Belgium) dissolved in 1x[Ca2+] KSOM for 
10 minutes, respectively. Ionomycin was made as 5mM, 10mM and 15mM stock solution in 
dimethyl sulfoxide (DMSO) to ensure the amount of DMSO used was comparable across the 
different groups. Furthermore, mouse MII oocytes were exposed to 10μM ionomycin dissolved 
in nominally [Ca2+]-free KSOM (without added Ca2+, but with ~10 μM), 1x[Ca2+] KSOM, 3x[Ca2+] 
KSOM or 6x[Ca2+] KSOM for 10 minutes respectively. [Ca2+]-free KSOM, 1x[Ca2+] KSOM, 
3x[Ca2+] KSOM and 6x[Ca2+] KSOM were prepared by adding 0mM, 1.71mM, 5.13mM, and 
10.26mM CaCl2 in home-made [Ca2+]-free KSOM. The osmotic concentrations of culture 
media were comparable in the different [Ca2+] KSOM groups. In the third group of experiments, 
mouse MII oocytes were exposed to 10μM ionomycin dissolved in one of the three commercial 
IVF media (as outlined below in human) for 10 minutes. Further culture was performed in the 
same culture media.  
 
All parthenogenetically activated mouse oocytes were cultured in KSOM with 2µg/ml 
Cytochalasin D (CCD) for 4 hours after ionomycin exposure. CCD is used to prevent extrusion 
of the second PB to create diploid parthenogenetic embryos. Mouse MII oocytes activated with 
10mM strontium chloride dissolved in [Ca2+]-free KSOM with 2µg/ml CCD for 4 hours were 
used as positive control. After activation, the mouse MII oocytes were extensively washed and 
cultured in 1xKSOM for the first 60-72 hours post-activation. Subsequently, embryos were 
transferred to Sydney IVF COOK blastocyst medium (Cook Ireland Ltd). Embryo development 
was assessed at 24 hours (two-cell), 72 hours (morula/early blastocyst) and 96 hours 
(blastocyst) post-activation. Three replicates were performed for each concentration 
combination. A minimum of 18 oocytes were included in each group.  
 
In human, in vitro matured GV-MII 24 hours, MI-MII 3 hours and MI-MII 24 hours oocytes were 
exposed to 10μM ionomycin dissolved in one of the following commercial IVF media for 10 
minutes: CC medium, Quinns Advantage® Fertilization medium (SAGE) (Cooper Surgical Inc, 
CT, USA), Vitrolife IVFTM (Vitrolife, Göteborg, Sweden) and Sydney IVF COOK embryo biopsy 
[Ca2+]-free medium (Cook Ireland Ltd, Ireland).  
 
Ca2+ imaging in mouse and human oocytes following ionomycin exposure 
Mouse and human MII oocytes were loaded with 7.5μM of the ratio metric Ca2+ sensitive dye 
Fura-2 acetoxymethyl (AM) ester (Invitrogen, Life Technologies Europe B.V., Belgium) at 37°C, 
6% CO2 and 5% O2 for 30 minutes and then washed extensively. Subsequently, oocytes were 
placed in glass bottom dishes (MatTek, Corporation, Ashland, USA) and Ca2+ imaging was 
performed on an inverted epi-fluorescence microscope (TH4-200, Olympus Soft Imaging 
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Solutions GmBH, Belgium) with a 20x objective. Fluorescence was recorded at an emission 
wave length of ~ 510 nm every 5 seconds for 10 minutes. The baseline was set first, for one 
minute prior to the addition of ionomycin. The ratio of both Ca2+ induced signals 
(340nm/380nm) was proportional to the concentration of free intracellular Ca2+ (expressed in 
arbitrary units, AU). During acquisition, fluorescently loaded oocytes were exposed to different 
concentrations of ionomycin and/or incubated with culture media containing different [Ca2+].  
 
All oocytes were distributed randomly across the different groups and tested within 2 hours 
after assessing the maturation state. A maximum of 3 oocytes were measured simultaneously. 
Baseline drifting was adjusted before retrieving values for amplitude (value at maximum 
increase in fluorescence intensity per peak) expressed in arbitrary units (AU). Ca2+ rises were 
compared for time to peak (time in minutes from baseline to value at maximum), frequency 
(the total number of oscillations per recording period) and area under the curve (AUC) of the 
Ca2+ rise (calculated and expressed in AU x minutes). 
 
The total calcium concentrations of three commercial media and KSOM were analyzed by the 
polarized Energy Dispersive X-Ray Fluorescence spectrometer (EDXRF) system (Rigaku NEX 
CG). The accuracy of this technology is 0.001 molar (40 mg/L for calcium), while the detection 
limit is around 0.0001 molar (Silva et al. 2012). 
  
Statistical analysis 
The Statistical Package for the Social Sciences version 21 (SPSS® Statistics, IBM corp., NY, 
USA) was used for statistical analysis. Means (time to peak, RA, AUC and calcium 
concentration) of the two groups were compared by Student’s t-test, while multiple groups 
were compared using one-way ANOVA and Bonferroni's Multiple Comparison Test. 
Proportions (activation and blastocyst formation rate) were compared by a contingency table 
analysis followed by a chi-square or Fisher’s exact test. Differences yielding a P value < 0.05 
were considered as being statistically significant. 
 
Results 
Different ionomycin concentrations elicited distinct Ca2+ responses in mouse oocytes  
Following the exposure of mouse MII oocytes to ionomycin, the intracellular Ca2+ level 
promptly increased. The time to peak (1.22 ± 0.39 min versus 1.27 ± 0.41 min versus 1.25 ± 
0.43 min) did not differ among the three groups with different concentrations of ionomycin. The 
RA of the Ca2+ rises and the AUC were significantly higher in the mouse oocytes exposed to 
10μM ionomycin compared to 5μM ionomycin (Table 1, Fig. 1a, b). However, when the 
concentration of ionomycin increased to 15μM, there was no significant increase of the RA and 




Table 1. The impact of the ionomycin concentrations on the Ca2+ rise of mouse oocytes 






the Ca2+ rise 
AUC of 
the Ca2+ rise 
5µM ionomycin 20 1.18 ± 0.25 4.20 ± 1.47 
10µM ionomycin 20 1.71 ± 0.60a 8.82 ± 4.19b 
15µM ionomycin 19 1.98 ± 0.82a 10.93 ± 3.84b 
Data represent the mean ± s.d. aP < 0.05 when compared to RA of 5µM ionomycin group, bP < 
0.01 when compared to AUC of 5µM ionomycin group. RA, relative amplitude. AUC, area 
under the curve. 
 
Fig. 1. Ca2+ response in mouse oocytes following ionomycin exposure. 
The single Ca2+ rise was characterized by a rapid upstroke followed by a slower decline 









Extracellular Ca2+ amount influenced intracellular Ca2+ responses in mouse oocytes 
upon application of 10μM ionomycin as AOA 
We assessed the impact of different [Ca2+] in the surrounding media on the 10μM ionomycin 
induced intracellular Ca2+ level of mouse oocytes. In the first set of experiments, we examined 
the effect of different [Ca2+] in the culture media on the ionomycin induced Ca2+ rise. The RA of 
the Ca2+ rise was similar in 1x[Ca2+] KSOM and Ca2+-free KSOM medium, however, the AUC 
was significantly larger in 1x[Ca2+] KSOM compared to Ca2+-free KSOM medium (8.82 ± 4.19 
versus 5.03 ± 2.31 AU, P < 0.01) (Table 2, Fig. 1b, d). In the second set of experiments, we 
investigated the ionomycin induced intracellular Ca2+ level dissolved in KSOM culture media 
with 3 or 6 times [Ca2+]. The RA and AUC of the ionomycin induced intracellular Ca2+ rise was 
significantly higher in 6x[Ca2+] KSOM when compared to 3x[Ca2+] KSOM, however, no 
significant difference was found in either RA or AUC of the Ca2+ rise when comparing the 
3x[Ca2+] KSOM to the 1x[Ca2+] KSOM group (Table 2). 
 
Table 2. The impact of the extracellular Ca2+ concentration on the intracellular Ca2+ response 






the Ca2+ rise 
AUC of 
the Ca2+ rise 
Ca2+-free KSOM  21 1.68 ± 0.58a 5.03 ± 2.31b,c  
1x[Ca2+] KSOM  20 1.71 ± 0.60a 8.82 ± 4.19 
3x[Ca2+] KSOM 16 1.64 ± 0.38a 7.87 ± 3.34b 
6x[Ca2+] KSOM 17 2.35 ± 0.84 12.48 ± 7.15 
Data represent the mean ± s.d. aP < 0.05 when compared to RA of 6x[Ca2+] KSOM medium, bP 
< 0.05 when compared to AUC of 6x[Ca2+] KSOM medium, cP < 0.01 when compared to AUC 
of 1x[Ca2+] KSOM medium. RA, relative amplitude. AUC, area under the curve. 
 
Three different clinical IVF media differentially affect the pattern of Ca2+ rise  
We further assessed the influence of different commercially available culture media on the 
10μM ionomycin induced intracellular Ca2+ level in mouse oocytes. The RA of the Ca2+ rise was 
not significantly different amongst the three groups. However, the AUC of the Ca2+ rise 
provoked in the commercial Vitrolife culture medium was significantly lower compared to the 










Table 3. The impact of calcium concentration on the Ca2+ rise of mouse oocytes following 10 





the Ca2+ rise 
AUC of 
the Ca2+ rise 
CC medium 21 2.01±0.42 9.45±5.06 
SAGE medium 17 1.90±0.29 10.96±4.87 
Vitrolife medium 19 1.83±0.26 7.03±2.34a 
Data represent the mean ± s.d. aP < 0.05 when compared to AUC of SAGE medium with P < 
0.05. RA, relative amplitude. AUC, area under the curve. 
 
Effect of different concentrations of ionomycin and [Ca2+] on mouse embryonic 
development 
Mouse MII oocytes were activated with different concentrations of ionomycin or 10μM 
ionomycin dissolved in different culture media, as aforementioned. There was no significant 
difference in the 2-cell formation rate amongst the 5μM, 10μM and 15μM ionomycin groups. 
However, all three groups showed significantly lower 2-cell formation rate compared to the 
strontium control (P < 0.05, Table 4). Interestingly, no blastocyst formation was observed in the 
5μM ionomycin group; in contrast, a significantly higher blastocyst rate (79%) was obtained 
when 10μM ionomycin was used (P < 0.01), while 42% blastocysts were formed in the 15μM 
ionomycin group (Table 4). Except for the 10μM ionomycin group, exposure to both 5μM and 
15μM ionomycin resulted in a significantly lower number of blastocysts compared to the 
strontium control (P < 0.01, Table 4). 
 
When comparing three different [Ca2+] in the culture medium during the ionomycin exposure, 
there was no significant difference in 2-cell formation rate within the 1x[Ca2+] KSOM, 3x[Ca2+] 
KSOM and 6x[Ca2+] KSOM group (Table 4). However, we observed a significantly decreased 
activation rate in all three ionomycin groups, when compared to the strontium control (P < 0.05, 
Table 4). Moreover, a significantly decreased blastocyst formation rate was observed in 
6x[Ca2+] KSOM group compared to the strontium control (P < 0.05, Table 4). Interestingly, we 
found a significantly lower 2-cell formation rate in Ca2+-free KSOM, compared to the other 
three KSOM groups (P < 0.05), and no blastocysts were obtained in the Ca2+-free KSOM 
group (Table 4). 
 
We further investigated the embryonic development potential after ionomycin activation in 
three commercial IVF media and subsequent culture in similar culture media (KSOM/COOK 
Blastocyst medium). No significant differences were observed in 2-cell and blastocyst 
formation rates among all three different IVF media used during activation (10 minutes) (Table 
4). However, Vitrolife medium resulted in a significantly reduced blastocyst formation rate 
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compared to the KSOM (P < 0.05) and strontium control (P < 0.01) (Table 4). Furthermore, a 
significantly reduced blastocyst formation rate was observed in SAGE medium compared to 
the strontium control (P < 0.01, Table 4). Additionally, during parthenogenetic activation CC 
medium resulted in comparable 2-cell and blastocyst formation rate when compared to the 
KSOM and strontium control (P < 0.01, Table 4). 
 
Table 4. The activation rate and subsequent embryonic developmental potential of mouse 
oocytes following exposure to different culture media supplemented with varying 
concentrations of ionomycin 




1x[Ca2+] KSOM+5µM ionomycin 18 8 (44)a 0c,d 
1x[Ca2+] KSOM+10µM ionomycin 20 14 (70)a 11 (79) 
1x[Ca2+] KSOM+15µM ionomycin 18 12 (67)a 5 (42)c 
Ca2+-free KSOM+10µM ionomycin 20 5 (25)b 0c 
3x[Ca2+] KSOM+10µM ionomycin 18 12 (67)a 9 (75) 
6x[Ca2+] KSOM+10µM ionomycin 19 13 (68)a 6 (46)c 
CC medium+10µM ionomycin 46 26 (57)a 17 (65) 
SAGE medium+10µM ionomycin 23 16 (70)a 7 (44)c 
Vitrolife medium+10µM ionomycin 28 20 (71)a 7 (35)c,d 
Ca2+-free KSOM+10mM Sr2+ 20 20 (100) 18 (90) 
Data represent numbers (percentage). aP < 0.05 when compared to 2-cell rate of 10mM Sr2+ 
medium, bP < 0.05 when compared to 2-cell rate of 10µM ionomycin with 1x[Ca2+] KSOM 
medium, cP < 0.05 when compared to blastocyst rate of 10mM Sr2+ medium, dP < 0.05 when 
compared to blastocyst rate of 10µM ionomycin with 1x[Ca2+] KSOM medium. 
 
Ionomycin dissolved in three different commercial IVF media influence the Ca2+ 
response of human oocytes  
Our study included a total of 75 oocytes (25 GV-MII 24 hours, 20 MI-MII 3 hours and 30MI-MII 
24 hours) from 33 patients, allocated to the different groups. The Ca2+-release patterns of the 
oocytes were investigated following exposure to 10μM ionomycin dissolved in CC medium, 
SAGE medium, Vitrolife medium and Ca2+-free COOK medium. The allocations of GV and MI 
oocytes across the commercially available culture media were analyzed by the Chi-square 
test, and no significant difference was observed (P = 0.175). Moreover, the overall mean age 
of the patients was 32.4±4.4 years, ranging from 22 to 43 years old. We performed an 
additional ANOVA test to compare the age of the patients across these four groups, and no 





Fig. 2. Ca2+ response of IVM human oocytes following ionomycin exposure combined 
with different IVF medium.  
 
Each trace represented for a human oocyte. 
 
Following the exposure of human oocytes to ionomycin, the intracellular Ca2+ level rapidly 
increased as observed in mouse oocytes. The single Ca2+ rise was characterized by a rapid 
upstroke followed by a slower decline towards the baseline (Fig. 2). Overall, the RA and AUC 
of Ca2+ rise of human oocytes were significantly lower compared to mouse oocytes across all 
observed commercial media (P < 0.001). The time to peak of the triggered Ca2+ rise was 
significantly higher in the SAGE group when compared to the Ca2+ rise induced in the other 
three groups (Table 5). The RA of Ca2+ flux induced by ionomycin did not differ among the 
commercial media groups (Table 5, Fig. 2). Interestingly, we observed that the AUC of the 
Ca2+-rise tended to increase concomitantly with an increase in the amount of total calcium 
present in the medium (Table 5). However, a significantly higher AUC was only observed in 












Table 5. The impact of calcium concentration on the Ca2+ rise of IVM human oocytes, 
comparison of three different commercially available IVF culture media.  
 No. 
oocytes 
Time to peak 
(minute) 
RA of 
the Ca2+ rise 
AUC of 




CC 16 1.88±0.43a 1.38±0.65 2.51±1.52 1.70 ± 0.01 
SAGE  16 2.54±0.40 1.11±0.25 2.87±0.92 2.75 ± 0.12c 
Vitrolife  21 2.16±0.40a 1.42±0.57 3.13±1.09b 2.82 ± 0.03c 
Ca2+-free  22 2.03±0.34a 1.26±0.55 1.99±0.75 NA 
Data represent the mean ± s.d. aP < 0.05 when compared to time to peak of SAGE medium, bP 
< 0.05 when compared to AUC of Ca2+-free medium, cP < 0.05 when compared to Calcium 




To date, the application of different AOA strategies to overcome fertilization failure after ICSI, 
has led to successful outcomes, with high rates of fertilization and pregnancies established by 
some groups (Heindryckx et al. 2005; Heindryckx et al. 2008; Kyono et al. 2009; Terada et al. 
2009; Ebner et al. 2012; Montag et al. 2012; Kim et al. 2014; Vanden Meerschaut et al. 2014). 
However, the non-standardization of protocols across laboratories and numerous variables 
affecting the procedure have also resulted in inconsistent data. In some instances the 
application of AOA protocols have in fact led to reduced fertilization and pregnancy rates, or no 
improvement in outcomes when compared to routine ICSI (Borges et al. 2009b; Borges et al. 
2009a; Ebner et al. 2012; Montag et al. 2012). In the present study, we investigated specific 
external parameters, which may potentially affect outcomes following the application of the 
most well-established AOA techniques.  
 
In mouse oocytes, both the Ca2+-oscillatory pattern and the embryonic developmental potential 
were affected by the concentration of ionomycin and the [Ca2+] in the culture medium during 
AOA. Suboptimal conditions during the application of AOA even in a short time interval of only 
10 minutes, had major effects on the subsequent oocyte activation rate and more importantly 
hampered embryonic developmental potential. These effects were directly associated with 
[Ca2+] and ionomycin concentrations in the medium used for AOA. We therefore reveal, for the 
first time, that the Ca2+-oscillatory pattern triggered by ionomycin of IVM human oocytes may 
be influenced by the type of IVF culture medium used during the AOA procedure. Our results 
suggest that this effect is likely correlated with the total calcium amount in the culture medium. 
These important new findings should be carefully considered when applying AOA protocols to 
restore fertilization rates in human. We further encourage IVF laboratories to define more 
standardized protocols for AOA and account for the possible effects of parameters such as the 
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culture media used during the AOA procedure.  
 
Ca2+ signaling serves as a universal clue for the completion of meiosis and initiation of embryo 
development (Ramadan et al. 2012; Wakai et al. 2013). The Ca2+ flux during ionomycin 
exposure is recorded as a single Ca2+ transient pattern (Swann and Ozil 1994; Gualtieri et al. 
2011), which was also observed in both our human and mouse oocytes. During Xenopus and 
starfish oocyte activation, ionomycin predominantly induces Ca2+ release from ER by targeting 
IP3 sensitive stores (Yoshida and Plant 1992; Vasilev et al. 2012). By exposing oocytes to 
ionomycin in Ca2+-free conditions, we provide further insights into the underlying mechanisms 
of ionomycin and its function in mammalian oocyte activation. In Ca2+-free medium, the 
observed Ca2+ rise originated mainly from the endoplasmic reticulum (ER). It was initiated 
immediately after exposure and reached a comparable RA, at the same time point, as the 
Ca2+-containing groups in both human and mouse oocytes. However, the AUC was 
significantly reduced in oocytes activated in Ca2+-free conditions, suggesting that ionomycin 
mediates Ca2+ release from both the IP3R and the surrounding culture medium in mouse and 
human oocytes.  
 
In mice, we found that AOA with ionomycin in Ca2+-free media led to a complete failure in 
blastocyst formation. Remarkably, Ca2+-free KSOM was used only during the 10-minute time 
interval of AOA and the subsequent embryo culture was performed in Ca2+-containing KSOM. 
Our results show that the type of culture medium used during the short process of AOA during 
ten minutes can affect not only the activation rate, but more importantly also impact further 
embryonic development in mouse. It is important to take into account that the in vitro culture of 
the mouse oocytes was performed in the SAME culture system (KSOM/Cook Blastocyst) in all 
the experimental groups. Therefore, the observed effect is only due to this small-time frame of 
artificial oocyte activation during 10 minutes in the various conditions. Importantly, the 
Ca2+-free medium could contain some Ca2+ (~10 μM) due to the contamination from the 
recipients in which the solution is stored. Therefore, the contribution and proportion of extra- 
and intracellular Ca2+ during ionomycin activation requires precisely investigation, for instance 
the utility of BAPTA-MA (chelation of intracellular Ca2+). 
 
Moreover, when subjecting oocytes to ionomycin with different human culture media, human 
oocytes showed an overall delayed time to peak (the speed of Ca2+ release through ER) and 
reduced time of the transient dropping from the peak to baseline (the speed of removing the 
free cytosolic Ca2+) compared to mouse oocytes (Wakai et al. 2013). Under the conditions of 
the current study, it may indicate that in human, ionomycin induces Ca2+ signaling mainly 





Given the limited availability of human oocytes for research, we tested the influence of 
ionomycin concentrations and [Ca2+] in the culture media on the Ca2+ oscillatory pattern and 
embryonic development potential in mouse oocytes. Our results indicate that Ca2+ signaling 
induced by 5μM ionomycin was not sufficient to allow for the critical threshold of Ca2+ signaling 
proposed by Toth et al. (Toth et al. 2006) to be reached. This resulted in adverse downstream 
effects on activation rate and blastocyst formation. Furthermore, our data reveal that higher 
concentrations of ionomycin, such as 15µM do not benefit oocyte activation rates. Although, 
applied during AOA (Ebner et al. 2012), such high concentrations of ionophore may have a 
negative impact on further embryonic development as shown in our mouse model. Therefore, 
inconsistent fertilization rates after AOA in human, may also be attributed to the varying 
concentrations of ionophore used, as reported concentrations range from 5μM to 15μM (Moaz 
et al. 2006; Ebner et al. 2012; Montag et al. 2012). Moreover, several studies have reported 
that ionomycin is more potent and specific than calcimycin (A23187) during oocyte activation 
at the same concentration in various species (Kauffman et al. 1980; Vasilev et al. 2012; 
Nikiforaki et al. 2016). As such, the impact of high ionomycin concentrations on subsequent 
embryonic development may be more profound, in turn directly affecting the efficiency of AOA. 
 
Supplementing the medium with a higher Ca2+ concentration during AOA increased the 
activation rates and further embryonic development of bovine and porcine oocytes (Miyoshi et 
al. 2008; Fernandes et al. 2013). Similarly, enhanced fertility in micro-inseminated mouse 
oocytes with a higher [Ca2+] IVF medium was described before (Fujimoto et al. 1994). In 
contrast, we did not find any improvement in either the Ca2+-oscillatory pattern nor mouse 
embryonic developmental potential after ionomycin exposure in the presence of higher [Ca2+] 
(3x) in the culture media. Conversely, our results showed a lower blastocyst formation rate with 
a higher rate of fragmentation in 6x[Ca2+] medium compared to other KSOM groups. Ca2+ 
transport during a rise in Ca2+ requires the action of the sarco-ER Ca2+-ATPases, plasma 
membrane Ca2+-ATPases, as well as the Na+/Ca2+ exchanger (Berridge et al. 2000; Bootman 
et al. 2001). The reduced embryonic development observed, may be attributed to inhibition or 
damage of the Ca2+ pump of the ER and plasma membrane, propagated by the high 
concentrations of intracellular Ca2+ through both specific transport and the non-specific 
channel after ionomycin assisted Ca2+ permeability (Mason and Grinstein 1993). This 
phenomenon could result in the dysfunction of intracellular Ca2+ regulation and hence 
influence the subsequent embryonic developmental potential.  
 
When comparing the AOA efficiency using ionomycin in combination with different commercial 
IVF media, we found the AUC of Ca2+ rise in human oocytes increased slightly with the 
concentration of the total calcium in the medium. However, in mouse oocytes, the Vitrolife 
medium containing a higher total calcium concentration, generated a significantly lower AUC 
during ionomycin exposure. Importantly, the blastocyst formation rate was significantly 
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reduced when AOA was performed in Vitrolife medium, despite using similar culture media to 
support mouse embryonic development. Conversely, CC medium resulted in similar activation 
and blastocyst rates compared to controls. As the Ca2+ pattern of mouse oocytes might be 
influenced by some other culture medium components, the embryonic development potential 
test in mice represents a better potential methodology to study the influence of commercial 
culture medium on human oocytes.  
 
Apart from being the result of varying concentrations of calcium, the altered Ca2+ pattern and 
blastocyst rate in mouse embryos could also be attributed to the variability of proteins, other 
ions or EDTA present in the commercial human embryo culture media (Morbeck et al. 2014a; 
Morbeck et al. 2017). Although the variation in composition of protein supplements in the 
medium could influence the blastocyst developmental potential in mouse (Morbeck et al. 
2014b), it cannot account for the observed difference, as similar concentrations of HSA 
(5mg/mL) are supplied to all human media. The concentration of external magnesium ions 
(Mg2+) may however play a role, as increased concentrations (2.5mM) of external Mg2+ has 
shown to inhibit the intracellular Ca2+ release pattern of sea urchin egg  (Graeff et al. 1995), 
whereas oocyte fertilization in medium with reduced concentrations of Mg2+ (0.2mM) 
significantly improves blastocysts rates in both  mouse and human (Herrick et al., 2015). To 
our knowledge, the concentrations of Mg2+ in the observed media varied from 1.5mM (CC 
medium) to unknown (assumed around 1.7-1.8mM, similar to other media from the same 
distributor), analyzed by colorimetric methodology (Morbeck et al. 2014a; Morbeck et al. 2017). 
Moreover, the altered Ca2+ pattern could also result from the undisclosed concentrations of the 
membrane-impermeable metal ion chelator EDTA, as EDTA impairs embryonic developmental 
potential at high concentrations (>5mM) (Berridge et al., 2000; Lee et al., 2007). Further 
investigations are required to verify the effect of these components. 
 
Due to the lack of available human oocytes for research, it was not possible to evaluate the 
effect of different amounts of Ca2+ and other components present in the culture medium during 
artificial activation on embryonic developmental potential. However, reports performing AOA in 
CC conditions have resulted in more optimal outcomes (Heindryckx et al. 2008; Vanden 
Meerschaut et al. 2014). Our results show that the type of culture medium used during the 
process of AOA can affect not only the activation rate, but more importantly also impact further 
embryonic development in mouse. Therefore, we recommend that clinics applying AOA 
technology should take this into account. Currently, more standardized protocols that 
synchronize the crucial components of AOA medium are warranted. 
 
In conclusion, we have demonstrated that both the concentration of ionomycin and [Ca2+] in 
the culture medium directly affects the procedure of AOA in mouse oocytes. Importantly, 
mouse embryonic developmental potential was significantly influenced by the concentration of 
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ionomycin and [Ca2+] in the surrounding culture medium. Exposure to suboptimal culture 
conditions during the crucial activation phase, even during this short time interval, not only has 
detrimental effects on oocyte activation, but also hampers downstream processes such as 
embryonic developmental potential. In addition, our data also indicated that ionomycin acts on 
both Ca2+ stores of ER and Ca2+ from the surrounding medium in oocytes. As such, these 
parameters should be considered when optimizing or applying AOA protocols. Further studies 
are required to determine the optimal ionomycin and Ca2+ concentrations for human oocytes 
and verify their effect on the Ca2+-oscillatory potential, activation efficiency and embryonic 
developmental competence.  
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5. Strontium fails to induce Ca2+ rise and activation in human oocytes 





Although strontium (Sr2+) is used as an agent in assisted oocyte activation (AOA), to overcome 
fertilization failure after ICSI in the clinic, its efficiency is still deemed controversial. The 
transient receptor potential ion channels, vanilloid 3 (TRPV3), have recently been reported to 
mediate Sr2+ induced mouse oocyte activation. Therefore, in the third study of this thesis, we 















Sr2+ did not promote Ca2+ oscillations or provoke activation in human oocytes. However, 
transcripts of TRPV3 channels were present in in vitro matured (IVM) MII human oocytes. The 
pattern of localization of TRPV3 protein in human oocytes differed from what has been 
reported in mouse oocytes. Both agonists of TRPV3, 2-aminoethoxydiphenyl borate (2-APB) 
and carvacrol, promoted a single Ca2+ rise and activated more than half of the exposed human 
oocytes. Thus, the benefit of clinical application using Sr2+ to overcome fertilization failure after 
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Study question: Are the transient receptor potential ion channel vanilloid 3 (TRPV3) channels 
present and functional to mediate strontium (Sr2+) induced artificial activation in human 
oocytes as was recently reported in mouse? 
Summary answer: Sr2+ is not able to induce Ca2+ rises and provoke activation in human 
oocytes, however, TRPV3 channels were present in in vitro matured (IVM) MII human oocytes 
at transcription level and are shown to be functional upon using TRPV3 agonists inducing Ca2+ 
rises and oocyte activation. 
What is known already: Selective activation of TRPV3 by agonists provokes Ca2+ entry and 
promotes mouse oocyte activation, and the absence of TRPV3 channels in mouse oocytes 
prevents Sr2+ mediated artificial activation. Sr2+ is sometimes used to overcome fertilization 
failure after ICSI in clinic, but its efficiency is still controversial and the mechanism how it 
mediates the Ca2+ flux has not been studied yet in human. 
Study design, size, duration: The protein distribution and the mRNA expression of the 
TRPV3 channels was investigated in in vitro matured (IVM) metaphase II (MII) and in in vivo 
matured (IVO) MII human oocytes. The Sr2+ and TRPV3 agonists induced Ca2+ response and 
subsequent embryonic developmental potential was further analysed in both mouse and 
human oocytes. 
Participants/materials, setting, methods: MII oocytes from B6D2F1 mice as well as IVM 
human oocytes and IVO oocytes with aggregates of smooth endoplasmic reticulum clusters 
(SER) were used. The expression of TRPV3 protein was determined by confocal microscopy 
and Reverse Transcription PCR, the temporal evolution of intracellular Ca2+ concentration was 
measured by time-lapse imaging after exposure to Sr2+ and TRPV3 agonists. Artificial 
activation efficiency was assessed using these agents.  
Main results and the role of chance: Sr2+ could not promote Ca2+ oscillations or provoke 
activation in human oocytes. Transcripts of TRPV3 channels were present in in vitro matured 
(IVM) MII human oocytes. The pattern of localization of TRPV3 protein in human oocytes 
differed from the one reported in mouse oocytes. Both agonists of TRPV3, 
2-aminoethoxydiphenyl borate (2-APB) and carvacrol promoted a single Ca2+ transient and 
activated more than half of exposed human oocytes.  
Large scale data: The availability of fresh IVO matured oocytes in human was limited. Data 
from TRPV3 knockout model are not included. 
Wider implications of the findings: The benefit of clinical application using Sr2+ to overcome 
fertilization failure after ICSI requires further validation. 
Study funding/competing interest(s): This study was supported by FWO-Vlaanderen, China 
Scholarship Council and Special Research Fund from Ghent University (Bijzonder 
Onderzoeksfonds, BOF). No competing interest declared. 
 





Mammalian oocyte activation is triggered by the sperm factor phospholipase C zeta (PLCζ), 
which initiates a series of oscillations of Ca2+ levels within the ooplasm (Saunders et al., 2002; 
Tesarik, 2002). PLCζ hydrolyzes the precursor lipid phosphatidylinositol 4,5-bisphosphate to 
form both diacylglycerol and inositol 1,4,5-trisphosphate (IP3). Further downstream, the IP3 
binds to its cognate receptors (IP3Rs) present in the oocyte and thus generates the Ca2+ 
release from endoplasmic reticulum (ER) (Fedorenko et al., 2014; Mak and Foskett, 2015). To 
enable the series of oscillations, the extracellular Ca2+ influx is further required to restore the 
Ca2+ concentration in the ER during oocyte activation (Miao et al., 2012; Wakai et al., 2013). As 
such, the Ca2+ signaling mediates successful fertilization and plays a vital role in supporting 
further embryonic development (Ramadan et al., 2012; Wakai et al., 2013). Irregularities in the 
characteristic Ca2+ oscillation pattern in the oocyte during activation may thus prevent 
successful fertilization and reduce embryonic developmental potential (Ajduk et al., 2011; Miao 
and Williams, 2012). 
 
In IVF centers worldwide, deficiencies in the oocyte activation mechanism are associated with 
fertilization failure or low fertilization rate following the treatment of intracytoplasmic sperm 
injection (ICSI) (Rawe et al., 2000; Yanagida, 2004; Swain and Pool, 2008; Neri et al., 2014). 
The activation potential of sperm from patients who experienced fertilization failure can be 
evaluated by heterologous ICSI models (Araki et al., 2004; Heindryckx et al., 2005). Thereafter, 
the technology of assisted oocyte activation (AOA) is frequently applied during ICSI, with the 
principle of inducing a Ca2+ increase within the oocytes. Thus far, a number of physical, 
mechanical and chemical AOA methods have been evaluated, with successful oocyte 
activation and development to term after applying electrical pulses (Egashira et al., 2009), 
modified ICSI procedures (Tesarik et al., 2002), Ca2+ ionophores (Heindryckx et al., 2008; 
Ebner et al., 2012; Vanden Meerschaut et al., 2014) and strontium chloride (SrCl2) (Kim et al., 
2012, 2014).  
 
Despite several studies reporting successful pregnancies obtained following AOA treatment 
with Sr2+ (Yanagida et al., 2006; Kyono et al., 2008; Kim et al., 2012, 2014), the efficiency of 
Sr2+ as an activating agent for human oocytes is still under debate. In contrast to mice and rats 
studies, in which repetitive Ca2+ transients are observed (Whittingham and Siracusa, 1978; 
Roh et al., 2003), there is a lack of evidence supporting the same for human oocytes 
(Versieren et al., 2010). Recently in mouse, transient receptor potential cation channels, 
subfamily V, vanilloid 3 (member 3) (TRPV3) were identified to mediate Sr2+ induced oocyte 
activation (Carvacho et al., 2013; Lee et al., 2016). The TRPV3 are highly 
temperature-dependent channels (Peier et al., 2002; Smith et al., 2002) and are generally 
modulated by various stimuli and ligands, including natural compounds like carvacrol, thymol 
and eugenol, as well as 2-aminoethoxydiphenyl borate (2-APB) (Ramsey et al., 2006; Xu et al., 
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2006). These agonists, in particular 2-APB and carvacrol, showed their capacity to activate 
TRPV3 channels and promote Ca2+ influx, and as consequence, provoked mouse oocyte 
activation (Carvacho et al., 2013; Lee et al., 2016).  
 
In animal studies, Sr2+ has shown to be a highly efficient activating agent in parthenogenetic 
activation (Kishikawa et al., 1999; Versieren et al., 2010) and somatic cell nuclear transfer of 
mouse (Otaegui et al., 1999), bovine (Méo et al., 2004; Yamazaki et al., 2005) and porcine 
oocytes (Che et al., 2007). Moreover, Sr2+ convinced to be the most effective AOA method in a 
mouse model with deficient sperm activation capacity (Vanden Meerschaut et al., 2013) or 
more recently in a knockout mouse model for PLCζ (Hachem et al., 2017), compared to other 
agents. Since Sr2+ induces Ca2+ rises similar to the peaks provoked by rodent sperm, it is of 
interest to investigate the Sr2+ triggered Ca2+ rise and oocytes activation, as well as the 
expression and functionality of the TRPV3 channels in human oocytes. In addition, the use of 
TRPV3 channels agonists, such as 2-APB and carvacrol, could be used as an alternative AOA 
method in human.  
 
Materials and methods  
All chemicals were purchased from Sigma-Aldrich unless otherwise indicated. 
 
Ethical Approval 
The study was approved by the local Ethical Committee of the Ghent University Hospital, 
Belgium (2009/130, 2010/808, and 2010/182). Written informed consents were obtained from 
all patients. All procedures involving animal handling and sacrifice were approved by the 
Ghent University Hospital Ethical Committee for Laboratory Animals (ECD no. 11/41). 
 
Source and culture of human oocytes 
Patients (25-38 years old) undergoing ICSI treatment at the Ghent University Hospital between 
October 2014 and June 2015, were included in this study. Patients undergoing a hormone 
stimulated cycle were administrated with a GnRH agonist (Decapeptyl; Ferring) or antagonist 
(Cetrotide;Merck Serono). Ovarian stimulation was performed by administering hMG 
(Menopur; Ferring) or recombinant FSH (Gonal-F; Merck Serono) at a dose of 112.5-300IU 
daily and ovulation was induced with 5000IU hCG (Pregnyl;MSD). Oocytes were enzymatically 
denuded by brief exposure to 80IU/ml hyaluronidase (Irvine Scientific), followed by mechanical 
denudation prior to ICSI. Nuclear status was assessed and classified as Germinal Vesicle (GV) 
(presence of a GV structure), Metaphase I (MI) (absence of a both polar body and a GV 
structure) or MII stage (presence of a polar body and absence of a GV structure). Donated GV 
oocytes were further cultured in medium 199, supplemented with 10ng/ml epidermal growth 
factor, 1mg/ml estradiol, 10mIU/ml recFSH, 0.5mIU/ml hCG, 1mM l-glutamine, 0.3mM sodium 
pyruvate, 0.8% (v/v) human serum albumin (Red Cross, Belgium), 100IU/ml penicillin G and 
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100 mg/ml streptomycin sulfate at 37°C in 6% CO2 and 5% O2 for 24h. Immature MI stage 
oocytes were cultured in Sydney IVF COOK cleavage (CC) medium (Cook Ireland Ltd) for 3h 
or 24h based on the 1st polar body extrusion. IVO fresh MII oocytes showing visible 
aggregates of tubular smooth ER clusters (SERs) were collected as well, for this study. 
Although fertilized SER oocytes can lead to healthy live births, the clinical application of them 
is still under concern at our Department, due to the earlier reported malformations and 
impaired pregnancy outcomes (Otsuki et al., 2004; Sa et al., 2011; Itoi et al., 2015). We 
included a total of 104 oocytes (37 GV-MII, 46 MI-MII and 21 IVO MII with SERs), allocated to 
the different groups. The distribution of IVM and IVO MII oocytes across the same sets of 
experiments was analyzed using the Chi-square test, and no significant difference was 
observed (Table I, P>0.05). 
 
Source and culture of mouse oocytes 
6-10-week-old B6D2F1 hybrid female mice were stimulated with 7.5IU pregnant mare serum 
gonadotrophin (PMSG, Folligon®, Intervet, Boxmeer, The Netherlands), followed by 7.5IU 
human chorionic gonadotrophin (hCG, Chorulon®, Intervet, Boxmeer, The Netherlands), 
46-48h later. MII oocytes were harvested 12-14h following hCG injection in HEPES buffered 
potassium simplex optimized medium (KSOM-HEPES) supplemented with 4mg/ml bovine 
serum albumin (BSA, Calbiochem). Cumulus cells surrounding the oocytes were removed by 
treatment with 200 IU/ml hyaluronidase (0.3 mg/ml, type VIII) in KSOM-HEPES. Oocytes were 
cultured under paraffin oil at 37°C in 6% CO2 and 5% O2 in KSOM containing 4 mg/ml BSA 
until further treatments (Lawitts and Biggers, 1991).  
 
Ca2+ imaging in human and mouse oocytes following the exposure to Sr2+ and TRPV3 
agonists 
Human and mouse oocytes were loaded with 7.5μM of the radiometric Ca2+ sensitive dye 
Fura-2 acetoxymethyl (AM) ester (Invitrogen, Life Technologies Europe B.V., Belgium) at 37°C 
in 6% CO2, 5% O2 and for 30min and then washed extensively. Subsequently, oocytes were 
placed in glass bottom dishes (MatTek, Corporation, Ashland, USA) and Ca2+ imaging was 
performed on an inverted epi-fluorescence microscope (TH4-200, Olympus Soft Imaging 
Solutions GmBH, Belgium) with a 20x objective. Fluorescence was recorded at an emission 
wavelength of ~510nm every 5s. The ratio of both Ca2+ induced signals (340nm/380nm) was 
proportional to the concentration of free intracellular Ca2+ (expressed in arbitrary units, AU).  
 
For measuring the Ca2+ responses of human oocytes following Sr2+ exposure, the fura-2 
loaded IVM and SERs oocytes were transferred to a drop of Ca2+/Mg2+ free Earle's Balanced 
Salt Solution (EBSS) supplemented with 10mM SrCl2 (Life Technologies). The Ca2+ images 
were recorded every 5s for a duration of 6h. Following the first 2h of exposure, a group of 
human oocytes (n=5) that did not respond to the Sr2+ was subsequently exposed to 10μM 
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ionomycin (cat. no. I9657) dissolved in COOK Cleavage medium for 15min. The Ca2+ images 
were acquired to assess their ability to mobilize the intracellular Ca2+. The Sr2+ induced Ca2+ 
oscillations of mouse oocytes were recorded every 5s for a duration of 2h, immediately after 
transferring the eggs to a drop of Ca2+-free KSOM with 10mM SrCl2, in the glass bottom dish.  
 
Following the application of TRPV3 agonists, the Ca2+ responses of both human and mouse 
oocytes were investigated. Ca2+ images were recorded from human oocytes that exposed to 
200μM 2-APB or 200μM carvacrol within 1% PVA supplemented albumin-free IVFTM medium 
(Vitrolife, Göteborg, Sweden) for 30min. While mouse oocytes were subjected to the same 
concentration of the agonists but supplemented in 1% PVA KSOM (BSA-free) medium for 
30min. The stock solutions of TRPV3 agonists were prepared by dissolving them in Dimethyl 
Sulphoxide (DMSO), as done for ionomycin in our clinic (Heindryckx et al., 2008). The amount 
of DMSO added to the activation medium was tested and proven not capable of inducing Ca2+ 
rise or activation of mouse oocytes.  
 
All oocytes were distributed randomly across the groups and tested within 2 hours after 
assessing the maturation state. A maximum of 3 oocytes were measured simultaneously. 
Baseline drifting was adjusted before retrieving values for amplitude (value at maximum 
increase in fluorescence intensity per peak) expressed in arbitrary units (AU). Frequency 
reflected the total number of oscillations per recording period. Area under the curve (AUC) of 
the Ca2+ rise was calculated and expressed in AU x minutes. 
 
Parthenogentetic activation of MII human and mouse oocytes  
To test the activation efficiency of 10mM Sr2+, human oocytes were incubated in Ca2+-free 
EBSS medium and mouse oocytes were activated in Ca2-free KSOM medium with Sr2+ in the 
duration of 4h. For creating diploid parthenogenetic embryos, 2µg/ml Cytochalasin D (CCD) 
was supplemented in both of the activation media. In the agonists activation tests, human 
oocytes were treated with 200μM 2-APB for 30min or 200μM carvacrol for 10min dissolved in 
IVF medium at 37°C, while mouse oocytes were exposed at the same conditions as 
aforementioned, but within KSOM medium (albumin-free 0.1% PVA) (Carvacho et al., 2013). 
CCD was supplemented to the subsequent culture medium for 4h. Following activation, human 
oocytes were further cultured in CC medium for 16h, and mouse oocytes were incubated in 
KSOM for 60-72h followed by an 24h extended culture in COOK Blastocyst medium. The 
activation of human oocytes was evaluated by a single pronuclear formation (1PN) 16 hours 
post treatment. Mouse embryo development was assessed at 24 hours (two-cell), 72 hours 






Immunofluorescence staining of TRPV3 channels 
Oocytes were fixed and stained as previously reported (Carvacho et al., 2013). Briefly, the 
zona pellucida (ZP) of the oocytes was removed with tyrode’s solution. The zona-free oocytes 
were washed intensively in 2% goat serum, 1% BSA-supplemented PBS and fixed in 
PBS-BSA containing 2% paraformaldehyde for 45 minutes at room temperature. Oocytes were 
washed and blocked in PBS containing 0.1M glycine, 2% goat serum and 0.01% Tween 20 for 
at least one hour. Oocytes were then permeabilized with 0.1% Triton X-100 for 15 minutes at 
room temperature. Subsequently, samples were washed with PBS supplemented with 2% 
goat serum and 1% poly-vinyl alcohol (PVA) followed by a incubation at 4oC with the primary 
antibody against TRPV3 (1:100, 10 μg/ml, Neuromab, USA). After washing, oocytes were 
treated with the secondary antibody Alexa Fluor 488-conjugated goat anti-mouse IgG (H+L) 
(1:200, Molecular Probes, Eugene, OR, USA) for one hour at room temperature, followed by 
extended washings. In addition, chromosomes were stained with Ethidium homodimer-2 
(1:500, Life Technologies, USA) for an hour at room temperature. The negative controls were 
treated with the secondary antibodies alone. Finally, the oocytes were mounted in Mowiol 
containing 0.01% phenylenediamine and imaged using a laser scanning microscope, Nikon 
A1R confocal microscope (Nikon Instruments, Paris, France) with a 60× Plan Apo VC oil 
immersion objective. The TRPV3 distribution and chromosome alignments were obtained from 
Z-stacks (0.5-0.75µm/Z-step), using ImageJ software. 
 
Reverse Transcription PCR on pooled IVM human oocytes  
RNA was extracted from two groups of pooled IVM MII and IVO SERs human oocytes (n=19 in 
total, Table I), using PicoPure RNA isolation kit as described by the manufacturer (Life 
Technologies, USA). The following cDNA synthesis was performed using the Superscript VILO 
cDNA synthesis kit (Invitrogen, USA). Primers were designed to amplify the fragment spanning 
Exon6 and Exon7 of TRPV3 (Forward AGGCTTCTACTTCGGTGAGAC, Reverse 
AGGGCGTGAAGGATGTTGTTG) using Primer3 program.  
 
The Reverse Transcription Polymerase Chain Reaction (RT-PCR) was performed on the 
cDNA of these two groups of human oocytes and Day 5 arrested human embryos (n=4), while 
GAPDH was used as a positive control. Briefly the PCR conditions are as follows: initial 
denaturation at 94°C for 5min followed by 35 cycles of denaturation at 94°C for 30s, annealing 
at 64°C for 30s, extension at 72°C for 45s and a final extension at 72°C for 10min. The 
RT-PCR products were subsequently loaded on to the fragment analyzer and analyzed using 
PROsize program. Subsequently, the RT-PCR products was purified using Exo-AP and 
bi-directional Sanger sequencing was performed on the purified RT-PCR products using Big 
Dye Terminator kit (ABI, USA). The Sanger sequencing products were further cleaned using 





The Statistical Package for the Social Sciences version 21 (SPSS® Statistics, IBM corp., NY, 
USA) was used for statistical analysis. Proportions were compared by a contingency table 
analysis followed by a chi-square or Fisher’s exact test. Means (RA and AUC) from multiple 
groups were compared using ANOVA and Bonferroni's Multiple Comparison Test. Differences 
yielding a P value <0.05 were considered as being statistically significant. 
 
Results 
Sr2+ failed to induce Ca2+ rise and activation in human MII oocytes  
To verify the Ca2+ oscillatory and activation ability of Sr2+ exposure, IVM and IVO MII human 
oocytes (n=25, Table I) were subjected to 10mM Sr2+. Following the exposure, the changes of 
intracellular Ca2+ levels of analyzed oocytes were recorded by Ca2+ imaging. However, no 
increases in the intracellular Ca2+ concentrations were observed in a total number of 15 
oocytes within a duration of 6h (Figure 1A showed records from the first 2h). In contrast, 
mouse oocytes exposed to the same concentration of Sr2+ showed dynamic intracellular Ca2+ 
oscillations during the 2h analysis (Figure 1B). To test the reactivity to Ca2+ triggers of the 
human oocytes, 5 IVM human oocytes were further subjected to 10μM ionomycin following a 
2h exposure of Sr2+. All 5 IVM oocytes exhibited a single Ca2+ rise with a rapid upstroke 
followed by a slower decline towards the baseline immediately after the ionomycin exposure 
(Figure 1C, Table II). Activation capacities of the human oocytes (n=10) were further evaluated, 
following Sr2+ exposure. None of the human oocytes showed 1 PN after 16h following Sr2+ 
exposure, in contrast, all of the mouse oocytes activated and cleaved, 16h post Sr2+ activation 
(Table III).  
 
Table I The allocations of IVM and IVO (SERs) human oocytes across all studying groups. 
  No. 
 oocytes (n) 
GV-MII   
n (%) 
MI-MII   
n (%) 
IVO with SERs 
n (%) 
Ca2+ imaging Sr2+ 15 6 (40%) 6 (40%) 3 (20%) 
 2-APB 16 6 (38%) 6 (38%) 4 (25%) 
 Carvacrol 16 8 (50%) 5 (31%) 3 (19%) 
Immunostaining TRPV3 10 4 (40%) 6 (60%) a/n 
RT-PCR Group I 11 3 (27%) 8 (73%) a/n 
 Group II 8 2 (25%) 5 (63%) 1 (12%) 
Activation test Sr2+ 10 2 (20%) 4 (40%) 4 (40%) 
 2-APB 9 3 (33%) 3 (33%) 3 (33%) 
 Carvacrol 9 3 (33%) 3 (33%) 3 (33%) 





Table II The Ca2+ response of human oocytes following the exposure to varied activation 
agents. 
Activation agent No.  
oocytes 
Survived 
oocytes n (%) 
Responded 
oocytes n (%) 
RA of  
the Ca2+ 
rise 
AUC of  
the Ca2+  
rise 
Sr2+ 15 15 (100%) 0 a/n a/n 
2-APB 16 16 (100%) 4 (25%) 0.70±0.07a 2.36±0.90b 
Carvacrol 16 16 (100%) 9 (31%) 2.32±0.73a 4.98±1.93b 
Ionomycin post 
Sr2+ 
5 5 (100%) 5 (100%) 2.44±0.20c 13.14±9.32d 
Ionomycin post 
2-APB 
9 8 (89%) 8 (100%) 1.91±0.74 6.45±5.50 
Ionomycin post 
carvacrol 
7 7 (100%) 7 (100%) 1.14±0.90c 2.30±0.80d 
ANOVA and Bonferroni's Multiple Comparison Test aP<0.01, b,c,dP<0.05, a/n, not applicable. 


















Human  Sr2+ 10 10 (100) 0a,b a/n a/n 
2-APB 9 8 (89)  5 (63)a a/n a/n 
Carvacrol 9 7 (78) 5 (71)b a/n a/n 
Mouse  Sr2+ 20 19 (95) a/n 19 (100)d 18 (95) 
2-APB 20 14 (70)c a/n 13 (93)e 12 (92) 
Carvacrol 20 20 (100)c a/n 1 (5)d,e 1 (100) 
Chi-square and Fisher’s exact test: a,b,d,eP<0.01, cP<0.05, a/n, not applicable. Values with 









Figure 1. Sr2+ is not capable of provoking Ca2+ rise in human oocytes. 
 
(A) Sr2+ cannot induce Ca2+ rise of human MII oocytes during 2 hours of measurement. (B) 
Mouse MII oocytes exhibit repetitive Ca2+ transients following the exposure to 10mM Sr2+. (C) 
Exposure of human oocytes to ionomycin following Sr2+ incubation verify the reactivity of 
human oocytes to another AOA trigger. 
 
TRPV3 channels are expressed in human oocytes  
The TRPV3 channels were recently identified as the major channels to conduct Sr2+ influx and 
induce activation of mouse oocytes (Carvacho et al., 2013; Lee et al., 2016). Since Sr2+ failed 
to activate human oocytes or elicit Ca2+ transients, we further verified the expression and the 
function of the channels. Following the fluorescence staining, we observed a uniform 
distribution of TRPV3 protein throughout the ooplasma of the analyzed human oocytes (n=10) 
(Figure 2A-B). To validate the staining, we further examined the TRPV3 localizations in mouse 
oocytes (n=10), which showed distributions that concentrated at plasma membrane as 
reported previously (Carvacho et al., 2013; Lee et al., 2016) (Figure 2 C-D). To further confirm 
this result, the TRPV3 expressions of human oocytes were investigated at transcriptional level 
by RT-PCR. The transcripts of TRPV3 were detected in two groups of pooled IVM MII and IVO 
SERs human oocytes (Table I), demonstrated by the expected mRNA products in both groups 
(Figure 3A). Sanger sequencing of the RT-PCR products further revealed that the sequencing 
reads were aligned with the TRPV3 cDNA sequence downloaded from the UCSC genome 
browser with the transcript containing 791 amino acids (NM_001258205) using DNASTAR 






Figure 2. The localization of TRPV3 protein in human MII oocytes. 
 
(A) Chromosomes of IVM human oocytes are encompassing two regular rings, observed from 
the optical axis passing through the spindle poles. (B) TRPV3 protein of human IVM MII oocyte 
shows a diffused, non-specific pattern. (C) Chromosomes of mouse IVO oocytes are aligned 
at the equatorial plate. (D) Mouse TRPV3 proteins are expressed and concentrated at the 
cytoplasmic membrane. 
 
Figure 3. The TRPV3 mRNA expression in IVM MII and IVO SER human oocytes. 
 
(A) The transcripts of TRPV3 are expressed in two groups of pooled IVM and IVO human 
oocytes. (B) Chromatogram showing the Exon 6-7 junction of the TRPV3 gene after sanger 




TRPV3 agonists triggered Ca2+ rise and provoked oocyte activation of human and 
mouse oocytes 
The Ca2+ oscillatory and activation ability of the TRPV3 channels, were further investigated by 
subjecting human oocytes to the agonists 2-APB and carvacrol. Following the exposure of 16 
MII human oocytes to 200μM 2-APB, the intracytoplasmic Ca2+ increased in 25% (4 out of 16) 
of them, with displaying a small rise during the first 5min of measurement (Figure 4A, Table II). 
When subjecting 16 human oocytes to the same concentration of carvacrol, a similar 
proportion (31%, 5/16) of the oocytes responded, and exhibited a significant increase in Ca2+ 
level compared to the Ca2+ rise triggered by 2-APB (P=0.0034), during the first 10min of 
exposure (Figure 4B, Table II). The 4 IVM oocytes which responded with much lower Ca2+ 
fluctuation (RA 0.28±0.14, AUC 1.54±0.56) were not included (Figure 4B, Table II). All of the 
human oocytes survived following these chemical exposures and imaging. The groups of 
human oocytes which failed to respond to these TRPV3 agonists, were further exposed to 
ionomycin to evaluate the response of the oocytes to other Ca2+ triggers. As a result, all 
oocytes exhibited a sharp Ca2+ rise following the ionomycin exposure, showing a positive 
reactivity to the Ca2+ ionophore (Table II).  
 
Figure 4. The TRPV3 agonists, 2-APB and carvacrol, induced Ca2+ response  
of both human and mouse MII oocytes. 
 
(A) Increased intracellular Ca2+ of human MI oocytes provoked by 200μM 2-APB, a small 
peak exhibited in 4 human oocytes. (B) 5 out of 16 human MII oocytes respond to 200μM 
carvacrol, showing a sharp Ca2+ rise. (C) Elevated intracellular Ca2+ of mouse oocytes 
provoked by 200μM 2-APB, showing a great Ca2+ peak. (D) Lower Ca2+ response in mouse 




The addition of 200μM 2-APB to MII mouse oocytes (n=26) dramatically increased Ca2+ levels 
and immediately provoked a protracted peak during the 30min exposure (Figure 4C). Almost 
all mouse oocytes (n=24, 92%) responded to 2-APB, the remaining oocytes failed to show any 
Ca2+ rise (Figure 4C). The same concentration of carvacrol also evoked increases of 
intracellular Ca2+ in 46% (n=12) of the mouse oocytes showing a small peak in 10min duration 
of exposure (Figure 4D), whereas, 52% of which exhibited a small Ca2+ rise fluctuation 
(absolute amplitude less than 0.2) in the first 5min of exposure (Figure 4D). 
 
Furthermore, the activation potential of human and mouse MII oocytes was investigated as 
well, following the application of these two TRPV3 agonists. We allocated in total 18 IVM and 
IVO human oocytes (Table I) and 40 mouse oocytes to the 2-APB and carvacrol activation 
tests. Interestingly, more than half of the human oocytes activated and formed 1PN, observed 
at 16h post stimulation (63% and 71% for 2-APB and carvacrol respectively, Table III). When 
exposing mouse oocytes to 200μM 2-APB, 70% of them survived following the stimulation, 
and subsequently, more than 90% of them cleaved and developed to blastocysts (Table III). In 
contrast, carvacrol induced significantly less (5%) cleavage to the 2-cell stage compared to the 
2-APB group (P<0.0001, Table III).  
 
Discussion 
To date, Sr2+ has been applied as an AOA method to overcome fertilization failure or low 
fertilization rates (Kyono et al., 2008; Kim et al., 2012, 2014), in several IVF centers. However, 
the efficiency and the exact mechanism of Sr2+ as an activation agent in human oocytes 
remains largely unknown. In the present study, we investigated the activation capacity and 
Ca2+ response of human oocytes after Sr2+ exposure. Since it was recently shown that the 
TRPV3 channel mediates Sr2+ induced artificial activation in mouse oocytes (Carvacho et al., 
2013), we evaluated the presence and functionality of these TRPV3 channels in human 
oocytes. We demonstrated that Sr2+ failed to mediate Ca2+ rise and induce activation in human 
oocytes, despite the presence and functioning of TRPV3 channels. 
 
In contrast to other artificial activation agents that induce a single Ca2+ transient of mammalian 
oocytes (Vanden Meerschaut et al., 2014; Nikiforaki et al., 2016), Sr2+ activates rodent eggs by 
inducing a series of Ca2+ like oscillations (Whittingham and Siracusa, 1978; Roh et al., 2003), 
which closely mimic the pattern of Ca2+ rises triggered by PLCζ at fertilization. As such, Sr2+ 
has been applied initially as an AOA agent in clinic to overcome fertilization failure after ICSI. 
Consequently, improved fertilization rates and embryo qualities were reported from several 
couples with repetitive fertilization failure (Kyono et al., 2008; Chen et al., 2010), 
frozen-thawed testicular spermatozoa (Kim et al., 2012) and a globozoospermia case (Yang et 
al., 2012), with resulting healthy live-births. Despite these studies showing the potential of Sr2+ 
to overcome activation failure in human, we demonstrated that Sr2+ was not capable of 
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inducing Ca2+ increase or provoking activation of human oocytes. These discrepancies could 
be due to the lack of diagnostic methods used in those studies, to show a real sperm-related 
activation deficiency in those reports (Kyono et al., 2008; Chen et al., 2010; Kim et al., 2014). 
Still, one patient with globozoospermia (Yang et al., 2012) was also successfully treated with 
Sr2+, which could be explained by the fact that some globozospermic patients can achieve 
successful fertilization even after the application of routine ICSI in the absence of AOA (Huang 
et al., 2010). Therefore, it is hard to illustrate whether the patients enrolled in those AOA 
studies using Sr2+ as the activating agent, really required AOA in first instance, as diagnostic 
evidences (heterologious ICSI, genetic screening of PLCz, Ca2+ pattern analysis) were not 
obtained to show a lack of activation capacity in their sperm. 
 
To enable activation of mouse oocytes, extracellular Sr2+ is permeating through its functional 
membrane channel, TRPV3 (Carvacho et al., 2013), promoting downstream oscillations in 
[Ca2+]i/[Sr2+] of the oocytes, probably by sensitizing IP3Rs and thus facilitating Ca2+ oscillations 
(Zhang et al., 2005), or substituting for Ca2+ in the potentiation of IP3Rs (Girard and Clapham, 
1993; Marshall and Taylor, 1994; Lee, 2016). Thus, the failure of activating human oocytes by 
Sr2+ alone, could be attributed to the absence of membrane TRPV3 channels, which was 
proven not the case in the present study, or unlikely the inability of residues to conduct Sr2+ 
(Latorre et al., 2007), as well as the insensitivity of IP3R1 in responding to Sr2+ in human 
oocytes. Further investigations are required to verify it.   
 
Furthermore, we did confirm that the transcripts of TRPV3 channels were expressed in IVM 
human oocytes. The TRPV3 channels were recently demonstrated to be expressed in pooled 
fresh IVO human oocytes by a whole transcriptome analysis as well, albeit registered low 
levels (Kocabas et al., 2006). The diffused cytoplasmic localizations of TRPV3 protein might 
contribute to the observed inability of conducting Sr2+ influx by TRPV3 or the aberrant Ca2+ 
signaling following 2-APB treatment, owing to trafficking failure of functional TRPV3 protein to 
the membrane during in vitro culture, as the cytoskeleton modulates the function of TRPV3 
channels (Kuipers et al., 2012; Smani et al., 2014; Lee et al., 2016). Unfortunately, we could 
not rule out the possibility of low specificity of the method that was used in the present setting. 
More future analysis, for instance, by TRPV3 tagging with Ruby fluorescent protein (Lee et al., 
2016), is required to verify this.  
 
Although the expressed TRPV3 channels in human oocytes, failed to conduct Sr2+ influx or the 
conducted Sr2+ was not sufficient to promote Ca2+ release from the ER, they were shown to be 
functional in supporting agonists triggered Ca2+ rise and oocyte activation in both mouse and 
human oocytes. In the view of the efficiency of activating rodent oocytes, 2-APB was 
suggested as a potential AOA agent targeting at TRPV3 channels (Lee, 2016; Lee et al., 
2016). However, in our view, it is immature to encourage it at this moment, as both 2-APB and 
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carvacrol activates multiple Ca2+ related channels (Bilmen and Michelangeli, 2002; Bilmen et 
al., 2002; Colton and Zhu, 2007; Pires et al., 2015) and the exact mechanism remains largely 
unclear. Moreover, 2-APB mediated Ca2+ influx exclusively from the external culture medium 
(Xu et al., 2006; Lee et al., 2016), whereas, Ca2+ ionophore promoted Ca2+ increase from both 
the ER and extracellular Ca2+ influx (processing data from our group). Currently, ionomycin is 
still the most recommended agent to overcome fertilization failure after ICSI (Heindryckx et al., 
2005; Vanden Meerschaut et al., 2014; Nikiforaki et al., 2016), due to its high efficiency in 
provoking Ca2+ rise and inducing activation as demonstrated in both mouse and human 
oocytes (Vanden Meerschaut et al., 2014; Nikiforaki et al., 2016).  
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6. Distinctions in Ca2+ oscillatory patterns of post-ovulatory aged and 





In the present study, we are investigating the differences in Ca2+ oscilation patterns in zygotes 
resulting from post-ovulatory aged and reproductively aged oocytes, as well as their embryo 

















We found variable disruptions in the Ca2+ oscillation pattern during activation of the 
post-ovulatory aged IVO oocytes and reproductive-aged IVM and IVO oocytes. The altered 
Ca2+ oscillation pattern of post-ovulatory aged IVO oocytes, further impaired embryo 
development. However, this was not the case in reproductively aged IVM and IVO mouse 
oocytes. Furthermore, by extending the in vitro culture time to 20-24 hours post GVBD, Ca2+ 
oscillatory ability and further blastocyst development were restored in IVM mouse oocytes with 
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Oocyte ageing, due to advanced female age (reproductive oocyte ageing) and prolonged in 
vitro culture (post-ovulatory ageing) are both factors associated with decreased fertilization 
capacity and poor embryo quality. Intracellular Ca2+-signal is essential for successful 
mammalian fertilization and subsequent embryonic development. We primarily investigated 
the Ca2+-release pattern and subsequent embryonic development potential of post-ovulatory 
aged and reproductive-aged mouse oocytes following artificial activation, compared to fresh 
collected control oocytes. In addition, we divided ageing oocytes into in vitro maturated (IVM) 
and in vivo matured (IVO) groups according to the oocyte maturation stage at retrieval, to 
further investigate the effect of IVM on the Ca2+-release pattern. Overall, IVM oocytes from all 
groups showed significantly lower frequencies of Ca2+-oscillations when compared to IVO 
oocytes (P<0.01). Following 4-6 hours in vitro ageing, IVM oocytes showed significantly higher 
frequency of Ca2+-oscillations and blastocyst formation rates when compared to fresh IVM 
oocytes (P<0.01). In contrast, the frequency of the Ca2+-rises of the IVO oocytes increased 
significantly with the time of ageing (P<0.01), coinciding with a declined relative amplitude (RA) 
and reduced embryonic development potential compared to the fresh IVO controls (P<0.01). 
When IVM oocytes were collected from 50-52 weeks reproductive-aged mice, a longer latent 
period and a higher frequency of the Ca2+-oscillations was observed, when compared to IVM 
oocytes from young mice, with comparable RA. The IVO oocytes from aged mice showed no 
significant difference in the frequency of Ca2+-oscillations compared to oocytes retrieved from 
young mice, but showed a decreased RA (P<0.01). In conclusion, distinct deregulations of the 
Ca2+-signaling pattern occur in post-ovulatory aged and reproductive-aged oocytes during 
activation, which could be an underlying reason of impaired embryonic development. Only the 
IVM oocytes that mature to MII oocytes in a narrow time-frame, show adequate embryo 
development potential. 
 
Keywords: Post-ovulatory ageing; Reproductive ageing; Ca2+-release; embryonic 




In mammals, an optimal window exists to fertilize Metaphase II (MII) stage oocytes, which is 
generally considered within 10h post ovulation (Marston and Chang 1964; Tarin, Perez-Albala 
et al. 1999). At fertilization, the sperm factor phospholipase C zeta (PLCζ) triggers specific 
Ca2+ oscillations within the ooplasm. Further downstream, binding of inositol 
1,4,5-trisphosphate to its receptors (IP3Rs) generates Ca2+-release from the endoplasmic 
reticulum (ER) of the oocyte. The Ca2+-fluxes are required for the initiation of multiple protein 
kinase signaling cascades (Parrington, Davis et al. 2007; Swann and Lai 2013; McGinnis, 
Pelech et al. 2014), further supporting successful fertilization and subsequent embryonic 
development.  
 
When there is no fertilization in this adequate time frame, oocytes experience deterioration in 
quality referred to as ‘post-ovulatory ageing’ (Lord and Aitken 2013). This can occur both in 
vivo and in vitro, either in the oviduct of the female reproductive tract or in the in vitro culture 
medium of assisted reproduction settings. Post-ovulatory aged oocytes can still be injected to 
rescue for example failed fertilization in the clinic (Nagy, Joris et al. 1993), or serve as a 
valuable source for establishing embryonic stem cell lines after nuclear transfer (Wakayama, 
Suetsugu et al. 2007; Thuan, Kishigami et al. 2010). However, they exhibit numerous 
aberrations in their cell biology, for instance, cell cycle factors declines (Kikuchi, Naito et al. 
2002), mitochondrial dysfunction (Tatone, Heizenrieder et al. 2011; Lord and Aitken 2013) and 
spindle-chromosomal abnormalities (Wakayama, Thuan et al. 2004).  
 
At fertilization, deregulation of the Ca2+-signaling has been observed in post-ovulatory aged 
oocytes, showing a higher frequency and a lower amplitude in the Ca2+ oscillatory pattern 
(Kolker, Fukuyama et al. 2003; Takahashi, Takahashi et al. 2003; Takahashi, Igarashi et al. 
2009). As such, these post-ovulatory aged oocytes activate pathways of apoptosis, 
fragmentation and cell death, instead of supporting fertilization and normal embryonic 
development (Gordo, Kurokawa et al. 2002; Takahashi, Igarashi et al. 2009). The clinical 
applications of these aged oocytes are further associated with decreased fertilization capacity 
(Marston and Chang 1964; Ben-Rafael, Kopf et al. 1986; Badenas, Santalo et al. 1989) and 
embryo quality (Yanagida, Yazawa et al. 1998; Lord, Nixon et al. 2013), as well as increased 
likelihood of early pregnancy loss (Wilcox, Weinberg et al. 1998) and abnormalities in offspring 
(Tarin, Perez-Albala et al. 1999).  
 
Moreover, in vitro maturation becomes an emerging procedure incorporated into the world of 
assisted reproductive technologies. Fertilizing in vitro matured (IVM) oocytes represents a 
cheaper and safer approach compared to routine in vitro fertilization, particularly for women 
suffering from polycystic ovary syndrome. However, the ability of both mouse and human IVM 
oocytes to release Ca2+ at fertilization is impaired (Cheung, Swann et al. 2000; Mann, Lowther 
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et al. 2010). The impact of post-ovulatory and reproductive ageing on IVM oocytes has not yet 
been elucidated. 
 
Post-ovulatory ageing is a process distinct from ovarian ageing, which occurs within the ovary 
of females towards the end of the reproductive life, as they approach the climacteric, known as 
“reproductive ageing” (Bentov and Casper 2013). Ovarian ageing is associated with a 
decrease in the number and quality of ovulated oocytes, thus contributes to an increased 
incidence of infertility. Although the physiological consequences of reproductive ageing are 
known as increased percentage of abnormal or degenerating oocytes (Tarin, Perez-Albala et 
al. 2001), chromosomal aneuploidy (te Velde and Pearson 2002), and the injury of 
mitochondrial DNA (Keefe, Niven-Fairchild et al. 1995; Thouas, Trounson et al. 2005; Tatone 
2008), their molecular changes, such as the Ca2+-oscillatory patterns are not investigated.  
 
Therefore, in this study, we assessed the strontium (Sr2+)-induced Ca2+-oscillations in IVO and 
IVM post-ovulatory aged and reproductive-aged B6D2F1 MII oocytes after parthenogenetic 
activation. In addition, the activation rates and subsequent embryonic developmental potential 
was further investigated in these oocytes. 
 
MATERIALS AND METHODS 
All chemicals and reagents were purchased from Sigma Chemical Co. (Bornem, Belgium), 
unless otherwise indicated. 
 
Ethical Approval 
The mice from B6D2F1 hybrids (Iffa Credo, Brussels, Belgium) were housed and bred 
according to the national legislations for animal care. All procedures involving animal handling 
were approved by the Ghent University Hospital Ethical Committee for Laboratory Animals 
(ECD no. 14/45). 
  
Culture of mouse oocytes 
Mouse oocytes at the germinal vesicle (GV) stage were isolated from the ovaries of young 
females (8- to 10-weeks old) or reproductive-aged (50- to 52-weeks old) female mice, 46-48h 
post intraperitoneal injection of 7.5IU pregnant mare's serum gonadotropin (PMSG, Folligon®, 
Intervet, Boxmeer, The Netherlands). The antral follicles were punctured to release 
cumulus-enclosed GV oocytes into the potassium simplex optimized medium (KSOM)-HEPES 
medium, which contained 4mg/ml bovine serum albumin (BSA, Calbiochem, Bierges, Belgium) 
(Fulton and Whittingham 1978). Subsequently, the granulosa cells were removed by 
mechanical denudation prior to in vitro maturation. Oocytes with intact GV structures were 
selected and intensively washed in KSOM-HEPES, then transferred into Minimum Essential 
Medium Alpha (α-MEM) with glutaMAXTM (Invitrogen, Life Technologies, Merelbeke, Belgium), 
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and supplemented with 5% heat-inactivated fetal bovine serum (FBS; Gibco BRL, Life 
Technologies, Merelbeke, Belgium), 5μg/ml insulin, 5μg/ml transferrin, 5ng/ml selenium (BD 
Bioscience, San Jose, California, USA), 50 mIU/ml FSH and 50mIU/ml hCG (Puregon, 
Organon, Oss, The Netherlands) (Vanhoutte, Nogueira et al. 2009). Nuclear status was 
assessed after 2h of in vitro culture, after which oocytes showing germinal vesicle breakdown 
(GVBD) were selected and further cultured for another 16h. For in vitro ageing, the IVM 
oocytes were transferred in the droplets of KSOM containing 0.4% BSA, cultured for an 
additional 0, 4, 8 or 20h (i.e. 16, 20, 24, 36h post GVBD) at 37oC in 5% CO2 and 6% O2, until 
further analysis. 
 
In vivo matured (IVO) oocytes at the MII stage were obtained by priming mice with 7.5 IU/ml 
PMSG followed by 7.5 IU/ml human chorionic gonadotrophin (hCG, Chorulon®, Intervet, 
Boxmeer, The Netherlands) 48 hours later. Cumulus-enclosed oocytes were recovered from 
the ampullae 14 hours post-hCG and were released from the cumulus cells by a short 
incubation in 200 IU/ml hyaluronidase (0.3 mg/ml, type VIII) at 37oC. Oocytes were washed 
intensively and transferred to microdrops of KSOM supplemented with 0.4% BSA (Lawitts and 
Biggers 1991). For in vitro ageing, IVO MII oocytes were incubated in this medium for eather 
16 (fresh control), 24, or 36 hours post hCG (i.e. 2, 10 or 22 hours in vitro culture) at 37oC 
under 5% CO2 and 6% O2 until further use.  
 
Intracellular Ca2+ measurements 
For measuring the Sr2+-induced Ca2+-oscillations, oocytes were loaded with 7.5μM of the 
Ca2+-sensitive dye Fura-2 acetoxymethyl (AM) ester (Invitrogen, Life Technologies Europe 
B.V., Belgium). Following the loading, cells were washed intensively in Ca2+-free KSOM 
medium and then transferred to a drop of parthenogenetic activation medium with 10 mM Sr2+ 
and 2µg/mL cytochalasin D (CCD) covered by light paraffin oil in the glass bottom dish 
(MatTek Corporation, Ashland, USA). Ca2+-imaging was performed on an inverted 
epi-fluorescence microscope (TH4-200, Olympus Soft Imaging Solutions GmBH, Belgium) 
with a 20x objective. The microscope was equipped with an Okolab stage micro-environmental 
chamber enclosed in a CO2 microscope cage incubator so that all measurements were 
conducted at 37°C under 6% CO2. Fluorescence was recorded at an emission wave length of 
~ 510 nm every 5 seconds for 2 hours with a filter switch that provided excitation alternating 
between 340 and 380 nm. Baseline drifting was adjusted before retrieving values for amplitude 
(value at maximum increase in fluorescence intensity per peak) expressed in arbitrary units 
(AU). Ca2+-peaks were compared for latency period (the time between the exposure and the 






To analyze their embryonic development potential, IVO and IVM MII oocytes were aged 
similarly and then parthenogenetically activated in Ca2+-free KSOM containing SrCl2 and CCD 
for 4 hours. The MII oocytes were washed and cultured in KSOM for the first 60-72 hours 
post-activation and embryos were then transferred to Cook Blastocyst medium (Cook; Sydney 
IVF Blastocyst medium, K-SIBM-50). Embryo development was assessed at 24 hours 
(two-cell), 72 hours (morula/early blastocyst) and 96 hours (blastocyst) post-activation.  
 
Statistical analysis 
The Statistical Package for Social Sciences version 21 (SPSS® Statistics, IBM corp., NY, USA) 
was used for statistical analysis. Means (the frequency of the peak and RA) and Medians (the 
latency time period) of multiple groups were compared using ANOVA and Kruskal-Wallis test 
respectively. Proportions (Survival, activation and blastocyst formation rate) were compared by 
a contingency table analysis followed by a chi-square or Fisher’s exact test. Differences 
yielding a P value <0.05 were considered as been statistically significant.  
 
Results 
Sr2+-induced Ca2+-oscillations after parthenogenetic activation of IVO and IVM 
post-ovulatory aged oocytes  
Following their exposure to Sr2+, the intracellular Ca2+-levels of the oocytes promptly started to 
increase and showed a series of Ca2+-oscillations. The first Ca2+-peak of fresh oocytes is 
normally characterized by a rapid upstroke followed by a big sustained ‘shoulder’ and a slower 
decline towards the baseline (Figure 1). The repetitive Ca2+-spikes of fresh oocytes were 
analyzed within a time interval of 2 hours and were compared to 24 hours and 36 hours 
post-hCG or post GVBD aged oocytes.  
 
Figure 1. The Sr2+-induced Ca2+-rises of IVO fresh and post-hCG aged mouse oocytes 
during parthenogenetic activation. 
 
 
Interestingly, 24 and 36 hours post-hCG aged IVO oocytes exhibited several small Ca2+-rises 
before the first great peak (Figure 1), however, the latency period did not differ across the two 
post-ovulatory ageing groups and the fresh controls (media 0.01 vs. 0.01 vs. 0.01 hour). The 
percentage of survived oocytes that responded to Sr2+ by showing Ca2+-oscillations was 
similar post parthenogenetic activation in the three IVO aged groups (98% vs. 100% vs. 87%) 
(Table 1). The frequency of the Ca2+-rises was significantly increased in the two IVO aged 
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groups compared to the fresh IVO controls (mean 14.33 vs. 16.92 vs. 11.30) (P<0.05, Table 1). 
Furthermore, the RA of the IVO oocytes was increased in the 24 hours post-hCG aged IVO 
group compared to the fresh controls, followed by a significant decrease along with the time of 
ageing (36 hours post-hCG aged IVO oocytes) (Table 1).  
 
Table 1. Sr2+-induced Ca2+-oscillations during parthenogenetic activation in both IVO 
and IVM post-ovulary ageing oocytes.  
Oocytes Culture time 
post 
hCG/GVBD 









RA of the 
Ca2+-spikes 
IVO 16h 45 98%  98% 11.30±5.01a,b 0.89±0.22a,b 
 24h 40 100%  100% 14.33±2.42 0.97±0.27b 
 36h 30 87%  92% 16.92±8.26 0.67±0.15 
IVM 16h 49 43%  78% 1.05±1.07c,d 1.00±0.63c 
 20h 44 55% 92% 8.13±5.17 0.92±0.20d 
 24h 33 42%  100% 6.57±2.79 1.11±0.30 
ANOVA with Bonferroni's Multiple Comparison Test; aP<0.01 when compared with 24 hours 
post-hCG IVO oocytes. bP<0.01 when compared with 36 hours post- hCG IVO oocytes. 
cP<0.01 when compared with 24 hours post-GVBD IVM oocytes. dP<0.01 when compared with 
36 hours post-GVBD IVM oocytes. Frequency and RA of Ca2+-spikes are shown as 
Mean±S.D.  
 
Upon the exposure of 36 hours post-GVBD aged oocytes (n=24) to Sr2+, all oocytes were 
damaged. Therefore, we included the 20 hours post-GVBD group, to investigate the impact of 
ageing on IVM oocytes in depth (Figure 2). Similar to IVO oocytes, no difference was observed 
in the time period of lactency across all three IVM aged oocytes (media 0.04 vs. 0.03 vs. 0.02). 
Although the percentage of survived oocytes that showed Ca2+-oscillations was similar among 
the three IVM aged groups (78% vs. 92% vs. 100%), significantly less oocytes survived from 
IVM groups (43% vs. 55% vs. 42%) during parthenogenetic activation, when compared to IVO 
aged groups (98% vs. 100% vs. 87%) (P<0.01, Table 1). Additionally, a significantly higher 
frequency of Ca2+-oscillations was observed in 20 and 24 hours post-GVBD aged oocytes 
when compared to fresh IVM controls (P<0.01) (Table 1). All IVM groups showed a significantly 
lower number of Ca2+-oscillations compared to IVO groups (P<0.01), except for the IVM 20 
hours post GVBD group, showing a similar frequency of Ca2+-oscillations as observed in IVO 
fresh oocytes (Table 1). Moreover, the RA of the Ca2+-oscillations was decreased in 20 hours 
post GVBD aged IVM oocytes compared to fresh IVM oocytes, which was increased again in 
24 hours post GVBD aged IVM oocytes when compared to 20 hours aged IVM oocytes 




Figure 2. The Sr2+-induced Ca2+-rises of IVM fresh and/or post GVBD aged mouse 
oocytes during parthenogenetic activation. 
 
 
Embryonic development potential after parthenogenetic activation in both IVO and IVM 
post-ovulary aged oocytes  
We compared the embryonic development potential of 24 hours and 36 hours post-hCG or 
post GVBD aged oocytes to fresh IVO or IVM MII oocytes after parthenogenetic activation. In 
the IVO groups, there was no significant difference in the percentage of oocytes that survived 
after parthenogenetic activation among all three groups. However, compared to the 
percentage (100%) of activated fresh IVO oocytes following Sr2+-exposure after 
parthenogenetic activation, the 2-cell formation rate was significantly lower in 24 hours and 36 
hours post-hCG aged oocytes (P<0.01, Table 2). Moreover, all oocytes with activation failure 
underwent fragmentation after 24 hours in these two aged groups. Nevertheless, there was no 
blastocyst formation in the 36 hours post-hCG aged group, while there was blastocyst 















Table 2. Embryo development potential after parthenogenetic activation in post-ovulary 
ageing oocytes from both in vitro and in vivo maturation. 
Ooocytes Aged hours 
post 
hCG/GVBD 








IVO 16h 51 90% 100%a,b 80%b 
 24h 52 100% 83%b 72% 











 24h 35 51%e 56%e 60%  
 36h 22 23% 0  N/A  
Two-tailed Fisher’s exact test; aP<0.01 when compared with 24 hours post-hCG IVO oocytes. 
bP<0.01 when compared with 36 hours post- hCG IVO oocytes. cP<0.01 when compared with 
20 hours post-GVBD IVM oocytes. dP<0.01 when compared with 24 hours post-GVBD IVM 
oocytes. eP<0.01 when compared with 36 hours post-GVBD IVM oocytes. NA: not applicable 
 
When subjecting IVM oocytes to Sr2+, the survival rate was significantly lower in 24 hours (51%) 
and 36 hours (23%) post GVBD ageing groups compared to the fresh (16h) IVM group (83%) 
(Table 2). Following parthenogenetic activation, the two-cell formation rates were similar 
among 20 and 24 hours post GVBD aged oocytes and the fresh IVM controls, whereas the 
blastocyst formation rate was significantly higher in 20 hours post GVBD aged oocytes among 
all IVM groups (P<0.05, Table 2). Additionally, no differences were found in survival rate, or in 
2-cell formation and blastocyst formation rate when compared 20 hours to 24 hours post 
GVBD aged oocytes (Table 2). Moreover, there was no 2-cell and blastocyst formation in 36 
hours post-GVBD aged oocytes after parthenogenetic activation (Table 2). Furthermore, fresh 
IVM oocytes showed significantly lower blastocyst formation rates compared to fresh IVO MII 
oocytes (26% vs. 80%, Table 2).  
 
Sr2+-induced Ca2+-oscillations during parthenogenetic activation in both IVM and IVO 
reproductive-aged oocytes 
Reproductive ageing contributes to the increasing incidence of infertility, which is associated 
with a decrease in number and quality of ovulated oocytes. The Ca2+-response of fresh IVO 
and IVM MII oocytes from 50-52 weeks old reproductive-aged mice were compared to fresh 
IVO and IVM MII oocytes from young mice during parthenogenetic activation in this study 
(Figure 3). The number of oocytes recovered from the aged mice was 5 times less than from 
the young mice, from both IVM and IVO (data not shown). Interestingly, the percentage of 
surviving oocytes (96% vs. 98%) and oocytes that showing Ca2+-oscillations (100% vs. 98%) 
was similar in IVO oocytes from aged and young mice after parthenogenetic activation (Table 
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3). Moreover, no significant difference was found in the period of latency and the frequency of 
Ca2+-oscillations, when compared IVO MII oocytes from old mice with IVO MII oocytes from 
young mice (Table 3). However, the RA of Ca2+-oscillations of IVO MII oocytes from aged mice 
was significantly lower when compared to IVO MII oocytes from young mice (P<0.01, Table 3).  
 
Figure 3. The Sr2+ induced Ca2+-rises of IVO and IVM reproductive-aged mouse oocytes 
during parthenogenetic activation. 
 
 
















RA of the 
Ca2+-spikes 
IVO  Aged 
(23)  
96% 100% 0.20 
(0.01-0.04) 
10.4 ± 2.1  0.79±0.28b 
 Young  
(45) 





45% 90% 0.54 
(0.21-1.49) 
5.6 ± 3.1a 0.98±0.43 
 Young  
(49) 
43%  78% 0.04b 
(0.01-0.17) 
1.05±1.07b 1.00±0.63 
Student-t test and Mann-Whitney test. aP<0.01 when compared with IVO oocytes from aged 
mice. bP<0.01 when compared with IVM oocytes from aged mice.Frequency and RA of 
Ca2+-spikes are shown as Mean±S.D. Latency is shown as median (range). 
 
In IVM groups, no difference was found in the percentage of surviving oocytes (45% vs. 43%) 
and oocytes showing Ca2+-oscillations (90% vs. 78%) when comparing aged mice versus 
young mice (Table 3). Interestingly, Sr2+ immediately initiated persistent oscillations in IVM 
oocytes from young mice. In contrast, there was a significantly longer latent period before the 
initial spike in the IVM oocytes from reproductive-aged oocytes, compared to IVM oocytes 
from young mice (media 0.54 vs. 0.04) (P<0.05, Table 3) (Figure 3). Furthermore, a 
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significantly higher frequency of the Ca2+-oscillations with similar RA was found in IVM oocytes 
from aged mice compared to young controls (Table 3). The number of the Ca2+-oscillations of 
IVM oocytes was significantly lower than IVO oocytes from aged mice, but displaying a higher 
RA (P<0.01, Table 3).  
 
We further analyzed the embryonic development potential of oocytes from aged mice. No 
significantly differences were found in either activation rate or blastocyst formation rate, when 
compared IVM and IVO oocytes from aged mice to oocytes from young mice (Table 4).  
 
Table 4. Embryo development potential after parthenogenetic activation in reproductive 
ageing oocytes from both in vitro and in vivo maturation. 
 Origin of the 
oocytes 









IVO Aged mice  35  97% 91% 84%  
 Young mice  28  100% 96% 85% 
IVM Aged mice  22  72% 88% 71% 
 Young mice 33  42% 100% 36%  
 
DISCUSSION 
Post-ovulatory and reproductive ageing have both been associated with a decreased 
fertilization capacity (Marston and Chang 1964; Ben-Rafael, Kopf et al. 1986; Badenas, 
Santalo et al. 1989), and increased abnormalities of the offspring (Tarin, Perez-Albala et al. 
2001). However, the impact of ageing on the Ca2+-oscillatory pattern of IVM and IVO oocytes 
had not been investigated yet. We found evidence of an abnormal Ca2+-oscillatory pattern 
during parthenogenetic activation, which coincided with impaired embryo developmental 
potential in post-ovulatory aged oocytes, but not in reproductive-aged oocytes. 
 
Intracellular Ca2+-oscillations accompany all the metabolic and cytological changes at oocyte 
activation (Tombes, Simerly et al. 1992; Vasilev, Chun et al. 2012). Besides by PLCz, 
Ca2+-rises can also be provoked by a variety of physical, mechanical and chemical activation 
stimuli (Vanden Meerschaut, Nikiforaki et al. 2014), of which Sr2+ is the most widely used 
artificial activating agent for rodent eggs (Whittingham and Siracusa 1978; Roh, Malakooti et al. 
2003). However, the possible variation of Sr2+-induced Ca2+-pattern in different types of aged 
oocytes was still unknown.  
 
In the current study, we found that the frequency of the Ca2+-oscillations promptly increased in 
the 24 hours aged groups (10 hours in vitro culture), whereas, the RA of the Ca2+-oscillations 
decreased in 36 hours post-hCG aged IVO oocytes. Prolonged culture ahead of activation 
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resulted in global changes in the abundance or activity of protein kinases that regulate the 
response to Ca2+, stress, and cell-cycle control (McGinnis, Pelech et al. 2014). In addition to 
the kinase changes, the altered Ca2+-oscillations of IVO post hCG aged oocytes can also be 
caused by decreased intracellular ER Ca2+ stores and impaired Ca2+ uptake by Ca2+-ATPase 
(Funahashi, Cantley et al. 1994; Hao, Liu et al. 2009; Zhao, Liu et al. 2015), as well as 
down-regulated production of ATP content from mitochondrial oxidative phosphorylation (Day, 
Johnson et al. 1998). Most importantly, extended in vitro culture may influence the integrity of 
the actin cytoskeleton that affects the cycling of the transient receptor potential ion vanilloid 3 
channels (Lee, Yoon et al. 2016), and thus alter the Sr2+-induced Ca2+-pattern in IVO 
post-ovulatory aged oocytes. These channels are recently defined as the mediators of 
Sr2+-induced mouse oocyte activation (Carvacho, Lee et al. 2013). Moreover, the altered Ca2+ 
pattern is consisting with the studies in oocytes that were aged before fertilization (Takahashi, 
Takahashi et al. 2003; Takahashi, Igarashi et al. 2009).  
 
Disrupted Ca2+-homeostasis of in vivo aged oocytes is associated with the onset of apoptosis 
or programmed cell death upon fertilization (Gordo, Wu et al. 2000; Gordo, Kurokawa et al. 
2002). Our result showed that adequate blastocyst formation rates could be obtained within 24 
hours post-hCG/GVBD aged oocytes from both IVO and IVM groups. By extending the in vitro 
ageing procedure to 36 hours post-hCG/GVBD, a significantly higher percentage of 
degeneration was observed in both IVO and IVM groups, with 85% of IVO oocytes and 80% of 
IVM oocytes fragmenting/degenerating following activation. During in vitro ageing, the 
cytoplasmic factors that are crucial for successful embryogenesis (Schultz and Heyner 1992; 
Minami, Suzuki et al. 2007), genome remodelling (Torres-Padilla, Bannister et al. 2006), and 
DNA reparation (Genesca, Caballin et al. 1992) might be affected. The reduction of 
anti-apoptotic protein BCL2 during in vitro ageing might be contributing to the high percentage 
of oocyte fragmentation. (Takahashi et al. 2009). 
  
Interestingly, the Ca2+-pattern and embryonic development analysis demonstrated that IVM 
oocytes undergo more dramatic changes than IVO oocytes during in vitro ageing. We 
observed that an adequate embryonic development potential after parthenogenetic activation 
could only be obtained during a very narrow time window (20-24 hours post GVBD) after IVM, 
compared to fresh IVM oocytes. Moreover, all IVM groups exhibited significantly lower number 
of Ca2+-oscillations compared to IVO aged oocytes. The observed compromised capacity of 
IVM MII oocytes to be activated and undergo development, may due to the reduced capacity 
of IVM oocytes to incorporate, release and use Ca2+ efficiently (Igarashi, Takahashi et al. 2005). 
Additionally, IVM human and mouse oocytes showed significantly lower concentrations of 
mtDNA and ATP content (Zeng, Ren et al. 2007; Ge, Tollner et al. 2012), as well as increased 
incidence of disrupted organization of the cytoskeleton and spindle configuration (Sanfins, Lee 
et al. 2003). Changes in the spindle position and distribution of IVM oocytes, in addition to their 
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inability to efficiently import Ca2+ to the site of injury, will result in cell death as well 
(Ouadid-Ahidouch 1998). 
 
Oocytes from reproductive-aged individuals are associated with a decrease in number and 
quality of ovulated oocytes, and an increased percentage of abnormal or degenerating oocytes 
(Tarin, Perez-Albala et al. 2001), chromosomal aneuploidy (te Velde and Pearson 2002), and 
the injury of mitochondrial DNA (Keefe, Niven-Fairchild et al. 1995; Thouas, Trounson et al. 
2005; Tatone 2008). The intracellular Ca2+-oscillatory pattern was determined in 50-52 weeks 
old B6D2F1 mice in this study. Although the number of collected IVO MII oocytes was 5 times 
less from aged than young mice, we did not observe a higher number of abnormal or 
degenerated oocytes. The frequency of Ca2+-oscillations exhibited by IVO oocytes was 
comparable in both groups. Interestingly, the frequency of Ca2+-oscillations increased 
significantly in IVM oocytes from aged mice compared to young mice, with longer latency 
before showing the initial Ca2+-rises after parthenogenetic activation. The lower metabolic 
state of IVM and aged oocytes may contribute to this result, as it is known that the dynamics of 
Ca2+-oscillations are linked to the metabolic status of the oocyte (Lam and Galione 2013; 
Williams, Boyman et al. 2013). Upon low mitochondrial activation (FAD2+) and subsequent 
low mitochondrial ATP production via oxidative phosphorylation, the signal might be insufficient 
to start the initial Ca2+-oscillation immediately after the parthenogenetic activation (Keefe, 
Niven-Fairchild et al. 1995; Dumollard, Marangos et al. 2004). The slow response could also 
result from a deficient enzymatic activity, which generates not enough ATP for Ca2+-diffusing. 
IVM further aggravated the inability to incorporate Ca2+ signaling (Igarashi, Takahashi et al. 
2005). Following the first Ca2+ rise, a rapid refilling of the Ca2+-stores in the ER is observed, 
which is in accordance with the high frequency of Ca2+-rises in oocytes (Wakai, Zhang et al. 
2013). To verify the abnormalities of reproductive-aged oocytes, spindle-chromosomal 
alignment and aneuploidy, which are all closely related to ageing oocytes (Wakayama, Thuan 
et al. 2004; Mailhes 2008), further investigations are required.  
 
We conclude that distinct deregulation of Ca2+ signaling is existing in post-ovulatory aged and 
reproductive-aged oocytes during oocyte activation. Moreover, the abnormal Ca2+-pattern after 
parthenogenetic activation is related to the impaired embryonic developmental potential in 
post-ovulatory aged oocytes, but not in reproductive-aged oocytes. IVM oocytes showed an 
impaired Ca2+ oscillatory ability and subsequent embryo development potential, but only 
during a narrow time window following maturation to the MII stage. Further studies should be 
carried out to investigated the quality of the cytoskeletal structures as well as the Ca2+ 
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7.  General Discussion 
 
Oocyte maturation and activation is intrinsically linked to Ca2+ signaling. The precise pattern of 
Ca2+ oscillations are necessary for successful fertilization, but can exert long-term downstream 
effects on both gene expression and embryo development. From the experiments carried out 
in this thesis, we obtained a better understanding of the role of Ca2+ during oocyte maturation, 
activation and ageing. The deregulation of Ca2+ signaling during these three processes are 
shown to be associated with certain aspects of female related infertility.  
 
7.1 Ca2+ signaling alterations during oocyte meiotic maturation  
During IVM, oocyte maturation is accompanied by spontaneous Ca2+ fluctuations released 
through the IP3R1 at GVBD and are crucial for meiotic progression and subsequent successful 
fertilization (Carroll and Swann, 1992). In chapter 3, we utilized the LT/Sv mouse strain to 
investigate Ca2+ signaling of IVM oocytes. The female LT/Sv mice show a high number of 
immature oocytes following ovulation induction, most of which remain arrested at the MI stage 
(Eppig, 1978; Hupalowska et al., 2008). This meiotic arrest is very similar to those observed in 
human showing maturation resistant oocytes (Beall et al., 2010). We further found impaired 
Ca2+-signaling during IVM of LT/Sv GV oocytes, with lower frequencies and amplitudes. 
 
Although it could be expected that the phenotypes or mutations from mouse maturation 
resistant oocytes can differ to those seen in humans, we observed very similar results 
regrading nuclear maturation of LT/Sv mouse oocytes compared to oocytes obtained from 
patients with >40% immature oocytes at retrieval. We could not perform Ca2+ analysis during 
IVM of human maturation resistant oocytes due to the lack of available oocytes in these 
patients. The observed Ca2+ signaling abnormalities may serve as a potential diagnostic 
method to investigate the cytoplasmic competence of IVM oocytes from maturation resistant 
patients. The role of abnormal Ca2+ signaling in human maturation resistance requires further 
validation.  
 
Compared to the amount of freshly retrieved LT/Sv maturation resistant oocytes, we obtained 
a higher proportion of maturation resistant oocytes following the in vitro culture of LT/Sv 
oocytes from GV stage. Abnormalities in organelles and the cytoskeleton that may occur 
during IVM are possible causes for maturation resistance, fertilization failure and reduced 
developmental embryo development (Neri et al., 2014). In mammals, oocytes undergo a 
prolonged and carefully regulated developmental processes, as a result of instructive 
paracrine and junctional interactions with their surrounding somatic cells. This dialogue 
between oocyte and somatic cells allows for the exchange of many regulatory signals that 
control oocyte metabolism, cytoskeletal remodeling, cell cycle progression and fertilization, all 
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of which are key events for initiating and sustaining early embryogenesis (Baudat et al., 2013). 
In vivo, the immature GV stage oocyte maintains direct communication with the surrounding 
cumulus and granulosa cells through gap junctions, permitting heterologous metabolic and 
electrical coupling (Homa, 1995). Therefore, co-culture of the immature oocytes with cumulus 
cells and treatment with conventional IVF may be helpful for patients for which an abnormally 
high number of immature oocytes were retrieved. However, the clinical outcome of patients 
showing a high number of retrieved immature oocytes is largely unknown. 
 
Interestingly, IVM oocytes retrieved from young mice showed restored Ca2+ signaling during 
prolonged (4-8h) in vitro culture in contrast to fresh IVM oocytes (16h post GVBD) (observed in 
Chapter 6). An adequate capacity to generate Ca2+ signals to support embryonic development 
after parthenogenetic activation could be obtained only in a narrow window (20-24 hours post 
GVBD) during the IVM process in mouse. The compromised capacity of IVM MII oocytes may 
be due to the reduced ability of incorporating and generating Ca2+ (Igarashi et al., 2005) or due 
to declined concentrations of mitochondrial DNA and ATP content in IVM oocytes (Zeng et al., 
2007; Ge et al., 2012). Furthermore, the increased incidence of abnormal cytoskeleton 
organization and aberrant spindle configuration during IVM may also be attributed to these 
deficiencies (Sanfins et al., 2003).  
 
Several studies have demonstrated that GV nuclear or cytoplasmic transfer represent potential 
treatment techniques to alleviate oocyte meiosis arrest, as shown in the maturation resistant 
mouse model (Hoffmann et al., 2012) and to overcome defects in human oocyte maturation 
(Cohen et al., 1997; Zhang et al., 1999). Nuclear transfer has been successfully applied for the 
treatment of mitochondrial diseases in a mouse model (Neupane et al., 2014) and more 
recently has been also applied in human to overcome mitochondrial diseases or even for 
infertility purposes such as embryonic arrest (Craven et al., 2017). Therefore, nuclear transfer 
may serve as highly effective therapeutic approach for overcoming maturation resistance in 
the clinic. Certainly, in depth embryo developmental and safety studies are required prior to 
the clinical implementation of such treatments.  
 
7.2 Ca2+ signaling alterations and Ca2+ based AOA treatments during fertilization  
At fertilization, hyperactivated sperm release the sperm specific factor PLCζ. Downstream, 
PLCζ hydrolyzes PIP2 to form IP3 and thereby triggers Ca2+ release from the ER by binding to 
its receptor, IP3R (Swann and Lai, 2013; Kashir et al., 2014). The pattern of Ca2+ signaling at 
fertilization varies between species (Busa and Nuccitelli, 1985; Gillot and Whitaker, 1994), 
however, the total amount of intracellular Ca2+ must reach a crucial threshold for successful 
oocyte activation. Some human sperm is not able to activate human oocytes in vitro causing 
fertilization failure after ICSI. For example, globozoospermic sperm cells usually cannot 
activate mouse or human oocytes by the failure of inducing a normal Ca2+ oscillatory pattern 
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(Kashir et al., 2010). More recently, more patients were identified whose sperm show aberrant 
calcium patterns after injection into mouse or human oocytes (Vanden Meerschaut et al., 
2014). 
 
To diagnose sperm activation deficiency, mouse based assays are commonly used in patients 
experiencing ICSI failures (Rybouchkin et al., 1996; Heindryckx et al., 2005). The mouse 
oocyte activation test is an established diagnostic test performed in patients participating in our 
fertility program, prior to the application of AOA (Heindryckx et al., 2005; Vanden Meerschaut 
et al., 2012). It involves the injection of human sperm into mouse oocytes to determine sperm 
activation capacity (Rybouchkin et al., 1996). In certain cases, the sensitivity of the mouse 
model can be further enhanced with the inclusion of Ca2+ analysis of both mouse and human 
oocytes. From our unpublished data, we demonstrate that oocyte Ca2+ analysis is a novel 
strategy for establishing human sperm activation deficiencies in patients experiencing ICSI 
failures. ICSI-AOA restores the fertilization rate only in patients displaying abnormal Ca2+ 
oscillations during human oocyte activation.   
 
To date, the application of different AOA strategies to overcome fertilization failure after ICSI, 
has led to successful outcomes (Heindryckx et al., 2005, 2008; Kyono et al., 2009; Terada et 
al., 2009; Ebner et al., 2012; Kim et al., 2014b). The commonly used AOA agent ‘ionomycin’ is 
a membrane permeable Ca2+ ionophore, which acts by creating pores in plasm membranes. 
The different Ca2+ transit pattern of oocytes from different species may be due to varying 
permeability to ionomycin or the distinct activity of the ER localized Ca2+ channels. Ionomycin 
will first act on the plasma membrane triggering Ca2+ entry; it will then diffuse into the oocyte 
where it may also affect the ER, where it can lead to an additionally release of Ca2+. 
Alternatively, there may be Ca2+-induced Ca2+ release. Calcimycin (A23187) acts similarly 
during oocyte activation, but is less potent and specific than ionomycin at the same 
concentration in various species (Kauffman et al., 1980; Vasilev et al., 2012; Nikiforaki et al., 
2016).  
 
Currently, the non-standardization of protocols across laboratories and numerous variables 
affecting the procedure have also resulted in inconsistent data and reduced AOA efficiencies. 
In some instances the application of AOA protocols have in fact led to reduced fertilization and 
pregnancy rates, or a lack of improvement in outcomes when compared to routine ICSI 
(Borges  Jr. et al., 2009a, 2009b; Ebner et al., 2012; Montag et al., 2012). In Chapter 4, we 
showed that the use of suboptimal conditions during the application of AOA during a short time 
interval of ten minutes, had major effects on the subsequent oocyte activation rate and more 
importantly severely hampered subsequent embryonic development. The in vitro culture of the 
mouse oocytes exposed to different AOA conditions was performed in the same culture 
system (KSOM/Cook Blastocyst) in all the experimental groups. Therefore, the observed 
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effects on AOA can only be attributed to the varying conditions during this short timeframe of 
10 minutes.  
 
The availability of human oocytes for research is very low, the only sources of human oocytes 
for research are IVM oocytes or IVO oocytes with aggregates of SERs which are not clinically 
used in our center or failed fertilized oocytes after IVF/ICSI and cryopreserved oocytes, which 
cannot be used for the patient. Therefore, mouse models play an important role to elucidate 
the mechanism of Ca2+ signaling during the AOA processes. 
 
In these experiments, mouse oocytes were utilized. We used KSOM medium, the most 
commonly used culture medium for mouse embryos. We designed 1xCa to 6xCa KSOM 
medium to evaluate the influence of external Ca2+ on the altered Ca2+-transient pattern and 
subsequent embryonic developmental potential. In KSOM medium, all components are known, 
thus the observed changes should exclusively result from the altered concentrations of 
external Ca2+, instead of the previously mentioned components supplemented in the culture 
media. However, KSOM is not the optimal culture medium for culturing human oocytes. 
Therefore, we kept the same culture media for activating and culturing the human oocytes, 
which are routinely used in human IVF labs.  
 
We demonstrated that AOA efficiency is largely influenced by the external amount of Ca2+ and 
the type of AOA agent. Therefore, we encourage IVF laboratories to use more standardized 
protocols for AOA and account for the possible effects of parameters such as the culture 
media, and the type and concentration of the AOA chemicals used during the procedure. 
Moreover, the variability of other components amongst various culture media could also 
impact oocyte Ca2+ influx during activation (Morbeck et al., 2014a, 2017). For example, 
variations in the composition of protein supplements and the concentration of Magnesium ions 
in the medium has been shown to influence blastocyst developmental potential in mouse 
(Graeff et al., 1995; Morbeck et al., 2014b). Further investigations are required to verify the 
effect of all these components on Ca2+ influx potential, and their subsequent effects on 
fertilization rates and embryonic developmental potential. Furthermore, AOA efficiency using 
ionomycin in combination with different commercial IVF media in human oocytes requires 
further investigation. Different combinations and concentrations of activating agents with 
certain types of commercial media could impose a different effect on the Ca2+ influx pattern.  
 
Therefore, we recommend that fertility clinics applying AOA should take this into account. 
Currently, more standardized protocols that synchronize the crucial components used during 
AOA are warranted. Standardization and necessary diagnostic testing needs to be performed, 
for instance, for couples experiencing failed fertilization after ICSI. Both the mouse oocyte 
activation test and mouse oocyte Ca2+ analysis represent heterologous ICSI models to 
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distinguish sperm- from oocyte-related activation deficiencies (Rybouchkin et al., 1996; Araki 
et al., 2004; Heindryckx et al., 2005). Moreover, Ca2+ oscillatory patterns can be an alternative 
method to evaluate the efficiency of different AOA methods.  
 
In contrast to other artificial activation agents that induce a single Ca2+ transient of mammalian 
oocytes (Vanden Meerschaut et al., 2014; Nikiforaki et al., 2016), Sr2+ activates rodent eggs by 
inducing a series of Ca2+-like oscillations (Whittingham and Siracusa, 1978; Roh et al., 2003), 
which closely mimic the pattern of Ca2+ rises triggered by PLCζ at fertilization. To date, Sr2+ has 
also been applied as an AOA method to overcome fertilization failure or low fertilization rates 
(Kyono et al., 2008; Kim et al., 2012, 2014a). To enable activation in mouse oocytes following 
Sr2+ exposure, extracellular Sr2+ permeates through its functional membrane channel, TRPV3 
(Carvacho et al., 2013), promoting downstream oscillations in [Ca2+]i/[Sr2+] of the oocytes, 
likely by sensitizing IP3Rs and thus facilitating Ca2+ oscillations (Zhang et al., 2005), or 
substituting for Ca2+ in the potentiation of IP3Rs (Girard and Clapham, 1993; Marshall and 
Taylor, 1994; Lee, 2016). 
 
In Chapter 5, we demonstrated that Sr2+ was not capable of inducing any Ca2+ increase or 
provoking activation of human oocytes. This could be attributed to the inability of residues to 
conduct Sr2+ (Latorre et al., 2007), as well as the insensitivity of IP3R1 in responding to Sr2+ in 
human oocytes. However, Sr2+ application in clinics has overcome fertilization failure after ICSI, 
and consequently improved fertilization rates and embryo quality in couples with repetitive 
fertilization failure (Kyono et al., 2008; Chen et al., 2010), resulting in healthy live-births. The 
most likely explanation may be due to the lack of diagnostic methods used in such studies and 
thus the inability to show a true sperm-related activation deficiency in reports claiming to 
overcome failed fertilization by AOA with Sr2+ (Kyono et al., 2008; Chen et al., 2010; Kim et al., 
2014a).  
 
Although the TRPV3 protein, expressed in human oocytes was shown to be functional in 
supporting agonists that triggered Ca2+ rise and oocyte activation in both mouse and human 
oocytes, oocytes failed to conduct Sr2+ influx or the conducted Sr2+ was not sufficient to 
promote Ca2+ release from the ER. In view of improving the efficiency of activating rodent 
oocytes, 2-APB was suggested as a potential AOA agent targeting the TRPV3 channels (Lee, 
2016; Lee et al., 2016). However, in our view, it is premature to encourage this at the moment, 
as both 2-APB and carvacrol activates multiple Ca2+ related channels (Bilmen and 
Michelangeli, 2002; Bilmen et al., 2002; Colton and Zhu, 2007; Pires et al., 2015) and the 
exact mechanism remains largely unclear. Moreover, 2-APB mediated Ca2+ influx originates 





7.3  Ca2+ signaling deregulation and potential interventions in ageing oocytes  
Oocyte ageing is the major determinant of developmental competence in embryos. The oocyte 
delivers half the chromosomal complement, but provides all the mitochondria DNA to the 
embryo. Therefore, maternal mitochondrial DNA may correlate to aging. Mice exhibit 
age-associated reproductive senescence in a similar manner as humans. Moreover, 
Ca2+-signaling is deregulated in post-ovulatory aged oocytes at fertilization, showing higher 
frequency and lower amplitude of the released Ca2+ patterns (Kolker et al., 2003; Takahashi et 
al., 2009a). As such, instead of supporting normal embryonic development, these oocytes 
activate apoptosis, fragmentation, and cell death pathways (Gordo et al., 2002; Takahashi et 
al., 2009a).  
 
During reproductive ageing, oocytes are exhibiting a decrease in number and quality of 
ovulated oocytes, with a concomitant increased percentage of abnormal or degenerating 
oocytes (Tarín et al., 1999), chromosomal aneuploidy (te Velde and Pearson, n.d.), and injury 
in the mitochondrial DNA (Keefe et al., 1995; Thouas et al., 2005). Concordantly, we obtained 
a significantly lower number (five times less) of oocytes in 50-52 weeks old B6D2F1 mice 
compared to controls. The retrieved IVO oocytes exhibited a similar frequency of 
Ca2+-oscillations as observed in young mice. However, the frequency of Ca2+-oscillations 
increased significantly in IVM oocytes from aged mice compared to young mice, with longer 
latency before the initial Ca2+-rises during parthenogenetic activation. Low mitochondrial 
activation (FAD2+) and subsequent low mitochondrial ATP production via oxidative 
phosphorylation may be insufficient to start the initial Ca2+-oscillation immediately after 
parthenogenetic activation (Keefe et al., 1995; Dumollard et al., 2004). The lack of enzyme 
activity to produce ATP could therefore impair Ca2+ flux. Interestingly, once the Ca2+ oscillatory 
ability has been restored in IVM oocytes from aged mice, rapid refilling of Ca2+-stores occurs, 
as observed in fresh young oocytes and in accordance with the observed high frequency of 
Ca2+-rises in reproductive-aged oocytes (Wakai et al., 2013).  
 
Impaired Ca2+ signaling did not lead to defective embryo development in reproductive-aged 
oocytes. An adequate embryo development rate was observed in these oocytes following 
parthenogenetic activation, compared to controls. Mouse oocytes may be more tolerant to 
ageing-related errors than their human counterparts. It has also been reported that inhibiting or 
stimulating the natural pattern of Ca2+-signaling of inseminated eggs has long-term effects on 
both gene expression and development to term, although the development to the blastocyst 
stage was not altered (Ozil et al., 2006). Therefore, more human samples need to be 
investigated in order to understand the phenotypic variation and physiological consequences 
of reproductive and post-ovulatory ageing. Polar body genetic screening may provide a 
window into the oocyte's genome and telomeres, which might improve prediction of the 




Oocyte-transmitted mitochondrial DNA is known to be especially susceptible to aging. 
Therefore, we used low oxygen tension (5%) for the in vitro culture of oocytes and embryos. 
Exposure to high oxygen concentration may lead to high ROS generation and compromises 
embryonic developmental activity (Bavister, 2004). In the in vitro aged groups, we found 
increased frequency and decreased RA in post-ovulatory aged IVO oocytes, as reported 
previously (Takahashi et al., 2009b). Prolonged culture prior to activation resulted in global 
changes in the abundance and activity of protein kinases that regulate the response to Ca2+, 
stress, and cell-cycle control (MCGinnis et al., 2014). In addition to the kinase changes, 
decreased [Ca2+]ER and impaired Ca2+ uptake by SERCA (Funahashi et al., 1994; Hao et al., 
2009; Zhao et al., 2015), as well as down-regulated ATP production from mitochondrial 
oxidative phosphorylation (Day et al., 1998), could also contribute to the observed Ca2+ 
signaling alterations. The Ca2+ transport during a Ca2+ rise requires the action of the SERCA, 
PMCA, as well as the Na+/Ca2+ exchanger (Berridge et al., 2000; Bootman et al., 2001).  
 
As we demonstrated distinctive Ca2+ patterns observed in two types of aged oocytes following 
parthenogenetic activation, cytoplasmic alterations may be different between 
reproductive-aged and post-ovulatory aged oocytes. Therefore, the etiologies and potential 
therapeutic approaches may also differ in these two types of aged oocytes. Reproductive 
ageing may occur as a result of inadequate ovarian angiogenesis in primordial follicles as well 
as in ovarian stroma vessels (Tatone, 2008). Hence, the activation of ovarian angiogenesis 
could be a new strategy for the improvement of the age-related decline of oocyte quality 
(Navot et al., 1991). For post-ovulatory aged oocytes, caffeine treatment represents a potential 
therapeutic method. Applying 10mM caffeine to ageing bovine (Lee and Campbell, 2008), 
porcine and mouse oocytes (Iwamoto et al., 2005), prevents the decline in MPF and MAPK 
activities and maintains normal meiotic spindle morphology (Ono et al., 2011). Given the 
importance of Ca2+ in oocyte aging, further investigation is necessary, to develop therapeutic 
approaches for re-establishing normal Ca2+ signals in aged oocytes.  
 
In summary, repetitive maturation resistance, failed fertilization and oocyte/maternal ageing 
represent certain types of infertility which are still challenging to overcome using currently 
available techniques (Bar-Ami et al., 1994; Avrech et al., 1997; Beall et al., 2010; Heindryckx 
et al., 2011). In this study, we demonstrated that these three processes are all associated with 
altered Ca2+ signaling. Our findings highlight plausible avenues for future diagnostic and 











































7. Future Perspectives 
 
The significantly high percentage of nuclear abnormalities observed in oocytes obtained from 
aged patients and patients presenting with >40% immature oocytes at retrieval has hindered 
the clinical use of IVO and IVM oocytes as a potential treatment. Currently, no curative 
methods are available for such cases in the clinic. The prevalence of patients showing 
maturation resistance, fertilization failure and ageing is increasing, and therefore the need for 
accurate diagnostic and therapeutic approaches is becoming more prominent.  
 
8.1 Ca2+ signaling analysis may be a potential diagnostic approach for ART failures 
We performed Ca2+ analysis in maturation resistant and ageing oocytes. The observed 
defective Ca2+-signaling of LT/Sv mouse maturation resistant oocytes at GVBD and during 
activation, sheds light on the physiological mechanism of human maturation resistant oocytes. 
This may allow for more effective diagnostic approaches in the future, such as the analysis of 
spontaneously released Ca2+ patterns in human immature oocytes during GVBD. We further 
establish variations in the Ca2+-oscillatory pattern in reproductive-aged and post-ovulatory 
aged oocytes, which pointed to diverse cytoplasmic alterations. As such, our findings may 
guide the discovery of future therapeutic targets, specific for certain types of ageing oocytes. 
For instance, the IP3R1 sensitizer may only be suitable in post-ovulatory aged oocytes, for 
restoring Ca2+ conductance. Furthermore, Ca2+ analysis may also be performed to evaluate 
the efficiency of potential therapeutic approaches. Correct Ca2+ signaling serves a crucial role 
in the completion of meiosis and initiation of embryo development. Therefore, re-establishing 
normal Ca2+ oscillatory patterns during meiosis maturation or oocyte activation may be a way 
to overcome maturation resistance and oocyte aging. In this regard, Ca2+ permeable channels 
ROC, TRPV and SOCE, SERCA, PMCA pathways may present potential targets.  
 
To date, diagnostic methods such as the mouse oocyte activation test and mouse Ca2+ 
analysis have been effectively used to establish sperm-related oocyte activation failure 
(Vanden Meerschaut et al., 2014). Following diagnosis, AOA methods are commonly applied 
to overcome fertilization failure. As the Ca2+ pattern of mouse oocytes may be influenced by 
external factors, such as components within the culture medium, evaluating the effect of such 
parameters on embryo development in mice may represents a suitable methodology for 
studying the influence of commercial culture media on human oocytes. However, as observed 
in our study, mouse oocytes are more sensitive to the effects of the surrounding environment 
compared to human oocytes; the value of mouse embryo tests to adequately reflect 





8.2 GV transfer represents a therapeutic approach for maturation resistant and ageing 
oocytes 
In the limelight of growing concern over the cytoplasmic etiology of maturation resistance and 
oocyte ageing, nuclear transfer at the GV stage seems to be a possible therapeutic approach, 
currently with the most promise. Several attempts have been made to apply this form of 
nuclear transfer in maturation resistant oocytes from mouse models, with only one study 
succeeding in obtaining matured MII mouse oocytes following GV transfer (Hoffmann et al., 
2012). The authors reported that transferring the GV nucleus from LT/Sv oocytes into 
enucleated oocytes from OF1 wild-type mice resulted in 70% (24/33) of MI oocytes transiting 
to the MII stage (Hoffmann et al., 2012). Furthermore, reconstructed xeno-oocytes containing 
a human GV nucleus and mouse cytoplasm obtained via GV transfer, demonstrated full 
maturation capacity (Zhang and Liu, 2015). This further demonstrates the possibility of 
re-establishing meiotic capacity by replacing the cytoplasm in maturation resistant oocytes.  
 
Furthermore, in the field of human reproductive aging, GV transfer has been successful in 
preventing oocyte aneuploidy, commonly caused by ooplasmic dysfunction (Takeuchi et al., 
1999, 2001; Eichenlaub-Ritter et al., 2004). By transferring GV nuclei of aged donors (>38 
years) into the cytoplasm of enucleated oocytes of young donors (<31 years), 58% of the 
reconstructed oocytes completed meiosis, with 80% of these showing normal ploidy (Zhang et 
al., 1999). Interestingly, Takeuchi et al. further demonstrated the potential capacity of 
reconstructed aged/young human oocytes to progress to the early cleavage stage of 
development (Takeuchi et al., 2001). Our group also previously performed GV nuclear transfer 
(Neupane et al., 20??). However, the inability of the reconstructed mouse oocytes to develop 
into blastocysts following the intervention, limits the suitability of this approach and requires 
further optimization of the IVM process. Although highly abnormal spindle-chromosome 
configurations have been observed in both aged and maturation resistant oocytes in human 
patients and in the mouse model, the possibility of spindle transfer and PN transfer also 
requires further assessment. Moreover, further investigations into the underlying mechanisms 
providing the healthy cytoplasm the ability to correct spindle and nuclear abnormalities are 
also of great interest. 
 
Nuclear transfer in both unfertilized oocytes and fertilized zygotes has shown promising results 
in mouse models, non-human primates and in humans (Craven et al., 2017). Moreover, 
offspring born from non-human primates and mice after nuclear transfer has been shown to be 
normal and healthy (Craven et al., 2017). Nuclear or cytoplasmic/mitochondrial transfer 
appear to be the most promising therapies in replacing the cytoplasmic origin of maturation 
resistance or minimizing the amount of aged mitochondrial DNA carryover. However, these 
techniques are still under investigation and require further validation in animal models before 
being applied for clinical trials in humans. Irrespective of the donor, ethical questions regarding 
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the involvement of the third set of (mitochondrial) DNA have also been raised and require 
further discussion. But currently, mitochondrial DNA copy number can be applied as a 
biomarker to identify high quality euploid embryos resulting from aged oocytes, with an aim to 
improve pregnancy outcomes.  
 
8.3 Genetic analysis will likely benefit ART failures  
Intensive knock-out studies in maturation resistance mouse models and gene screenings in 
human maturation resistant patients, have recently established seven mutations associated 
with MI arrest involving the candidate gene, TUBB8 (Feng et al., 2016; Chen et al., 2017; 
Huang et al., 2017). This gene accounts for almost all expressed β-tubulin within the oocyte. 
The mutations affect α/β-tubulin heterodimer assembly and microtubule dynamics and thus 
result in spindle-assembly defects and maturation arrest, in human oocytes (Feng et al., 2016; 
Chen et al., 2017; Huang et al., 2017). Therefore, specific gene modifications or mRNA 
interference are also a potential approach in diagnosing and treating such defects. Although 
promising, prior to applications in human, such interventions require comprehensive follow-up, 
both after fertilization and throughout the life of the offspring, to ensure their safety. 
  
As part of this PhD research, we further described the difference between the Ca2+ oscillatory 
pattern in oocytes following reproductive aging and post-ovulatory aging. 
Aneuploidy screening by fluorescence in situ hybridization may reveal a deeper view of the 
ageing mechanism and provide possible therapies. In the clinic, several interventions that 
reduce oxidative stress and increase the proportion of euploid embryos have resulted in viable 
deliveries (Meldrum et al., 2016). Newer interventions, such as CoQ10 or gene modification 
are emerging and promisingly improving age related dysfunctions (Meldrum et al., 2016). 
Nevertheless, the benefits of these interventions on oocyte ageing require further 
investigation.  
 
Exposure of oocytes to suboptimal culture conditions during the crucial activation phase (AOA), 
even during a very short time interval of 10min, not only has detrimental effects on oocyte 
activation, but also hampers downstream processes such as embryonic developmental 
potential. Here, we demonstrate the effects of external Ca2+ concentration, following the 
application of the most well-established AOA techniques. However, the impact of varied 
concentrations of other components in commercial human embryo culture media requires 
further investigation, examples include Mg2+, Zn2+ and EDTA. Moreover, evaluating genetic 
profiles of oocytes or early stage embryos following different AOA protocols may aid in further 
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